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Mitochondrial retrograde signalling communicates the functional status of mitochondria 
to the cell by regulating nuclear gene transcription. Mitochondrial dysfunction is strongly 
associated with several neurodegenerative diseases, but little is known about 
mitochondrial retrograde signalling in the nervous system. Mitochondria and the 
endoplasmic reticulum (ER) share physical and functional links, but the impact of 
mitochondrial dysfunction on ER biology has been underexplored. In this thesis, I 
harnessed the array of genetic and functional tools available in the fruit fly, Drosophila 
melanogaster, to investigate mitochondrial retrograde signalling via the ER in the nervous 
system.  
I employed overexpression of mitochondrial transcription factor A (TFAM) as a 
model of mitochondrial dysfunction. The mitochondrial network was fragmented in the 
cell bodies of motor neurons overexpressing TFAM, and the morphology of the ER was 
also changed. There was an increase in the number of candidate ER-mitochondrial contact 
sites. Mitochondrial Ca2+ levels were substantially increased by TFAM overexpression, 
as were the levels of cytosolic Ca2+ in stimulated neurons. 
Mitochondrial dysfunction activated the ER stress signalling pathway, the 
unfolded protein response (UPR), in Drosophila motor neurons. Genetic manipulation of 
the UPR revealed that multiple components modify the function of Drosophila motor 
neurons with mitochondrial dysfunction. In particular, knock-down of the UPR 
transcription factors ATF4, XBP1 and ATF6 suppressed the neuronal functional 
impairments caused by mitochondrial dysfunction. 
Characterisation of the transcriptional response to mitochondrial dysfunction 
suggested that ATF4 is a key regulator of retrograde signalling in the Drosophila nervous 
system; 58% of genes that were significantly regulated by TFAM overexpression, were 
similarly regulated by overexpression of ATF4. Knock-down of ATF4 in conjunction 
with TFAM overexpression reversed the transcriptional changes caused by TFAM 
overexpression for 30% of genes. Therefore, I have established that the ER UPR is a 
mitochondrial retrograde signalling pathway in Drosophila neurons, and importantly, that 
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Mitochondria are bimembraneous subcellular organelles that produce the majority of 
cellular ATP, and also play key roles in calcium (Ca2+) homeostasis, lipid synthesis and 
intracellular signalling pathways. 
 
1.1.1 Origins and discovery 
 
Mitochondria or their vestiges are found in all eukaryotes (Hampl, Silberman et al. 2008), 
and are thought to be derived from an α-proteobacteria (Yang, Oyaizu et al. 1985) that 
was endocytosed by a host cell at least 1.45 billion years ago (Javaux, Knoll et al. 2001) 
in a symbiotic act. The identity of the host cell is debated and intimately entwined with 
attempts to understand the domains of life (reviewed in (Williams and Embley 2014)), 
but is thought to be an archaebacteria (Kelly, Wickstead et al. 2011, Williams, Foster et 
al. 2012). Mitochondria are social entities that make physical and functional contacts with 
many other subcellular organelles, including the endoplasmic reticulum (Vance 1990), 
lysosomes (Wong, Ysselstein et al. 2018), and peroxisomes (Mattiazzi Ušaj, Brložnik et 
al. 2015). An alternative to the standard theory of endosymbiotic evolution proposes that 
extrusions of the archaebacterial membrane progressively surrounded a city of 
α-proteobacteria until finally closing around them (Fig. 1.1) (Baum and Baum 2014). This 
‘inside-out’ sequence of events would explain the creation of the extensive 
endomembrane system and inter-organellar contacts within the eukaryotic cell that are 
not explained by the simple mechanism of endocytosis. 
 Mitochondria were first discovered as intracellular granules by 19th century 
microscopists, but remained without designation until 1890 when histologist Richard 
Altmann noted their ubiquity and, with immense foresight, proposed that they were 
‘elementary organisms’ with metabolic and genetic roles, colonising a host cell (reviewed 
in (Ernster and Schatz 1981)). Intensive work over the intervening years has established 








1.1.2 Energy production pathways in mitochondria 
 
Mitochondria have two membranes. The outer mitochondrial membrane (OMM) 
separates the organelle from the cytosol, whilst the inner mitochondrial membrane (IMM) 
divides the mitochondria into two major compartments; the matrix and the intermembrane 
space. The IMM is configured in a series of folds, termed cristae (Palade 1953). 
Three major metabolic pathways are situated within the mitochondria generating 
the bulk of cellular energy; fatty acid oxidation supplies acetyl-CoA for the Krebs (Citric 
acid cycle), and both pathways generate reduced co-factors (NADH and FADH2) for the 
production of ATP via oxidative phosphorylation. The oxidation of fatty acids and the 
Krebs cycle occur in the mitochondrial matrix (with the exception of succinate oxidation, 
see below), whilst the enzyme complexes mediating oxidative phosphorylation are found 
in the IMM. 
Figure 1.1 Schematic of the ‘inside-out’ theory of eukaryotic cell origin. Adapted from 
(Baum and Baum 2014). 
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1.1.2.1 Fatty acid oxidation and the Krebs cycle (Citric acid cycle) 
 
Activated fatty acids are transported into mitochondria via the carnitine shuttle. Once 
inside the matrix, a series of enzymatic reactions add a ketone group to the β carbon and 
the fatty acid chain is cleaved between the α and β carbons, producing two-carbon units 
in the form of acetyl-CoA (discovery milestones reviewed in (Ghisla 2004)). 
Elucidation of the molecular mechanisms by which aerobic respiration produces 
CO2 represents one of the scientific achievements of the 20
th century. In a series of papers 
in 1937-8 (Krebs 1937, Krebs and Johnson 1937, Krebs, Salvin et al. 1938), Hans Krebs 
and collaborators outlined eight reactions (Fig. 1.2), beginning and ending with citrate, 
that oxidise the two-carbon acetyl-CoA, generating CO2, NADH, and GTP. 
In the first three steps of the reaction, citrate is oxidised to succinyl-CoA with the 
release of two CO2 molecules. Succinyl-CoA is hydrolysed to succinate, which is then 
oxidised by Complex II (succinate dehydrogenase) of the ETC (see 1.1.2.2), reducing 
FAD to FADH2 and forming fumarate. The following two steps create oxaloacetate, 
which in the last step condenses with acetyl-CoA to reform citrate. 
In 1949, Kennedy and Lehninger demonstrated that the enzymes of the Krebs 
cycle reside within the mitochondria (Kennedy and Lehninger 1949).  
 
Figure 1.2 Reactions of the Krebs cycle occurring within the mitochondrial matrix. 
Adapted from (Raimundo, Baysal et al. 2011). 
18 
 
1.1.2.2 Oxidative phosphorylation (OXPHOS) 
 
Mitochondria generate the majority of cellular ATP via a process termed oxidative 
phosphorylation (OXPHOS). Four protein complexes embedded within the IMM oxidise 
the NADH and FADH2 produced by the Krebs cycle, glycolysis (in the cytosol) and fatty 
acid oxidation, and convey the electrons to acceptors of progressively increased reduction 
potential in a series of steps known as the electron transport chain (ETC) (Fig. 1.3). In the 
final step, two electrons are donated to oxygen (1/2 O2), reducing it to H2O. The free 
energy released by the ETC is used to pump protons from the matrix into the 
intermembrane space, creating a chemiosmotic H+ gradient across the IMM. This gradient 
is used to drive the synthesis of ATP from ADP by a fifth protein complex. 
The concept that proton pumping could be coupled to phosphorylation was first 
mooted in 1950 (Davies and Ogston 1950), but not followed up until Peter Mitchell 
proposed his chemiosmotic hypothesis in 1961 (Mitchell 1961). Much subsequent 
theoretical and experimental work, particularly from the laboratories of Paul Boyer and 
Efraim Racker, led to the mainstream acceptance of the chemiosmotic hypothesis by the 
mid-1970s (reviewed in (Ernster and Schatz 1981)).  
Complex I (NADH:ubiquinone oxidoreductase) of the ETC is a multi-subunit 
L-shaped protein complex which accepts electrons from the reduced NADH (+ H+) 
generated by the Krebs cycle and glycolysis, and donates them to the mobile electron 
carrier ubiquinone (Q). NADH binds the peripheral (matrix) arm of the Complex I, where 
it is oxidised by the prosthetic flavin mononucleotide (FMN). Single electrons are 
subsequently transferred from FMNH2 through a series of iron-sulfur clusters, eventually 
reducing ubiquinone to ubiquinol (QH2) via its semiquinone state (Q
.-). The membrane 
arm of Complex I translocates four protons across the IMM. Structural analyses of  
Complex I indicate that proton pumping occurs via four Na+/H+ antiporter homologues, 
that are activated by conformational changes caused by the reduction of ubiquinone and 
the stabilisation of the semiquinone state (reviewed in (Wirth, Brandt et al. 2016)). 
 QH2 shuttles through the membrane to Complex III (ubiquinol-cytochrome c 
oxidoreductase) where is reoxidised via the Q cycle with the concomitant transfer of four 
protons into the intermembrane space and reduction of cytochrome c. Complex III has 
single binding sites for QH2 (site Qo) and Q (site Qi). Binding of QH2 to Qo is via hydrogen 
bonds to an Rieske iron-sulfur cluster and cytochrome b1 located within Complex III. 





to cytochrome c via the Rieske iron-sulfur cluster, whilst the other passes to cytochrome 
b1, and thence onto Q bound at Qi, creating semiquinone, Q
.-. The newly oxidised Q, 
leaves Qo, whilst the protons involved in the hydrogen bonding of QH2 at Qo are released 
into the intermembrane space. A second turn of the Q cycle oxidises another molecule of 
QH2 at Qo and reduces the Q
.- at Qi to QH2, with the simultaneous uptake of two protons 
from the matrix. QH2 then leaves Qi and is free to reenter the Q cycle at Qo. The Q cycle 
was first proposed by Peter Mitchell (Mitchell 1976). Experimental evidence in support 
of the mechanism is reviewed in (Slater 1983). 
Cytochrome c is mobile in the membrane, and is oxidised by Complex IV 
(cytochrome c oxidase). The energy released is used to pump four more electrons (per 
two molecules of NADH oxidised at Complex I) across the IMM. Electrons from 
cytochrome c molecules are transferred across Complex IV via a cytochrome a-copper 
centre, and transferred to O2 with the simultaneous uptake of four protons from the matrix 
to form 2H2O ((Iwata, Ostermeier et al. 1995, Tsukihara, Aoyama et al. 1995) and 
reviewed in (Yoshikawa, Muramoto et al. 2011)). 
Electrons can also enter the ETC via Complex II. In this reaction, succinate is 
oxidised by the Complex II FAD cofactor, and the electrons pass through a series of 
iron-sulfur clusters before reducing ubiquinone (which can then be re-oxidised by 
Complex III) (Yankovskaya, Horsefield et al. 2003). The difference in reduction potential 
between Complex II and ubiquinone is small, and therefore insufficient free energy is 
generated by the oxidation of succinate to pump protons into the intermembrane space.  




The combined affect of Complexes I-IV is therefore to generate a electrochemical 
proton gradient across the IMM, the membrane potential component of which is ~140 mV 
in healthy mammalian mitochondria (Gerencser, Chinopoulos et al. 2012). Dissipation of 
the proton gradient ‘across’ Complex V, drives the synthesis of ATP from ADP.   
Complex V (ATP synthase) is a composed of two subunits; the FO subunit is 
situated within the IMM, and the F1 subunit protrudes into the matrix. The ‘flow’ of 
protons back across the IMM drives rotation of the FO subunit within the IMM which 
creates the conformational changes necessary in the F1 subunit for the synthesis of ATP. 
The first crystal structure of ATP synthase was determined in the lab of John Walker 
(Abrahams, Leslie et al. 1994). 
ATP exits the mitochondria via the ADP/ATP transporter, which catalyses the 
export of one ATP molecule, coupled to the import of one ADP molecule (Pebay-
Peyroula, Dahout-Gonzalez et al. 2003). 
 
1.1.2.2.1 Generation of reactive oxygen species (ROS) 
 
Early in the biochemical characterisation of mitochondria it was discovered that the 
organelle could produce the reactive oxygen species (ROS) hydrogen peroxide (H2O2) 
(Hinkle, Butow et al. 1967). Subsequent investigation established that complexes of the 
ETC can produce the ROS superoxide (O2
.-) by transferring an electron to O2 (Loschen, 
Azzi et al. 1974). O2
.- is rapidly converted to H2O2 by an intra-mitochondrial superoxide 
dismutase (SOD) (Weisiger and Fridovich 1973), which therefore acts as an O2
.- sink, 
favouring the production of further O2
.- from O2. Abnormal ROS production can lead to 
oxidative stress-induced tissue damage, and is associated with disease, including a wide 
range of neurodegenerative conditions (reviewed in (Manoharan, Guillemin et al. 2016)). 
Complex I produces the majority of mitochondrial O2
.-, via two mechanisms. 
When the matrix NADH/NAD+ ratio is high - driving electron transfer to the FMN co-
factor in Complex I  - but the production of ATP is low, electrons ‘back up’ onto FMN, 
from where they can be transferred to O2, creating O2
.-. When ATP production is low, but 
the electrochemical gradient (proton motive force) high, electrons are forced backwards 
along the ETC and transferred from Q to Complex I. The site of electron transfer from 
Complex I to O2 has not been definitively established, but is likely to be either or both 
FMN or the Q binding site within the IMM. The rate of O2
.- production is determined by 
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the matrix concentration of O2 and the proportion of reduced electron carriers available 
for reaction with O2 (reviewed in (Murphy 2009)).  
Both Complex II (Quinlan, Orr et al. 2012) and Complex III (Cadenas, Boveris et 
al. 1977) can also produce ROS.  
 
1.1.3 Mitochondria structure and function  
 
With the exception of erythrocytes, all mammlian cells contain mitochondria. The area 
and density of mitochondria in eukaryotic cells varies immensely, and is not always 
correlated with energy demand (Veltri, Espiritu et al. 1990). 
 
1.1.3.1 Composition and permeability of mitochondrial membranes 
 
The IMM and OMM present different barriers to the transfer of ions and proteins from 
the cytosol. The OMM is permeable to charged and neutral species ≤ ~5 kDa (Parsons, 
Williams et al. 1966) via the abundant voltage-dependent anion channel (VDAC) (also 
known as porin) (Colombini 1979, Zalman, Nikaido et al. 1980). The IMM is permeable 
only to uncharged molecules ≤ ~100-150 Da (Klingenberg and Pfaff 1966), and the 
passage of ions across the IMM requires the activity of specific channels. Proteins 
translated in the cytosol are canonically targeted to the mitochondrial compartments by 
N-terminal (matrix) and internal (IMM, OMM and intermembrane space) amino acid 
sequences, and are transported across the IMM and OMM by separately regulated 
complexes known as the translocase of the outer membrane (TOM) and translocase of the 
inner membrane (TIM) (reviewed in (Wiedemann and Pfanner 2017)). The activity of 
TIM requires the mitochondrial membrane potential (Gasser, Daum et al. 1982).  
In common with other eukaryotic membranes, the bilayer-forming lipid 
phosphatidylcholine (PC) is a substantial element of both mitochondrial membranes, 
constituting ~41-49% of the total lipid content (Vance 2015). In line with 
α-proteobacterial origins, phosphatidylethanolamine (PE) is enriched in the 
mitochondria, whilst cardiolipin (CL) is unique to the organelle (Marinetti, Erbland et al. 
1958, Getz, Bartley et al. 1968, Tian, Feng et al. 2012). Both lipids have small headgroups 
that give them a wedge shape, thought to assist the shaping of mitochondrial cristae 
(reviewed in (Rampelt, Zerbes et al. 2017)). In yeast, PE and CL are synthetic lethal – the 
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organism cannot survive without both (Gohil, Thompson et al. 2005). They are enriched 
in the IMM where they interact with multiple proteins and have important roles in ETC 
activity. CL is essential for the proper function and stability of Complex III (Yu and Yu 
1980), Complex IV (Robinson, Zborowski et al. 1990) and Complex V (Smith Eble, 
Coleman et al. 1990), in addition to stabilising supercomplex assemblies of the ETC 
proteins (Pfeiffer, Gohil et al. 2003). The headgroup of CL can buffer protons and has 
been proposed to function as a ‘proton trap’ for OXPHOS; maintaining the pH of the 
intermembrane space within a tolerable window, whilst supplying protons to, or 
absorbing them from, the ETC complexes and Complex V (Haines and Dencher 2002). 
PE is required for full activity of Complexes I and IV (Tasseva, Bai et al. 2013), and has 
disputed roles in supercomplex formation (Bottinger, Horvath et al. 2012, Tasseva, Bai 
et al. 2013). Both lipids have extensive and specific regulatory roles in mitochondrial 
protein import that go beyond maintaining mitochondrial membrane potential via the 
ETC (reviewed in (Bottinger, Ellenrieder et al. 2016)). 
 
1.1.3.2 Mitochondrial DNA (mtDNA) 
 
Mitochondria contain a double-stranded circular genome (mtDNA) (Nass and 
Nass 1963, Nass 1966, Van Bruggen, Borst et al. 1966) enclosed by the IMM, and 
composed of light (C-rich) and heavy (G-rich) strands. In humans, mtDNA is 
approximately 16.5 kb, and encodes 13 polypeptide subunits of the OXPHOS complexes, 
2 rRNAs and 22 tRNAs (Anderson, Bankier et al. 1981). Drosophila mtDNA encodes the 
same array of genes, and is approximately 19.5 kb in size (Lewis, Farr et al. 1995). 
mtDNA is transcribed polycistronically (Aloni and Attardi 1971, Ojala, Montoya et al. 
1981) by a mitochondrial-specific RNA polymerase, POLRMT (Greenleaf, Kelly et al. 
1986, Tiranti, Savoia et al. 1997). mtDNA replication is performed by a DNA polymerase 
and accessory factors specific to the mitochondria (reviewed in (Holt and Reyes 2012)). 
Transcription of mtDNA occurs from two promoters, the light strand promoter (LSP) and 
the heavy strand promoter (HSP) (Montoya, Christianson et al. 1982). The presence of 
just two transcription factors, mitochondrial transcription factor A (TFAM) and 
mitochondrial transcription factor B2 (TFB2M) is sufficient for POLRMT initiation 
(Litonin, Sologub et al. 2010, Ramachandran, Basu et al. 2017). TFAM and TFBM2 bind 
to LSP and HSP, separate the mtDNA strands by inducing bends and recruit POLRMT 
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(Ramachandran, Basu et al. 2017). The transcribed mtDNA is translated by mitochondria-
specific ribosomes (O'Brien 1971). 
TFAM is a ~25 kDa protein with DNA-binding high mobility group (HMG) 
domains (Fig. 1.4 A) (Fisher and Clayton 1988, Fisher, Lisowsky et al. 1992, Parisi, Xu 
et al. 1993). mtDNA is packaged into protein-nucleic acid complexes termed nucleoids 
(Nass 1969). A role for mammalian TFAM in mtDNA packaging was initially inferred 
by its colocalisation and co-purification with nucleoids (Garrido, Griparic et al. 2003, 
Istiaq Alam, Kanki et al. 2003) and ability to bend DNA (Fisher, Lisowsky et al. 1992). 
Subsequently, it has been demonstrated that TFAM is the only protein required for 
compaction of mammalian mtDNA into nucleoids (Kaufman, Durisic et al. 2007, Kukat, 
Davies et al. 2015), however the mechanism and mtDNA content of the nucleoids are 
disputed. In agreement with previous studies (Iborra, Kimura et al. 2004, Legros, Malka 
et al. 2004), Kaufman et al. reported multiple mtDNA molecules in a single nucleoid, and 
proposed that mtDNA was condensed via the creation of loops that were progressively 
filled in by other TFAM molecules (Fig. 1.4 B) (Kaufman, Durisic et al. 2007). By 
contrast, Kukat et al. described single mtDNA copies per nucleoid, and a mechanism 
whereby TFAM bends the mtDNA, bringing regions of the circle into close apposition 
and facilitating cross-strand binding (Fig. 1.4 C)  (Kukat, Davies et al. 2015). 

























Figure 1.4 Structure of TFAM and models of mtDNA condensation by TFAM. (A) 
Electrostatic surface potential plots of TFAM inferred from 2.5 Å crystal structure. 
Yellow = mtDNA binding surfaces. Blue = positive potential, red = negative potential. 
From (Ngo, Kaiser et al. 2011) (B) Loop filling model of TFAM condensation of 
mtDNA by (Kaufman, Durisic et al. 2007). (C) Cross-strand binding model of TFAM 
condensation of mtDNA by (Kukat, Davies et al. 2015). 
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1.1.3.3 Mitochondrial Ca2+ handling 
 
Mitochondria are intracellular stores of Ca2+ (Deluca and Engstrom 1961). The uptake of 
Ca2+ into mitochondria is an energetically favourable process, driven by the large negative 
electrochemical potential across the IMM of healthy mitchondria (Gunter and Gunter 
1994, Kirichok, Krapivinsky et al. 2004). Ca2+ influx proceeds across the OMM through 
VDAC, and then via facilitated diffusion across the IMM, predominantly carried and 
regulated by the mitochondrial calcium uniporter (MCU) complex (Fig. 1.5) (De Stefani, 
Raffaello et al. 2011). Transport of Ca2+ into the mitochondria is therefore not directly 
coupled to the import or export of any another ion. In mammals, the MCU complex 
comprises oligomers of the pore-forming Mcu (Baughman, Perocchi et al. 2011) and six 
regulatory subunits, including the essential MCU regulator, mitochondrial (EMRE) 
(Sancak, Markhard et al. 2013). The MCU complex, including a homologue of EMRE, is 
conserved in Drosophila, but it is not known whether the other regulatory subunits are 
conserved (Choi, Quan et al. 2017). In mammals, an isoform of the ryanodine receptor 
(RyR) has been discovered in the IMM of cardiomyocytes and striatal neurons, and makes 
a minor contribution to mitochondrial Ca2+ influx (Jakob, Beutner et al. 2014). 
Drosophila possess a single RyR isoform (Takeshima, Nishi et al. 1994, Sullivan, Scott 
et al. 2000), and it is not known whether any fraction of the protein localises to the IMM. 
 Efflux of Ca2+ from the mitochondria is mediated by Na+-dependent (Crompton, 
Kunzi et al. 1977) and Na+-independent mechanisms (Crompton, Moser et al. 1978). The 
Na+/Ca2+ exchanger NCLX mediates the Na+-dependent mechanism (Palty, Silverman et 
al. 2010), whilst the Drosophila protein LETM1 has been identified as a mitochondrial 
H+/Ca2+ antiporter (Jiang, Zhao et al. 2009). Approximately 33kJ of energy is required to 















1.1.3.4 Mitochondrial dynamics 
 
Mitochondria exist as a dynamic network in the cell, undergoing frequent remodelling 
via fission and fusion. The biogenesis of mitochondria occurs via the augmentation and 
reconfiguration of existing mitochondrial networks, and requires the co-ordinated 
synthesis of nuclear-encoded and mtDNA-encoded proteins. The transcriptional 
co-activator peroxisome proliferator activated receptor γ co-activator 1α (PGC-1α) is 
considered the master regulator of the nuclear genes for mitochondrial biogenesis 
(Puigserver, Wu et al. 1998). Interaction of (PGC-1α) with the nuclear respiratory factor 
1 and 2 (NRF1 and NRF2) transcription factors can control the transcription of OXPHOS 
genes (Wu, Puigserver et al. 1999). NRF1/2 can also regulate the transcription of TFAM 
(Virbasius and Scarpulla 1994). 
 Mitochondrial fusion is regulated by distinct but co-regulated mechanisms of 
IMM and OMM fusion. Fusion of the OMM requires the proton (but not electrical) 
gradient across the IMM and the minimal hydrolysis of GTP, while conversely, fusion of 
the IMM requires a high input of GTP and the IMM membrane potential (Meeusen, 
McCaffery et al. 2004). The GTPases mitofusin and OPA1 (Cipolat, Martins de Brito et 
Figure 1.5 Mitochondrial Ca2+ handling. Adapted from (Hajnóczky and Csordás 
2010). For ER Ca2+ handling, see Section 1.3.4. For ER-mitochondrial Ca2+ transfer, 
including information on ER-mitochondrial tethers known to regulate Ca2+ transfer, 
see Section 1.4.2.   
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al. 2004) mediate the fusion of the OMM and IMM respectively. Mitofusin operates via 
homotypic interactions that require the presence of the protein on both fusing 
mitochondria (Koshiba, Detmer et al. 2004).  
 Mitochondrial fission occurs via recruitment of dynamin-related protein 1 (Drp1) 
to the OMM by a complex of Fis1 and Mdv (Karren, Coonrod et al. 2005) and its 
subsequent constriction of the mitochondria, and scission of the membranes. 
 The components of damaged mitochondria are recycled in a process known as 
mitophagy. In mammals, the best characterised regulators of mitophagy are the 
Parkinson’s Disease (PD) associated genes pink1 and parkin. PINK1 is imported into 
healthy mitochondria and degraded. When the mitochondrial membrane potential is 
reduced by dysfunctional OXPHOS, translocation of PINK1 fails, and it remains in the 
OMM where it phosphorylates and thereby activates the E3 ubiquitin ligase Parkin, which 
then marks the mitochondria for degradation (Kim, Park et al. 2008, Narendra, Tanaka et 
al. 2008, Sha, Chin et al. 2010).    
 
 
1.1.4 Mitochondrial dysfunction and disease 
 
Given the critical role of the organelle in the metabolic and signalling life of the cell, it is 
unsurprising that mitochondrial dysfunction is associated with a panoply of diseases. 
Tissue-specific energy demands and heteroplasmy ensure that these diseases display a 
wide range of clinical symptoms and variable penetrance. Diseases can be caused by 
mutations/deletions in both mtDNA-encoded genes and nuclear-encoded proteins related 
to mitochondrial function. 
Early onset mitochondrial diseases are predominantly severe, and often caused by 
autosomal recessive mutations in nuclear genes. The estimated prevalence of childhood 
onset mitochondrial disease is 6.2/100,000 births (Skladal, Halliday et al. 2003). The high 
energy demand of the nervous system means that mitochondrial dysfunction frequently 
causes neurological syndromes, such as Leigh syndrome, associated with mutations in 
the OXPHOS complexes and their assembly factors (reviewed in (Lake, Bird et al. 2015)), 
and Alpers-Huttenlocher syndrome, caused by mutations in the (nuclear-encoded) 
mtDNA polymerase (reviewed in (Saneto, Cohen et al. 2013)). Patients with these 
diseases can also present pathologies in other tissue with high energy demand, including 
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cardiac and skeletal muscle. Mitochondrial diseases diagnosed in adulthood are estimated 
to affect ~1/4,300 adults, and are predominantly caused by mtDNA mutations (~87% of 
cases) (Gorman, Schaefer et al. 2015). There are recognised mitochondrial syndromes 
caused by mtDNA mutations, such as Leber’s hereditary optic neuropathy (LHON), 
myoclonic epilepsy with red-ragged fibers (MERRF) and mitochondrial encephalopathy, 
lactic acidosis and stroke-like episodes (MELAS), but many patients do not display the 
well-defined symptoms of these syndromes (reviewed in (Lightowlers, Taylor et al. 
2015)). 
Mitochondrial dysfunction is also convincingly linked to the pathogenesis of 
neurodegenerative disease. Parkinson’s Disease (PD) is classically defined by the specific 
loss of dopaminergic neurons from the substantia nigra pars compacta, manifesting 
symptoms of bradykinesia, resting tremor and rigidity due to the location of the SNc 
within the motor circuits of the basal ganglia. The association between PD and 
mitochondrial dysfunction first came to light in a study of recreational drug users who 
had developed PD-like symptoms. It was established that they had injected 1-methyl-4-
phenyl-1,2,5,6-tetrahydropyridine (MPTP) (Langston, Ballard et al. 1983), whose 
metabolite, MPP+, was characterised as an inhibitor of Complex I (Nicklas, Vyas et al. 
1985). Subsequently, post-mortems of PD patients revealed deficient Complex I activity 
(Schapira, Cooper et al. 1989). Genes mutated in juvenile onset PD include the 
mitochondrial quality control proteins PINK1 (Valente, Abou-Sleiman et al. 2004) and 
parkin (Kitada, Asakawa et al. 1998), LRRK2 (Zimprich, Biskup et al. 2004), which is 
known to associate with the OMM, and the ROS-sensitive chaperone DJ-1 (Bonifati, 
Rizzu et al. 2003). Reduced activity of the ETC complexes has been found in Alzheimer’s 
disease cases (Maurer, Zierz et al. 2000), as well as downregulation of the mRNA 
encoding the ETC subunits (Manczak, Park et al. 2004). The mitochondrial cascade 
hypothesis of Alzheimer’s disease proposes that baseline mitochondrial function and the 
rate of decline – affected by e.g. exposure to environmental factors – ultimately determine 
the onset of synapse loss, neurodegeneration and the formation of plaques and tangles 







1.1.5 Mitochondrial retrograde signalling 
 
The nuclear genome encodes the vast majority (~1,200) of mitochondrial proteins (Calvo, 
Clauser et al. 2016), as well as the signalling and transcription factors that control 
mitochondrial biogenesis and dynamics. These species constitute an anterograde signal 
from the nucleus to the mitochondria. Mitochondrial retrograde signals communicate the 
health and integrity of mitochondria to the cell, and in particular, the nucleus where gene 
transcription is altered in response to these retrograde signals. Given the strong 
association of mitochondrial dysfunction with disease, understanding these retrograde 
signals presents a valuable opportunity to gain insight into the pathogenesis of diseases 





1.1.5.1 Mitochondrial retrograde signalling in yeast [adapted excerpt from (Hunt 
and Bateman 2018)] 
 
The phenomenon of retrograde signalling was identified in a landmark paper from the 
Butow laboratory in 1987. Subtractive hybridisation of cDNAs from yeast strains 
harbouring mtDNA lesions uncovered variations in the abundance of nuclear-encoded 
mRNAs, both compared to controls and between the disparate dysfunction models 
(Parikh, Morgan et al. 1987). Subsequent studies have focused upon rho0 cells - an 
extreme form of mitochondrial dysfunction whereby mtDNA is entirely absent. In 
addition to ETC deficiency, the Krebs cycle is not operational in rho0 cells due to the 
compromised function of succinate dehydrogenase. The classical marker of retrograde 
signalling in yeast is upregulation of the peroxisomal isoform of citrate synthase (CIT2) 
(Liao, Small et al. 1991). CIT2 operates within the glyoxylate cycle, supplying citrate that 
Figure 1.6 Schematic of anterograde and retrograde signalling.  
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can be oxidised to α-ketoglutarate by the first three enzymes of the Krebs cycle. 
α-ketoglutarate can subsequently be transaminated to glutamate, supplying the cells with 
nitrogen. In addition, the glyoxylate cycle permits the net synthesis of glucose from the 
β-oxidation of fatty acids; isocitrate is cleaved to form succinate and glyoxylate, the latter 
of which can undergo condensation with acetyl-CoA to form malate, and then ultimately 
glucose via gluconeogenesis. The β-oxidation (Chelstowska and Butow 1995, Epstein, 
Waddle et al. 2001), glycolytic, and mitochondrial biogenesis pathways are also 
upregulated by retrograde signalling in rho0 cells (Traven, Wong et al. 2001), alongside 
a substantial proliferation of peroxisomes (Epstein, Waddle et al. 2001). 
 
Transcriptional control of this metabolic adaptation can be exerted by a 
heterodimer of two bHLH/ZIP proteins, Rtg1 and Rtg3 (Fig. 1.6), in concert with the 
histone acetyltransferase complex, SAGA-like (SLIK) (Liao and Butow 1993, 
Chelstowska and Butow 1995, Pray-Grant, Schieltz et al. 2002). Localisation of 
Rtg1/Rtg3 is regulated by the putative phosphatase Rtg2 (Sekito, Thornton et al. 2000). 
Rtg2 is also a core component of SLIK (Pray-Grant, Schieltz et al. 2002), and therefore 
has a chromatin remodelling role in addition to promoting the partial dephosphorylation 
of Rtg3 and its consequent translocation to the nucleus in tandem with Rtg1. A wealth of 
positive and negative regulators act on the pathway; whilst bound to the mutually 
redundant 14-3-3 proteins Bmh1/2, the phosphoprotein Mks1 inhibits the nuclear 
translocation of Rtg1/3. When Mks1 binding switches reversibly to Rtg2, retrograde 
signalling is activated (Liu, Sekito et al. 2003). The evolutionarily conserved TOR 
pathway is a negative regulator of yeast retrograde signalling, integrating nutrient sensing 
with the response to mitochondrial dysfunction. TOR modulates the Rtg pathway both 











Experimental adjustment of mitochondrial membrane potential, in both rho0 and 
rho+ cells, controlled the expression of CIT2, the nuclear translocation of Rtg1/3, and the 
retrograde response-associated increase in replicative lifespan, indicating that this 
parameter may be the proximal signal of mitochondrial dysfunction. A ROS scavenger 
did not prevent the transduction of defective membrane potential to Rtg2, and therefore 
the signalling intermediaries between mitochondrial dysfunction and the Rtg pathway 
remain unknown (Miceli, Jiang et al. 2011). The fate of succinate formed in the glyoxylate 
cycle has not been determined – it cannot be efficiently oxidised to fumarate by succinate 
dehydrogenase – and the metabolite may yet be found to have a signalling role. 
 
Many of the nuclear gene changes in response to mitochondrial dysfunction are 
not Rtg-dependent (Epstein, Waddle et al. 2001), and a more recently discovered pathway 
places mitochondrial ROS upstream of epigenetic changes that downregulate 
subtelomeric transcription (Schroeder, Raimundo et al. 2013). Phosphorylation of the 
histone demethylase Rph1 by Rad53 and Tel1 – kinases previously associated only with 
nuclear DNA damage – reduced its binding to subtelomeric chromosomal regions. 
Consistent with this observation, HSK36me3 marks increased in the same locations, as 
did the binding of the silencing protein Sir3. 
Figure 1.7 The canonical yeast Rtg1-3 retrograde signalling pathway in yeast. From 




Other recent work in yeast has uncovered mechanisms that promote cytosolic 
proteostasis in response to impaired import of mitochondrial proteins (Wang and Chen 
2015, Wrobel, Topf et al. 2015). Whilst changes in nuclear gene expression were detected 
when translocation into the intermembrane space was diminished (Wrobel, Topf et al. 
2015), studies have largely focused on alterations in the proteome. Upregulation of 
proteasome activity and the abundance of its assembly factors, was hypothesized to 
ameliorate the burden of mistargeted mitochondrial proteins in the cytosol in a direct 
model of impaired import (Wrobel, Topf et al. 2015). Proteosomal activity, alongside 
modifications to translation rates and specificity, was also regulated in response to 
mutations in the adenine nucleotide translocase, the inner membrane protease YME1 and 




Mitochondrial dysfunction is strongly associated with the initiation and metastasis of 
cancerous tumours. As a result, much retrograde signalling research in mammals has been 
performed in cancer models. The yeast Rtg1-3 genes are not conserved in higher 
eukaryotes, and mammalian cells do not possess an alternative ‘signature’ retrograde 
signalling pathway. Instead, the identified cellular responses to mitochondrial 
dysfunction have been strongly cell-type-specific, myriad and sometimes contradictory.  
 
Pulmonary carcinoma (Amuthan, Biswas et al. 2001, Amuthan, Biswas et al. 
2002, Guha, Srinivasan et al. 2007), breast carcinoma (Yu, Shi et al. 2009), prostate 
cancer (Moro, Arbini et al. 2009) and colorectal cancer (Guo, Zheng et al. 2011) cell lines 
all became increasingly proliferative, invasive, and/or resistant to apoptosis, following a 
reduction in mtDNA copy number. However, in rho0 osteosarcoma cells, proliferation 
was reduced (Arnould, Vankoningsloo et al. 2002). Cytosolic Ca2+ levels regulate many 
signalling pathways, and elevated Ca2+ was detected in both the pulmonary carcinoma 
and osteosarcoma cells. The differing pathways activated by raised Ca2+ may hold the 
key to the phenotypic outcomes; in the rho0 osteosarcoma cells the calcium/calmodulin-
dependent kinase IV (CaMKIV) stimulated the CREB transcription factor, whilst in the 
pulmonary carcinoma cells, the phosphatase calcineurin and Ca2+-dependent MAP 
kinases were activated. Even when the same Ca2+-dependent factors are activated, the 
downstream pathways frequently differ. In a skeletal muscle model, retrograde signalling 
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via calcineurin was found to cause proliferation via upregulation of the insulin-like 
growth factor-1 receptor, independently of growth factors. Events downstream of 
calcineurin included the activation and nuclear-localisation of the classical stress-
response transcription factors NFAT, CREB, C/EBPδ and NFκB, the latter via a novel 
dephosphorylation of inhibitor IκBβ by calcineurin. These transcription factors 
functioned collaboratively and required phosphorylated RNA-binding protein 
heterogeneous ribonucleoprotein hnRNPA2 as a transcriptional co-activator for the 
upregulation of target genes, the full complement of which is currently unknown (Guha, 




One of the earliest demonstrations of retrograde signalling in mammalian cells was the 
finding that ROS-based signals from the mitochondria were required for the 
transcriptional response to hypoxia mediated by HIF-1α in hepatoma cells. The increase 
in ROS production in response to hypoxia was abolished in rho0 cells, and upregulation 
of hypoxia-responsive transcripts also failed to occur (Chandel, Maltepe et al. 1998). 
Subsequently, ROS have been shown to regulate the activity of NF-κB in colorectal 
carcinoma cells (Formentini, Sanchez-Arago et al. 2012), and the relative 
mitochondrial/nuclear localisation of the ubiquinone biosynthesis factor 
demethoxyubiquinone monooxygenase (CLK-1/COQ7) in a manner akin to ATFS-1 in 
the mtUPR (see below). In C. elegans, nuclear localised CLK-1 functions to reduce ROS, 
but counterintuitively, also to downregulate transcription of mtUPR chaperones 
(Monaghan, Barnes et al. 2015). 
 
1.1.5.4 The mitochondrial unfolded protein response (mtUPR) [adapted excerpt 
from (Hunt and Bateman 2018)] 
 
The mitochondrial unfolded protein response (mtUPR) is a collection of retrograde 
signalling pathways that are activated by unfolded or aggregated proteins in the 
mitochondria. These pathways serve to restore proteostasis within the organelle, and 
mitigate reduced mitochondrial ATP production. Whilst early mammalian mtUPR 
research established the use of a mitochondrially-targeted aggregation-prone truncated 
ornithine transcarbamylase (OTC-Δ) model (Zhao, Wang et al. 2002), subsequent 
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research in generalised mitochondrial stress models has not always strictly confirmed an 
unfolded protein burden within the mitochondria, and the results must be considered with 
this caveat. Transcriptional upregulation of the nuclear-encoded mitochondrial 
chaperones of the Hsp60, Hsp70 and Hsp10 families is conserved across C. elegans, 
Drosophila and mammalian mtUPR models, and bolsters mitochondrial protein folding 
capacity (Martinus, Garth et al. 1996, Zhao, Wang et al. 2002, Haynes, Petrova et al. 
2007, Nargund, Pellegrino et al. 2012, Owusu-Ansah, Song et al. 2013, Baqri, Pietron et 
al. 2014, Wu, Williams et al. 2014, Munch and Harper 2016). Components of the 
mitochondrial import machinery, in particular the stress-sensitive tim-17/Tim17A, can 
also be regulated by the mtUPR, but results are not consistent across experimental 
paradigms, with both up- and down-regulation witnessed (Aldridge, Horibe et al. 2007, 
Nargund, Pellegrino et al. 2012, Rainbolt, Atanassova et al. 2013). In some models, 
clearance of unfolded matrix proteins is enhanced by upregulation of the Lon and 
ClpP/ClpX proteases, and this degradation may also have a signalling role (see below) 
(Zhao, Wang et al. 2002, Owusu-Ansah, Song et al. 2013, Baqri, Pietron et al. 2014, Wu, 
Williams et al. 2014, Fiorese, Schulz et al. 2016). In a direct unfolded protein model in 
HeLa cells, downregulation of the RNase P component MRPP3 impaired processing of 
mt-tRNA precursors, and consequently contributed to an observed reduction in 
translation of mtDNA-encoded proteins (Munch and Harper 2016). Microarray analysis 
in C. elegans has also indicated that the mtUPR invokes ROS scavenging, increased iron-
sulfur cluster assembly, and metabolic reprogramming that includes the upregulation of 
glycolytic and regulatory enzymes (Nargund, Pellegrino et al. 2012). There are also 
branches of the mtUPR, such as the enhancement of AMPK-mediated autophagy seen in 
a Drosophila OTC-Δ model (Pimenta de Castro, Costa et al. 2012), that do not signal via 
the nucleus. 
 
The most comprehensive investigation of mtUPR pathways has been undertaken 
in C. elegans. In that organism, transcriptional induction of hsp-60 can be regulated by 
the transcription factors DVE-1 (Haynes, Petrova et al. 2007) and ATFS-1 (Nargund, 
Pellegrino et al. 2012), and the ubiquitin-like protein UBL-5 (Haynes, Petrova et al. 
2007). A small fraction of DVE-1 is found complexed with UBL-5 under conditions of 
mitochondrial stress, but the requirement for this physical interaction in activating the 
mtUPR has not been established (Haynes, Petrova et al. 2007). Knock-down of the ClpP 
protease attenuated upregulation of hsp-60 and ubl-5, and nuclear accumulation of DVE-
1 (Haynes, Petrova et al. 2007) and ATFS-1 (Haynes, Yang et al. 2010), placing ClpP at 
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the head of all known C. elegans mtUPR pathways. ClpP-mediated hydrolysis of matrix 
proteins is increased under conditions of mitochondrial stress and the resultant peptides 
are exported into the intermembrane space by the ABC transporter HAF-1 (Haynes, Yang 
et al. 2010), from where they diffuse through the semi-porous outer membrane into the 
cytosol. Both inhibition of the proteolytic activity of ClpP, and a haf-1 deletion mutant, 
decreased the induction of ubl-5, indicating a yet-to-be elucidated role for the effluxed 
peptides in the signal transduction of at least one mtUPR pathway. HAF-1 was also 
required for the nuclear accumulation of ATFS-1 in some mitochondrial stress conditions 
(Nargund, Pellegrino et al. 2012), but is not required for the nuclear translocation of DVE-
1 (Haynes, Yang et al. 2010). 
 
ATFS-1 activity is controlled by organelle partitioning: it has both a nuclear 
localisation sequence (NLS) within its C-terminal leucine zipper domain and an N-
terminal mitochondrial targeting sequence (MTS) (Fig. 1.7). Under normal physiological 
conditions, ATFS-1 is imported into the mitochondrial matrix and degraded by the Lon 
protease. When the mitochondrial import machinery is compromised and/or HAF-1 is 
activated by upstream mtUPR components, mitochondrial import of ATFS-1 is impaired, 
and instead the protein accumulates in the nucleus and upregulates its target genes 
(Nargund, Pellegrino et al. 2012). An ATFS-1 orthologue has been identified in 
Litopenaeus vannamei (King Prawn) (Chen, Yue et al. 2016), but the protein does not 










The mammalian mtUPR presents a more complex picture. The pathways activated 
have proven to be myriad, acutely dependent on cell and stress type, and in many 
experimental paradigms the mtUPR appears cross-regulated with the integrated stress 
response (ISR) [see Section 1.5.2, The PERK pathway]. Activating Transciption Factor 
5 (ATF5) was recently proposed to signal the mammalian mtUPR in a manner analogous 
to ATFS-1. A weak N-terminal MTS was identified in ATF5, in addition to its known 
NLS in the bZip domain. Expression of ATF5 is activated at the level of translation by 
phosphorylation of the initiation factor eIF2α, and hence at least in part by the ISR. When 
eIF2α phosphorylation was induced by the proteasome inhibitor Bortezomib, endogenous 
ATF5 became detectable in HeLa cells, and was enriched in the mitochondrial fraction. 
In the absence of experimental confirmation, nuclear translocation of ATF5 in response 
to mitochondrial stress was inferred from the transcriptional dependence of mtUPR 
targets on the protein; upregulation of HSP60, mtHSP70 and the protease LONP1 was 
abolished by knockdown of ATF5 in paraquat and OTC-Δ HEK293T cell models. 
Induction of LONP1 was also ATF5-dependent in HEK293T cells treated with the 
mitochondrial toxins piericidin, antimycin and oligomycin (Fiorese, Schulz et al. 2016). 
 
However, more latterly, a multi-omics study of four diverse mammalian 
mitochondrial stress models identified ATF4 and the ISR as key co-ordinators of the 
stress response in HeLa cells, and failed to detect upregulation of the proposed mtUPR 
targets or ATF5. In addition, neither paraquat treatment of HeLa cells, nor transfection of 
OTC-Δ, recapitulated the ATF5 results seen by Fiorese and colleagues in the HEK293T 
line (Quiros, Prado et al. 2017). Further, whilst a direct unfolded protein model in HeLa 
cells again described an ATF4-mediated response, involvement of the ISR was excluded, 
and instead a role for ATF3 was suggested (Munch and Harper 2016). Pioneering work 
from the Hoogenrad lab that established the OTC-Δ model had previously implicated the 
bZIP transcription factor CHOP in the mtUPR in COS-7 cells (Zhao, Wang et al. 2002) 
and subsequently involvement of the c-Jun/JNK pathway (Horibe and Hoogenraad 2007), 
as later seen in Drosophila, and murine intestinal epithelial cells (Rath, Berger et al. 
2012). In the latter study, the authors proposed a mtUPR pathway that placed ClpP-
mediated proteolysis upstream of phosphorylation of c-Jun and eIF2α by the ISR kinase 
PKR. A mtUPR pathway that utilises estrogen receptor activity and is unique to protein 
stress within the intermembrane space has also been outlined in MCF-7 adenocarcinoma 
cells (Papa and Germain 2011). In HepG2 liver cells, knockdown of ABCB10, the 
putative human homologue of C. elegans HAF-1, reduced expression of the mtUPR 
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chaperones and the LONP1 protease, but did not affect the efflux of peptides from the 
mitochondria, suggesting a conserved role for ABCB10 in some, but not all, of the mtUPR 
pathways (Yano 2017). Involvement of the mammalian homologues of UBL5 and DVE-
1 in the mtUPR has not been explored (Haynes, Petrova et al. 2007). 
 
1.1.5.5 Mitochondrial retrograde signalling in the nervous system 
 
Despite the strong association between mitochondrial dysfunction and neurodegenerative 
disease, comparatively little retrograde signalling research is conducted in the nervous 
system. 
 
With regards to the mtUPR, it has been established in C. elegans that the ATFS-1 
pathway is active in neurons. Additionally, under certain types of mitochondrial stress, 
the nervous system has cell non-autonomous control over mtUPR activation in distal 
tissues of the worm, adapting the biology of these tissues to the stress conditions. This 
non-autonomous control is dependent on the presence of functional ATFS-1 and DVE-1 
- but not UBL-5 or HAF-1 - in the nervous system, and could be induced by neural 
overexpression of an N-terminally truncated form of ATFS-1 lacking an MTS (Shao, Niu 
et al. 2016). 
 
In mammals, mitochondrial metabolic activity appears pivotal for the 
development of neuronal phenotypes. Pharmacological inhibition of the ETC in 
human-induced pluripotent stem cells (Fang, Qing et al. 2016), and genetic ETC 
manipulation in murine adult neural stem cells (Beckervordersandforth, Ebert et al. 2017) 
results in diminished neuronal differentiation, however the underlying mechanisms and 
contribution, if any, of mitochondria-to-nucleus signalling remain to be determined. 
 
Gene expression profiling of the mammalian response to neuronal mitochondrial 
dysfunction has highlighted how the sophisticated biomolecular composition of the 
organelle, and its role as an integrator of multifarious signalling pathways, renders the 
mitochondrion a chaotic system; very similar perturbations in mitochondrial function can 
result in widely differing cellular responses. Transcription of nuclear-encoded OXPHOS 
genes was found to be unchanged in differentiated human neuronal precursors treated 
with Complex I inhibitor MPP+ (Krug, Gutbier et al. 2014), but broadly downregulated 
in murine primary cortical neurons exposed to an alternative Complex I inhibitor, 
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rotenone (Yap, Chen et al. 2013). Similarly contradictory results arose for the import of 
extracellular cysteine. Upregulation of the cystine transporter SLC7A11 was considered 
an important facilitator in the synthesis of the antioxidant glutathione (Krug, Gutbier et 
al. 2014), whilst downregulation of the Slc1a1 cysteine transporter was identified as an 
obstacle to this synthesis, despite the upregulation of other genes involved in glutathione 
production (Yap, Chen et al. 2013). Two in vivo PD models of Complex I inhibition in 
the substantia nigra contain little overlap in the transcriptional changes they report. In 
rotenone-treated rats, the defining transcriptional response was an antagonistic up- and 
down-regulation of cell death pathway components (Meurers, Zhu et al. 2009), whilst 
MPTP-treated mice predominantly displayed changes in the regulation of synaptic and 
cell cycle-related genes (Miller, Callahan et al. 2004). However, encouragingly, two in 
vitro PD models utilising the Complex I and V inhibitor 6-OHDA report some common 
transcriptional changes (Holtz and O'Malley 2003, Ryu, Angelastro et al. 2005), and in 
one of the studies, the antagonistic upregulation of pro- and anti-apoptotic genes and 
increased expression of cell cycle-related genes, reported in the rat rotenone model (Ryu, 
Angelastro et al. 2005). In both 6-OHDA models, genes from the endoplasmic reticulum 
unfolded protein response pathways (ER UPR) (see Section 1.5) were upregulated. In 
common with other transcriptional analyses of neuronal mitochondrial dysfunction 
(Moisoi, Klupsch et al. 2008, Mazzio and Soliman 2012, Yap, Chen et al. 2013, Krug, 
Gutbier et al. 2014), expression of the ER UPR transcription factor ATF4 was upregulated 
in one 6-OHDA model (Ryu, Angelastro et al. 2005).   
 
The functional consequences of mitochondrial retrograde signalling appear 
detrimental. A mtDNA mutation that causes hereditary deafness in humans, was shown 
to cause the apoptotic loss of murine spiral ganglion neurons via ROS-dependent 
activation of the transcription factor E2F1 (Raimundo, Song et al. 2012). Mutation of the 
molecular chaperone TRAP1 protects Drosophila against ROS-induced death via the 
transcription factor FOXO, implying that activity of wild-type TRAP1 is a damaging 







1.2 Drosophila as a model organism 
 
The fruit fly Drosophila melanogaster gained worldwide scientific recognition as a model 
genetic organism in the ‘fly room’ of Thomas Hunt Morgan at Columbia University in 
the early 1900s. Drosophila breed rapidly (~10 days from embryo to adult at 25 °C) and 
require little space to house, and therefore allow the conduct of large scale investigations 
spanning multiple generations.  Morgan and his students used both naturally occurring 
and induced mutations to demonstrate that genes are inherited as distinct units on 
chromosomes, and could be mapped by their recombination frequency ((Morgan, 
Sturtevant et al. 1915) and reviewed in (Benson 2001)). Subsequent work over the 
intervening century has built an extensive Drosophila genetic toolkit for investigations of 
fundamental biological processes and disease mechanisms. 
As early as 1918 the first balancer chromosome was introduced by Herman 
Muller, who used females with the dominant eye mutation Bar on an X chromosome with 
inversions to examine the rate of lethality caused by irradiation of males flies (Muller 
1918). Balancers are homozygous lethal chromosomes created by mutagenisation and 
characterised by multiple inversions. Balancers chromosomes are sufficiently corrupted 
to prevent homologous recombination with a wild-type chromosome partner when they 
are present in heterozygotes. Dominant markers identify the presence of the balancer, and 
therefore allow heterozygous mutations or other genetic manipulation on the partner 
chromosome to be tracked and identified through generations (by the absence of the 
marker) (reviewed in (Kaufman 2017)). 
Despite gaining fame with Thomas Hunt Morgan, Drosophila had actually made 
their laboratory debut a few years previously, in the lab of William Castle at Harvard 
University, where they were employed in behavioural analyses (reviewed in (Greenspan 
2008)). The first Drosophila paper from the Castle lab detailed the reactions of the fly to 
gravity, light and mechanical stimulation (Carpenter 1905), and the findings underpin 
many of the today’s functional assays, including the climbing assay. Behavioural analysis 
in Drosophila accelerated in the 1960s, driven by the work of Seymour Benzer who, 
amongst many discoveries, identified genes controlling circadian rhythm (Konopka and 
Benzer 1971), learning (Dudai, Jan et al. 1976) and lifespan (Lin, Seroude et al. 1998), 
and there are now many established protocols for the assessment of Drosophila function. 
In late 1970s and early 1980s, Christiane Nüsslein-Volhard and Eric Wieschaus 
again utilised Drosophila’s tractability to pioneer the large-scale forward genetic screen, 
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looking for genes contributing to the patterning of the larva (Nüsslein-Volhard and 
Wieschaus 1980). They screened over 10,000 Drosophila lines produced by 
mutagenisation with ethyl methane sulfonate, and discovered 61 loci contributing to 
patterning on Chromosome II alone (Nüsslein-Volhard, Wieschaus et al. 1984). 
A drawback to forward genetic screens is the subsequent need to map the 
identified mutations to the gene in which they reside. A first step towards large scale 
reverse genetic screens, in which the gene under manipulation is known, was taken by 
Brand and Perrimon in 1993, when they optimised the upstream activation sequence 
(UAS) for use in Drosophila with the yeast transcriptional activator, Gal4. The 
spatiotemporal expression of Gal4 is controlled by the location of its insertion into the 
genome, for example, Gal4 inserted into the synaptobrevin locus (nSyb-Gal4) is 
expressed in all post-mitotic neurons. Flies carrying the Gal4 insert are crossed to flies 
with the UAS sequence upstream of a transgene of interest, and their progeny express the 
transgene in a time and tissue-specific manner (Brand and Perrimon 1993). 
Subsequently, the discovery of RNA interference (RNAi) (Fire, Xu et al. 1998) 
and completion of the Drosophila genome sequence – which revealed that between 
62-75% of human disease genes have homologues in the fly, dependent on scoring 
stringency (Adams, Celniker et al. 2000, Fortini, Skupski et al. 2000, Bier 2005) – paved 
the rest of the way towards reverse genetic screens in Drosophila. The first Drosophila 
UAS-RNAi library, the ‘GD’ library, covering 88% of predicted protein-coding genes in 
the genome was announced in 2007 (Dietzl, Chen et al. 2007), and was used to conduct 
the first ever tissue-specific reverse genetic screen – in any organism – which identified 
23 new regulators of the Notch pathway in the development of thoracic sensory bristles 
(Mummery-Widmer, Yamazaki et al. 2009). There are now four large Drosophila 
UAS-RNAi libraries available worldwide (reviewed in (Heigwer, Port et al. 2018)), as 
well as UAS-open reading frame (ORF) lines for the overexpression of genes of interest 
(Bischof, Bjorklund et al. 2013). Drosophilists studying mitochondria are also aided by 
MitoDrome, the complete catalogue of all the Drosophila mitochondrial genes that are 
encoded by the nuclear genome (Sardiello, Licciulli et al. 2003). 
In recent years, Drosophila have been successfully exploited to model human 
disease, either by manipulating the homologous Drosophila gene, or ectopically 
expressing the human disease gene. For example, the first mutant animal models of the 
PD-associated gene parkin were established in flies, and demonstrated that mutation of 
parkin led to mitochondrial defects (Greene, Whitworth et al. 2003, Pesah, Pham et al. 
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2004). Subsequently, the first in vivo models of PINK1 mutation were also fly models, 
displaying similar mitochondrial dysfunction to that of the parkin mutants. In these 
PINK1 models it was first shown that overexpression of wild-type parkin could 
compensate for loss of PINK1, and that the two genes operated within the same pathway 
(Clark, Dodson et al. 2006, Park, Lee et al. 2006, Yang, Gehrke et al. 2006). Both 
mutation of parkin, and downregulation of the catalytic subunit of mtDNA polymerase 
lead to dopaminergic neuron loss in Drosophila (Whitworth, Theodore et al. 2005, 
Humphrey, Parsons et al. 2012). Genetic and pharmacological manipulations of 
glutathione S-transferase (Whitworth, Theodore et al. 2005) and the cap-dependent 
translation inhibitor 4E-BP (Tain, Mortiboys et al. 2009) in Drosophila parkin mutants 
have been shown to suppress this neuron loss, and therefore represent therapeutic targets 
for neurodegenerative disease identified via the Drosophila model system. 
 
1.2.1 Drosophila models of neuronal mitochondrial dysfunction and retrograde 
signalling 
 
The Drosophila model system has been used to examine mitochondrial retrograde 
signalling in a variety of contexts. The mtUPR has not been methodically determined in 
Drosophila, but hsp60 and the fly homologue of mtHsp70 were both upregulated by 
overexpression or mutation of the mitochondrial chaperone TRAP1 (Baqri, Pietron et al. 
2014), knockdown of the ETC Complex I component ND-75 (Owusu-Ansah, Song et al. 
2013), ubiquitous overexpression of OTC-Δ, and in PINK1 and parkin mutant flies 
(Pimenta de Castro, Costa et al. 2012). In addition to induction of the canonical 
chaperones, nuclear translocation of Dve and upregulation of ClpP (Baqri, Pietron et al. 
2014) and ClpX (Owusu-Ansah, Song et al. 2013) were also detected in some models. In 
the Drosophila ND-75 RNAi model, it was discovered that the raised levels of hsp60, 
mthsp70 and ClpX could be abrogated by overexpression of the antioxidant enzymes 
catalase and glutathione peroxidase I. Additionally, overexpression of the D-Jun and 
Relish transcription factors  of the JNK and NF-κB redox signalling pathways induced 
chaperone and protease expression in wild-type flies (Owusu-Ansah, Song et al. 2013), 
lending weight to the idea that ROS production and signalling may be downstream of 





Whilst much research has focused on the molecular changes invoked by 
mitochondrial unfolded protein stress, little attention has been paid to the functional 
consequences of mtUPR activation. In wild-type Drosophila, overexpression of Hsp60 
isoforms extended lifespan and improved the locomotor function of aged flies. 
Knockdown of Hsp60C or ClpX reduced the mitohormetic effect of ND-75 RNAi on fly 
lifespan and mobility, and also similarly impaired wild-type controls (Owusu-Ansah, 
Song et al. 2013).  
 
Drosophila possess a complex nervous system that is topologically similar to the 
mammalian one; two brain lobes and a spinal cord equivalent (the ventral nerve cord 
(VNC)) are composed of a neuronal cortex containing cell bodies that project into, and 
form circuits via, a neuropil (Fig. 1.9) (Power 1943). Functionally, signal propagation in 
Drosophila neurons is via Na+/K+ action potentials (Tanouye, Ferrus et al. 1981), and the 
identity and release mechanisms of neurotransmitters are also closely aligned with the 
mammalian system (reviewed in (Martin and Krantz 2014)). Synaptic plasticity occurs in 





Figure 1.9. Schematic of the Drosophila central nervous system. MN = motor neuron. 
IN = interneuron. Adapted from (Freeman 2015). 
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The immense variety of retrograde signals that can occur in response to 
mitochondrial dysfunction are highly cell-type and context specific. Mitochondrial 
retrograde signalling in the nervous system remains underinvestigated, despite the 
potential to shed light on the numerous neurodegenerative diseases associated with 
mitochondrial dysfunction; the number of studies conducted is modest, and many have 
been purely molecular investigations of gene expression changes using in vitro models of 
acute toxic insult. By using in vivo Drosophila models of neuronal mitochondrial 
dysfunction, the extensive genetic tools and behavioural assays at the disposal of fly 
researchers, can be harnessed to tie the functional consequences of retrograde signalling 
to the molecular changes. 
 Analysis of retrograde signals in Drosophila PINK1 and parkin mutants 
uncovered the upregulation of genes co-ordinating one-carbon metabolism and nucleotide 
salvage pathways (Tufi, Gandhi et al. 2014, Celardo, Lehmann et al. 2017). Further 
enhancement of these pathways by genetic manipulation or food supplements, was able 
to suppress the neurodegenerative phenotypes, once again demonstrating that therapeutic 
targets can be identified by work in the Drosophila model system.  
Whilst the PINK1 and parkin mutants are extremely relevant direct models of 
disease genes, the mutations are systemic. The Gal4-UAS system has enabled the specific 
targeting of genetic manipulations causing mitochondrial dysfunction to subsets of 
neurons. Overexpression of the mitochondrial transcription factor and mtDNA packaging 
protein TFAM in Drosophila neurons has been found to inhibit the expression of 
mitochondrially-encoded genes. When targeted to motor neurons, TFAM overexpression 
significantly reduced the number and volume of mitochondria in the distal axon and 
synapse of third instar larvae, and prevented normal active zone development, but did not 
lead to cell loss (Cagin, Duncan et al. 2015). TFAM overexpression has been used in 
Drosophila sensory neurons alongside overexpression of the mitochondrial structural 
protein prel as a mitochondrial dysfunction model to examine dendritic arborisation  
(Tsuyama, Tsubouchi et al. 2017). Both TFAM overexpression and prel overexpression 
caused dendritic arbor loss in sensory neurons. The retrograde signal was determined to 
travel via phosphorylation of the translation initiation factor eIF2α, and arborisation could 
be rescued by promoting the dephosphorylation of eIF2α.  
Importantly, TFAM overexpression in motor neurons produces flies with 
locomotor and wing inflation deficits, thus allowing functional assays of candidate 
modifiers of neuronal mitochondrial retrograde signalling (Cagin, Duncan et al. 2015). 
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Climbing and wing inflation ability is reduced to about 50% of wild-type in the TFAM 
overexpression model, meaning that both suppression and exacerbation of the phenotype 
can be detected in the assays. Knock-down of the fly homologue of HIF-1α, and 
components of the Ras-ERK-ETS pathway, in Drosophila motor neurons suppressed the 
locomotor impairments caused by overexpression of TFAM (Cagin, Duncan et al. 2015, 
Duncan, Granat et al. 2018), identifying both pathways as therapeutic targets to be 























1.3 The endoplasmic reticulum (ER) 
 
Mitochondria are physically and functionally connected to the endoplasmic reticulum 
(ER). The (ER) is a membrane system within the cytoplasm of eukaryotes. The ER was 
discovered in the first successful electron micrographs of cells (Porter, Claude et al. 
1945). The net-like structure was not initially detected in the ectoplasm (near the plasma 
membrane) and was therefore named the endoplasmic reticulum (Porter and Kallman 
1952). We know today that the ER is both continuous with the outer nuclear envelope 
(Watson 1955) and in contact with the plasma membrane (Pichler, Gaigg et al. 2001). In 
neurons, the ER extends from the cell bodies down the length of the axon into the synaptic 
boutons (Broadwell and Cataldo 1983, Broadwell and Cataldo 1984). The lipid 
composition of the ER membranes varies temporally and spatially according to the 
demand for synthesis, the trafficking of lipids to other organelles, and secretion into the 
extracellular space. In yeast, over half the ER membrane lipid content is 
phosphatidylcholine (PC), with phosphatidylinositol (24%) and 
phosphatidylethanolamine (10%) also constituting significant fractions (Tuller, Nemec et 
al. 1999). Functionally and morphologically (Palade 1955), the ER is divided into ‘rough’ 
and ‘smooth’ compartments, although the distinction is not always absolute. 
 
1.3.1 The rough ER 
 
The rough ER is classically composed of membrane sheets decorated with synthesising 
ribosomes, and is the site of folding and modification of proteins to be secreted or 
embedded in cellular membranes (Redman 1969). ER targeting signals are located at the 
N-termini of proteins and vary considerably, but all contain a central stretch of ≥8 
hydrophobic residues (reviewed in (Martoglio and Dobberstein 1998)). The translated 
signal sequences of the nascent polypeptides bind to signal recognition particles (SRPs) 
in the cytosol and the ribosome-SRP complex is recruited to the ER by SRP receptors in 
the ER membrane. The SRP is then switched for a subunit of the Sec61 translocon and 
the protein is transferred through, or into, the ER membrane as it is synthesised (reviewed 
in (Walter, Gilmore et al. 1984) and (Nyathi, Wilkinson et al. 2013)). Once in the ER 
lumen, under normal conditions proteins are folded with the assistance of molecular 
chaperones and post-translationally modified by glycosylation. A 14-sugar precursor 
oligosaccharide is transferred to target asparagines co-translationally, and the group is 
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subsequently trimmed and/or added to with other sugar residues (reviewed in (Aebi 
2013)). ER-resident proteins are retained within the ER by a four-amino acid KDEL motif 
(Munro and Pelham 1986, Pelham 1989), whilst proteins destined for secretion or other 
subcellular compartments are trafficked to the Golgi. Proteins that are not folded or 
processed correctly can be retrotranslocated back into the cytosol for degradation in a 
pathway termed ER-associated degradation (ERAD) (reviewed in (Meusser, Hirsch et al. 
2005)). 
 
1.3.2 The smooth ER 
 
The smooth ER lacks ribosomes and is canonically composed of membrane tubules. It is 
the site of lipid and steroid synthesis, detoxification of xenobiotics and the products of 
metabolism, Ca2+ buffering and the final stages of the protein production. New 
subdomains of the ER continue to be identified, including ER exit sites (ERES) which 
mark the transition of ER tubules to vesicles which transit to the Golgi, cortical ER, the 
site of ER-plasma membrane contacts, and the ER quality control compartment (ERQC) 
where improperly processed proteins are held for ERAD (reviewed in (Lynes and 
Simmen 2011)). 
 
1.3.3 Creation and maintenance of ER morphology 
 
The cylindrical shape of ER tubules is maintained by the reticulon and REEP families 
(Voeltz, Prinz et al. 2006), along with ADP-ribosylation factor-like 6 interacting  protein 
1 (Arl6IP1) (Fig. 1.10) (Yamamoto, Yoshida et al. 2014). These factors are composed of 
two partial-membrane-width α-helices (Reticulon-homology domains (RHDs)) and 
reside in the outer leaflet of the ER membrane where they act as wedges that induce 
positive curvature. 
The diameter of ER sheets and tubules are similar, at around 60-100 nm, thought 
to be due to the same families of proteins creating both the cylindrical tubules and the 
curves at the edges of the sheets. The intra-luminal distance within the sheets is 
maintained by the phosphoprotein Climp-63, which acts as a spacing bridge between the 
membranes (Shibata, Shemesh et al. 2010). The flat surface of the sheets is maintained 
by the coiled coil domain proteins Kinectin and p180 (Shibata, Shemesh et al. 2010). 
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Climp-63, Kinectin and p180 are not conserved in Drosophila (Goldstein and 
Gunawardena 2000, Shibata, Shemesh et al. 2010), and the diameter of ER tubules and 
sheets is reduced to around 30 nm in flies (Shibata, Shemesh et al. 2010), theoretically 
because of the absence of the Climp-63 spacer. 
ER morphology is dynamic, and reconfigurations are an energy-dependent 
process. The mammalian, yeast and plant GTPases, Atlastin and Sey1p and RHD3 
respectively, possess RHDs (Hu, Shibata et al. 2009, Chen, Stefano et al. 2011, Anwar, 
Klemm et al. 2012). They mediate membrane fusion via the dimerisation of their GTPase 
domains. Subsequent hydrolysis of GTP causes conformational changes in the proteins 
that pull the ER membranes together and force fusion (Bian, Klemm et al. 2011, Byrnes 
and Sondermann 2011, Byrnes, Singh et al. 2013, Yan, Sun et al. 2015). The Drosophila 
homologue of Atlastin has displayed fusion capabilities in vitro (Orso, Pendin et al. 2009). 
The genesis of new tubules appears to be dependent on distortions created by 






Figure 1.10 Proteins shaping the ER. From (Zhang and Hu 2016) 
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1.3.4 ER Ca2+ 
 
The ER is the major intracellular Ca2+ store. ER Ca2+ uptake from the cytosol is mediated 
by the Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA). Depletion of Ca2+ from the 
ER lumen results in the activation of store-operated Ca2+ entry (SOCE) by physical 
interaction of the ER membrane-resident Ca2+ sensor STIM with the plasma membrane 
Ca2+ channel Orai (Fig. 1.11) (Liou, Kim et al. 2005, Roos, DiGregorio et al. 2005, Feske, 
Gwack et al. 2006, Vig, Peinelt et al. 2006, Zhang, Yeromin et al. 2006). SOCE elevates 
the cytosolic Ca2+ concentration, which is used to replenish the ER stores via the SERCA 
pump. Ca2+ is released from the ER in response to activation of inositol triphosphate (IP3) 
or ryanodine (RyR) receptors. In neurons, the RyR mediates calcium-induced calcium 
release - is activated by raised cytosolic Ca2+. The IP3 receptor is activated by IP3 created 
by the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane 
by activated phospholipase C (reviewed in (Putney and Tomita 2012, Carreras-Sureda, 









Figure 1.11 Major ER Ca2+ uptake and release mechanisms. Adapted from (Carreras-
Sureda, Pihán et al. 2018). 
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1.4 ER-mitochondrial contacts  
 
The physical and functional links between the ER and mitochondria are the subject of 
much recent research. Protrusions from the ER can mark the site of mitochondrial fission 
and play an active role in constriction of the mitochondrial membrane (Friedman, Lackner 
et al. 2011). Separately, the two organelles are tethered together at regions of the ER 
called mitochondria-associated membranes (MAMs), which can occur in both the rough 
and smooth ER (Csordás, Renken et al. 2006). The close apposition of the ER and 
mitochondria was first noted in 1960 (Robertson 1960), but it was another thirty years 
before biochemical evidence of their physical association was obtained, when a 
membrane fraction sedimenting immediately above the mitochondrial band from rat liver 
homogenate was found to contain the enzymes required for phospholipid synthesis 
(Vance 1990). MAMs facilitate the shared functions of the ER and mitochondria, 
including the transfer of Ca2+, lipid synthesis and the regulation of autophagy (Gomez-
Suaga, Paillusson et al. 2017). Abnormal ER-mitochondrial contacts are a feature of many 
diseases, including Alzheimer’s, PD and amyotrophic lateral sclerosis (reviewed in 
(Paillusson, Stoica et al. 2016)), metabolic diseases such as diabetes (reviewed in (López-
Crisosto, Bravo-Sagua et al. 2015)) and lysosomal storage diseases (reviewed in 
(Annunziata, Sano et al. 2018)). 
 
1.4.1 ER-mitochondrial tethering proteins 
 
In yeast, the maintenance of mitochondrial morphology protein 1 (Mmm1) and three 
members of the mitochondrial distribution and morphology protein (Mdm) family form 
a well-characterised tethering complex termed the ER-mitochondria encounter structure 
(ERMES) (Kornmann, Currie et al. 2009). The components of ERMES are not conserved 
in higher eukaryotes, and the identity of the mammalian ER-mitochondrial tethers is 
controversial. Binding between mitofusin2 in the ER and mitofusin 1/2 in the OMM has 
been proposed to constitute part of the mammalian connection between the ER and 
mitochondrial (de Brito and Scorrano 2009). However, the effect of mitofusin ablation 
on ER-mitochondria contacts is the subject of impassioned debate, with studies finding 
that a lack of mitofusin reduces ER-mitochondria contacts (Naon, Zaninello et al. 2016, 
Naon, Zaninello et al. 2017), whilst others fiercely defend their observation that mitofusin 
is a negative regulator of MAM formation, and that mitofusin knockout increases 
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ER-mitochondrial contacts (Cosson, Marchetti et al. 2012, Filadi, Greotti et al. 2015, 
Wang, Garcin et al. 2015, Leal, Schreiner et al. 2016, Filadi, Greotti et al. 2017). 
Regardless of how this debate is resolved, the inter-organelle distance at MAMs varies 
considerably (Csordás, Renken et al. 2006) and, accordingly, over 20 different proteins 
have been proposed to have roles in the physical linkage of mitochondria to the ER (Fig. 
1.9) (reviewed in (Csordás, Weaver et al. 2018)). The identity of ER-mitochondrial 





1.4.2 ER-mitochondrial Ca2+ transfer 
 
Ca2+ transfer between the ER and mitochondria is mediated by the close appostion of 
VDAC and the IP3 receptor, linked by the chaperone GRP75 (Szabadkai, Bianchi et al. 
2006, De Stefani, Bononi et al. 2012). Locally high concentrations of Ca2+ in these 
‘microdomains’ overcome the low Ca2+ affinity of the MCU in the IMM, and facilitate 
efficient import of Ca2+ into the matrix (Rizzuto, Brini et al. 1993, Rizzuto, Pinton et al. 
1998). The VDAC-to-IP3 receptor linkage is not required for the maintenance of 
ER-mitochondrial contacts (Csordás, Renken et al. 2006), and the efficacy of Ca2+ 
transfer is also regulated in the dendrites of mouse cortical neurons by the SMP-domain 
protein PDZD8 (Hirabayashi, Kwon et al. 2017), and in HEK293 cells by the presence of 
tethering complexes comprised of the transmembrane ER protein vesicle-associated 
membrane protein-associated protein B/C (VAPB) and the OMM resident protein 
tyrosine phosphatase interacting protein 51 (PTPIP51) (De Vos, Mórotz et al. 2012). 
Drosophila do not possess a homologue of PTPIP51.  
Figure 1.12 ER-mitochondrial contact proteins.From (Csordás, Weaver et al. 2018). 
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1.4.3 ER-mitochondrial lipid synthesis 
 
ER-mitochondria contacts are also the site of lipid exchange for the co-operative synthesis 
of phosphatidylethanolamine (PE), cardiolipin (CL) and phosphatidylcholine (PC). PE is 
synthesised in the IMM by the decarboxylation of phosphatidylserine (PS) (Borkenhagen, 
Kennedy et al. 1961, Dennis and Kennedy 1972, Percy, Moore et al. 1983), and PE 
generated elsewhere in the cell is not substantially trafficked to mitochondria 
(Burgermeister, Birner-Grunberger et al. 2004). PS is synthesised in the ER, and 
transferred to the mitochondria via MAMs. Some PE is returned to the ER where it can 
be methylated to create PC (reviewed in (Flis and Daum 2013)). Phosphatidic acid, the 
precursor to CL is also synthesised within the ER, transported to the mitochondria via 
MAMs and then converted to CL in a series of enzymatic reactions (Chang, Heacock et 
al. 1998, Chang, Heacock et al. 1998, Osman, Haag et al. 2010). 
In yeast, a number of candidates for the ER-to-mitochondria transfer of 
phospholipids have been identified, including ERMES (AhYoung, Jiang et al. 2015), 
interaction of a second complex, the endoplasmic reticulum membrane protein complex 
(EMC), with the mitochondrial TOM protein, Tom5 (Lahiri, Chao et al. 2014), and 
binding of the intermembrane space proteins Ups1 (Connerth, Tatsuta et al. 2012, 
Watanabe, Tamura et al. 2015) and Ups2 (Miyata, Watanabe et al. 2016) with Mdm35. 
The exact molecular mechanism(s) by which the transfer occurs is unknown. In 
mammals, the OMM protein SLC25A46 interacts with homologues of the EMC, and 
mutation of SLC25A46 can alter the phospholipid composition of mitochondria (Janer, 
Prudent et al. 2016), but little else is known about the machinery of ER-mitochondria 










1.5 The ER unfolded protein response (UPR) 
 
The ER unfolded protein response (UPR) is the collective term for three pathways that 
are activated by a loss of proteostasis in the ER and function to ameliorate the protein 
stress. Each branch of the ER UPR begins with a ER transmembrane protein, and ends 






1.5.1 The IRE1 pathway 
 
Inositol-requiring enzyme 1 (IRE1) is the most conserved of the ER UPR transmembrane 
proteins, and is found in all eukaryotes (Mori 2009). IRE1 exists as a monomer in the 
membrane of the unstressed ER, but oligomerises in response to ER stress, permitting 
autophosphorylation of its cytoplasmic domain (Zhou, Liu et al. 2006, Korennykh, Egea 
et al. 2009, Ali, Bagratuni et al. 2011). Once phosphorylated, IRE1 gains ribonuclease 
activity (Ali, Bagratuni et al. 2011) and catalyses the specific splicing of the basic leucine 
zipper domain (bZIP) transcription factor XBP1 (Sidrauski and Walter 1997, Gonzalez, 
Sidrauski et al. 1999). In the absence of IRE1 activation, XBP1 mRNA is processed by 
Figure 1.13 Overview of the ER UPR. From (Godin, Creppe et al. 2016). 
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the canonical spliceosome, leading to the production of an inactive, truncated form of the 
protein. In response to ER stress, the phosphorylated IRE1 dimer removes an additional 
26-nucleotide intron from XBP1 mRNA, creating a messenger that encodes a full-length 
active transcription factor. XBP1 translocates to the nucleus where it upregulates 
transcription of genes that serve to alleviate the unfolded burden within the ER (Cox and 
Walter 1996, Yoshida, Matsui et al. 2001). 
IRE1 ribonuclease activity can also catalyse the bulk degradation of ER-targeted 
mRNAs encoding secreted and plasma membrane proteins, in a process termed regulated 
IRE1-dependent decay (RIDD). RIDD is quickly activated in response to ER stress, and 
functions to reduce the protein folding demand on the ER before the transcriptional 
alterations mediated by XBP1 take effect (Hollien and Weissman 2006). RIDD requires 
ER stress in addition to activated IRE1, indicating that other stress-responsive factors 
regulate the process (Hollien, Lin et al. 2009). Recently, inhibition of the ER 
transmembrane Protein kinase RNA-like endoplasmic reticulum kinase (PERK) was 
shown to block the degradation of a subset of RIDD-targeted transcripts (Moore and 
Hollien 2015) indicating that mRNA degradation is regulated by at least two branches of 
the ER UPR. 
 
1.5.2 The PERK pathway  
 
PERK is at the head of the second ER UPR branch. Like IRE1, PERK also undergoes 
oligomerisation and transautophosphorylation in response to ER stress (Harding, Zhang 
et al. 1999, Zhou, Liu et al. 2006, Su, Wang et al. 2008) and upon this activation, PERK 
gains kinase activity and phosphorylates Ser51 of the translation initiation factor eIF2α 
(Harding, Zhang et al. 1999, Harding, Zhang et al. 2000). P-eIF2α inhibits the exchange 
of GDP for GTP on eIF2β (Rowlands, Panniers et al. 1988), thus decreasing the 
availability of the ternary complexes eIF2-GTP-tRNAiMet and therefore reducing 
ribosome initation. Phosphorylation of eIF2α therefore suppresses global cap-dependent 
translation, reducing the load on the cell’s protein folding machinery. 
In mammals, eIF2α is the substrate of four kinases that are stimulated by separate 
cellular insults, and its phosphorylation marks the point of convergence of what is termed 
the integrated stress response (ISR). In addition to PERK, eIF2α can be phosphorylated 
by the heme regulated inhibitor (HRI) when the availability of heme is reduced (Levin, 
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Ranu et al. 1976, Ranu and London 1976, Farrell, Balkow et al. 1977), General control 
nonderepressible 2 (GCN2) in response to amino acid starvation (Chen, Throop et al. 
1991, Dever, Feng et al. 1992, Sood, Porter et al. 2000), and Protein kinase RNA-
activated (PKR) in response to viral infection (Galabru and Hovanessian 1985). Only 
PERK and GCN2 are conserved in Drosophila (Malzer, Szajewska-Skuta et al. 2013). 
GADD34 functions as a negative feedback loop within the PERK branch of the 
ER UPR by targeting protein phosphatase 1 (PP1) to eIF2α, resulting in its 
dephosphorylation (Novoa, Zeng et al. 2001). In mammals, GADD34 is translationally 
regulated by 5’UTR uORFs (Lee, Cevallos et al. 2009), and transcriptionally upregulated 
by the ATF4 (see below) target CHOP (Marciniak, Yun et al. 2004). Drosophila do not 
possess a homologue of CHOP, but fly GADD34 is also regulated by 5’UTR uORFs that 
lead to its direct upregulation in response to phosphorylation of eIF2α (Malzer, 
Szajewska-Skuta et al. 2013).  
 
1.5.2.1 Activating transcription factor 4 (ATF4) 
 
Whilst eIF2α phosphorylation inhibits cap-dependent translation, it upregulates the 
translation of a specific subset of proteins that contain upstream open reading frames 
(uORFs) in their 5’UTRs. One such protein is activating transcription factor 4 (ATF4). In 
unstressed conditions, the ribosome initiates at the first uORF in the ATF4 5’UTR, and 
after translating the short peptide sequence, scans to the second uORF where translation 
reinitiates. The second uORF overlaps the ATF4 start codon, thus preventing the 
translation of ATF4. When the supply of ternary complexes is reduced by 
phosphorylation of eIF2α, the ribosome is unable to reinitiate at the second uORF and 
instead scans further to the ATF4 start codon where it begins translation (Vattem and 
Wek 2004). 
ATF4 is a bZIP transcription factor of the ATF/CREB family, and was previously 
known as CREB2 (Hai, Liu et al. 1989, Karpinski, Morle et al. 1992). ATF4 can form 
heterodimers with the AP-1 and C/EBP transcription factor family members, and 
transcriptional regulation by ATF4 is context dependent, with both activation and 
repression reported (reviewed in (Hai and Hartman 2001)). ATF4 interacts with a number 
of proteins which regulate its stability and transcriptional targets. In particular, 
P300/CBP-associated factor is a ATF4 co-activator required for the full induction of 
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CCAAT-enhancer-binding protein (C/EBP) homologous protein (CHOP) in response to 
amino acid starvation in mammalian cell cultures (Chérasse, Maurin et al. 2007), and 
ATF4 complexes with Nrf2 to upregulate the anti-oxidant heme-oxygenase-1 in response 
to the ROS-inducer cadmium (He, Gong et al. 2001). ATF4 has a half-life of 
approximately 30 minutes in HeLa cells, with its degradation mediated by association 
with the E3 ubiquitin ligase component βTrCP, followed by proteasomal digestion 
(Lassot, Ségéral et al. 2001). 
In Drosophila, ATF4 is also known as cryptocephal, as the heads of mutants fail 
to fully emerge from the thorax. Drosophila ATF4 plays a key role in the regulation of 
molting (ecdysis), by upregulation of ecdysis triggering hormone (ETH) in response to 
activation of the ecdysone receptor isoform B2 (Hewes, Schaefer et al. 2000, Gauthier 
and Hewes 2006, Gauthier, VanHaaften et al. 2012). The translational regulation of ATF4 
by uORFs is conserved in Drosophila (Kang, Ryoo et al. 2015). 
 
1.5.3 The ATF6 pathway 
 
Another bZip transcription factor, ATF6, resides in the ER membrane and constitutes the 
entirety of the third branch of the ER UPR (Yoshida, Haze et al. 1998). In response to ER 
unfolded protein stress, vesicles containing ATF6 bud from the ER membrane and are 
trafficked to the Golgi, where the Site-1 (S1P) and -2 proteases (S2P) hydrolyse ATF6 
within the luminal and membrane segments respectively. The cleaved cytoplasmic 
portion translocates to the nucleus where it activates ER UPR target genes (Haze, Yoshida 
et al. 1999, Ye, Rawson et al. 2000, Chen, Shen et al. 2002). A single isoform of ATF6 
is conserved in Drosophila, and has been demonstrated to activate mTor in response to 
ER stress in S2R+ cells, in a manner dependent on S1P and S2P (Allen and Seo 2018). 
 
1.5.4 Activation and regulation of the ER UPR pathways 
 
In the 1970s and 80s, expression of two heat shock protein-related genes, glucose-
regulated protein 78 (GRP78) and 94 (GRP94), was found to be increased by stresses 
related to the endoplasmic reticulum, including manipulation of calcium homeostasis, 
inhibition of glycosylation and the deliberate expression of mutated, unfoldable proteins 
((Kozutsumi, Segal et al. 1988) and reviewed in (Lee 1987)). GRP78 was confirmed as a 
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molecular chaperone (Munro and Pelham 1986), also known as BiP, and binds the luminal 
face of IRE1, PERK (Bertolotti, Zhang et al. 2000) and ATF6 (Shen, Chen et al. 2002) 
monomers in unstressed cells. How IRE1, PERK and ATF6 are activated by unfolded 
protein stress remains to be fully elucidated, however it seems that separation of BiP from 
the three proteins plays a role in their activation. Deletion of the BiP-interacting regions 
of PERK and ATF6 led to the constitutive activation of PERK (Ma, Vattem et al. 2002), 
and translocation of ATF6 to the Golgi (Shen, Chen et al. 2002), suggesting that 
dissociation of BiP – probably to assist in the processing of unfolded proteins - directly 
activates those pathways. The dimersiation of IRE1 is promoted by loss of BiP (Bertolotti, 
Zhang et al. 2000, Kimata, Ishiwata-Kimata et al. 2007), but the subsequent binding of 
unfolded proteins is also thought necessary for IRE1 activation (Kimata, Ishiwata-Kimata 
et al. 2007), and BiP is considered a negative regulator of IRE1 that prevents excessive 
activation, rather than a direct activator (Pincus, Chevalier et al. 2010). 
  Whilst the IRE1, PERK and ATF6 branches of the ER UPR constitute separate 
pathways that are capable of simultaneous activation, it is also clear that cross-regulation 
of the branches can occur. PERK and ATF4 activation are required for both the 
transcriptional induction and ER-to-Golgi trafficking of ATF6 in mouse liver and MEFs 
treated with the ER stressor tunicamycin (Teske, Wek et al. 2011). ATF4 also upregulates 
transcription of IRE1 in mouse liver in response to tunicamycin treatment (Tsuru, Imai et 
al. 2016), whilst transcription of XBP1 is induced by ATF6 (Yoshida, Matsui et al. 2001).    
 
 
1.5.5 The ER UPR in disease 
 
The ER UPR is implicated in an extremely wide range of human diseases. Both PERK 
and IRE1 activation have been shown to drive the migration of T cells into skin lesions 
caused by the autoimmune disease vitiligo (Li, Zhu et al. 2017). Treatment with the 
chemical lipid chaperone 4-phenyl butyric acid (4-PBA) reduced ER stress and 
suppressed cell death in a macrophage model of atherosclerosis (Erbay, Babaev et al. 
2009). Similarly, IRE1 activity was increased in macrophages extracted from the synovial 
fluid of rheumatoid arthritis patients, and blocking IRE1 ribonuclease activity via the 
small molecule inhibitor 4µ8C reduced joint inflammtion in a mouse model of the disease 
(Qiu, Zheng et al. 2013). Phosphorylation of eIF2α and induction of XBP1 splicing 
associated with apoptosis in pancreatic β-cells, were prevented by treatment with the 
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unsaturated fatty acid oleate in a model of palmitate-induced diabetes (Sommerweiss, 
Gorski et al. 2013). 
 In the nervous system, the ER UPR is associated with ischaemia, 
neurodegeneration and neuropsychiatric disorders. Blood cells from patients with bipolar 
disorder displayed attenuated activation of the ER UPR in response to thapsigargin or 
tunicamycin treatment (So, Warsh et al. 2007). Reducing eIF2α dephosphorylation via 
the phosphatase inhibitor salubrinal protected rat hippocampal neurons from 
excitotoxicity produced by administration of the glutamate receptor agonist kainate 
(Sokka, Putkonen et al. 2007). Manipulation of the ER UPR to alleviate the symptoms of 
neurodegenerative disease has also been achieved. Boosting the level of eIF2α 
phosphorylation by salubrinal treatment was also neuroprotective in a PD mouse model 
generated by overexpression of mutant α-synuclein (Colla, Coune et al. 2012). Another 
inhibitor of eIF2α dephosphorylation, Sephin1, alleviated the motor symptoms of mice in 
models of Charcot-Marie-Tooth 1B disease and amyotrophic lateral sclerosis (ALS), 
whilst also reducing the aggregation of SOD1 (Das, Krzyzosiak et al. 2015). Ablation of 
XBP1 in the same mouse model of ALS upregulated autophagy and increased the removal 
of the mutant SOD1, leading to increased life span (Hetz, Thielen et al. 2009). XBP1 
knockout also increased survival in developing mice with the 6-OHDA model of PD, but 
was detrimental in older mice, causing neuron loss even without 6-OHDA treatment 
(Valdés, Mercado et al. 2014). 
 
1.5.6 Impact of ER stress on mitochondria 
 
Dysfunction of the ER can have dramatic consequences for mitochondria. A rare study 
of the early adaptations to ER stress caused by the glycosylation inhibitor tunicamycin, 
found increased ER-mitochondrial contacts and the enhanced transfer of Ca2+ to the 
mitochondria from the ER, which at this stage was associated with enhanced respiratory 
function (Bravo, Vicencio et al. 2011). Many investigations of apoptosis induced by ER 
stress that has not been adequately rectified by activation of the UPR, have reported the 
fragmentation of mitochondria, frequently attributed to Ca2+ overload and dissipation of 
the mitochondrial membrane potential (Frank, Gaume et al. 2001, Breckenridge, 
Stojanovic et al. 2003, Hom, Gewandter et al. 2007). 
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Given the close association of the ER with mitochondria, it is unsurprising that 
many studies have examined the effect of ER stress on mitochondrial morphology and 
function. Strikingly, however, the reverse is not true. Whilst investigations have 
established that the ER UPR can been activated by mitochondrial dysfunction (see 4.1), 
and ER-mitochondrial contacts are altered in disease models (see 6.1.4), none has 
























1.6 Premise of this thesis 
 
Mitochondrial dysfunction is associated with a wide range of neurodegenerative diseases, 
however few therapies exist, and comparatively little research has focused upon 
mitochondrial signalling in the nervous system. The Drosophila model system has been 
used to show that defective neuronal mitochondria can alter nuclear gene transcription 
and cellular signalling programs via mitochondrial retrograde signalling. Crucially, this 
signalling can be manipulated to improve neuronal function. There are close physical and 
functional links between mitochondria and the endoplasmic reticulum (ER), and ER stress 
has been shown to alter mitochondrial form and function. The impact of mitochondrial 
dysfunction on ER biology has been less explored, but given their physical links and 
shared functions, it is likely that perturbed ER biology has a critical role in the 
communication of mitochondrial dysfunction in the nervous system. 
In this thesis, I hypothesise that mitochondrial dysfunction will alter aspects of 
ER biology and activate retrograde stress signalling in the form of the ER UPR. I further 
hypothesise that these retrograde signals will have functional consequences for the 
affected neurons, and that their characterisation and manipulation will identify novel 
therapeutic targets for neurodegenerative disease. I use the Drosophila model system in 
order that the functional consequences of manipulation of ER UPR genes can be assessed 
alongside characterisation of the molecular changes they may mediate.  
I will address my hypotheses via the following aims: 
1. Characterise the impact of neuronal mitochondrial dysfunction on ER biology, in 
particular, ER morphology, ER-mitochondrial contacts and Ca2+ handling. 
 
2. Determine whether the ER UPR is activated by mitochondrial dysfunction in 
neurons, and whether this activation has functional consequences. 
 
3. Determine the nature of ER UPR retrograde signalling (if any) to the nucleus in 
neurons with mitochondrial dysfunction by characterising transcriptional changes 












Absolutely RNA Microprep kit (Agilent Technologies, Stratagene) 
QIAquick Nucleotide Removal Kit (Qiagen) 
QIAquick Gel Extraction Kit (Qiagen) 
DNAse I Amplification Grade kit (Sigma-Aldrich) 





P-eIF2α (1:500, rabbit Anti-Phospho-eIF2α (Ser51), Cell Signaling Technology 9721), 
ATF4 (1:250, rat, produced in this study, see Section 2.2.5), β-Gal (1:1,000, mouse Anti-
β-Galactosidase, Promega Z378A), Puromycin (1:500, mouse Anti-Puromycin, clone 
12D10, Millipore MABE343) 
Secondary antibodies: 
All 1:1,000. Goat anti-rabbit Alexa Fluor 546 (Invitrogen A11035), Cy5 AffiniPure 
donkey anti-rat (JIR 712-175-153), goat anti-mouse Alexa Fluor 633 (Invitrogen, 
A21052), goat anti-mouse Alexa Fluor 680 (Invitrogen A21058). 
Conjugated antibodies: 
HRP-Cy3 (1:1,000, Cy3 AffiniPure Goat Anti-Horseradish Peroxidase, Stratech 123-
165-021-JIR), HRP-Alexa Fluor 647 (1:1,000, Alexa Fluor 647 AffiniPure Goat Anti-






2.1.3 Fly stocks  
 
Spacial and temporal control of transgene expression in Drosophila utilised the 
Gal4-UAS system (Brand and Perrimon 1993). The yeast transcriptional activator Gal4 
is inserted into the control locus of a relevant gene, which then regulates the tissue- and 
time-specific expression of the Gal4 protein. The upstream activation sequence (UAS) has 
been optimised for Gal4 binding, and is cloned upstream of a transgene of interest. Flies 
carrying a Gal4 insert (the driver line) are crossed to flies carrying the UAS-transgene 
insert, producing offspring which express the transgene in a tissue- and time-specific 
manner (Fig. 2.1). For example, in the OK371-Gal4 driver line, Gal4 is inserted into the 
locus of the vesicular glutamate transporter and thus Gal4 is expressed in all glutamatergic 









Figure 2.1 Overview of the Gal4-UAS system. From (Brand and Perrimon 1993). 
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Stock Source & stock number Construct 
ID 
Background strain 
w1118 Bloomington 6326  
Gal4 driver lines 
w*;D42-Gal4 Bloomington 8816  
w*;Da-Gal4 Bloomington 55851  
w1118;OK371-Gal4 Bloomington 26160  




w; Sco/Cyo; MKRS/TM6B Alic Lab, University College 
London 
 
w; Sco/Cyo Bateman Lab, King’s College 
London 
 
UAS-TFAM3M; Mef2/TM6B Mef2 from Bloomington 
27390 
 
Mitochondrial dysfunction models  
w1118;UAS-TFAM3M (Cagin, Duncan et al. 2015)  
y1,sc*,v1;UAS-ND75 dsRNA Bloomington 33910 HMS00853 
















from Bloomington 30909 
 
OK371-Gal4,Rtnl1∷YFP Rtnl1∷YFP (II) from (Lowe, 
Rees et al. 2014) 
 
Mitochondrial reporter 








Ca2+ imaging  
w1118;OK371-Gal4, 
UAS-GCAMP6m 
UAS-GCAMP6m (II) attP40 
from Bloomington 42748 
 
w1118;OK371-Gal4, UAS-CaMPARI w*;UAS-CaMPARI (II) 





UAS-4mtGCAMP3 (III) from 
(Drago and Davis 2016) 
 
w*;UAS-dTrpA1 (III) attP2  Bloomington 26264  
y1,v1;UAS-Stim dsRNA Bloomington 27263 JF02567 
ER UPR  
w1118; UAS-PERK dsRNA VDRC 16427 GD5584 
y1,sc*,v1;UAS-PERK dsRNA Bloomington 35162 GL00030 
y1,v1;UAS-PERK dsRNA Bloomington 42499 HMJ02063 
w1118;UAS-PERK (III) (Malzer, Daly et al. 2010)  
y1,v1;UAS-eIF2α dsRNA/TM3, Sb1 Bloomington 44449 GLC01598 
UAS-eIF2α (III) AttP 86Fb FlyORF F001282 P002239 
y1,sc*,v1;UAS-GADD34 dsRNA Bloomington 33011 HMS00811 
UAS-GADD34 dsRNA VDRC 107545 KK104106 
UAS-GADD34-HA (III) AttP 86Fb FlyORF F003018 P006001 
y1,v1;UAS-ATF4 dsRNA Bloomington 25985 JF02007 
w1118;UAS-ATF4 dsRNA VDRC 2935 GD1407 
UAS-ATF4-HA (III) AttP 86Fb FlyORF F000106 P000084 
y1,sc*,v1;UAS-IRE1 dsRNA Bloomington 35253 GL00141 
y1,sc*,v1;UAS-IRE1 dsRNA Bloomington 62156 HMC05163 
UAS-IRE1 (III) (Coelho, Cairrão et al. 2013)  
y1,v1;UAS-XBP1 dsRNA Bloomington 25990 JF02012 
y1,sc*,v1;UAS-XBP1 dsRNA Boomington 36755 HMS03015 
w*;UAS-XBP1-EGFP (II) Bloomington 60730  
y1,v1;UAS-ATF6 dsRNA Bloomington 26211 JF02109 





Integrated stress response 
y1,sc*,v1;UAS-GCN2 dsRNA Bloomington 35355 GL00267 
UAS-GCN2 dsRNA VDRC 103976 KK103566 
Lacz reporters 









from Tear lab, King’s College 
London 
 





2.2.1 Fly maintenance and breeding 
 
Flies were maintained in incubators with a 12 hour light/dark cycle. General fly stocks 
were maintained at 18 °C, and working stocks at 25 °C. Virgin females were collected in 
the morning and evening. With the exception of experimental crosses, all fly work 
(maintenance of stocks, collection of flies for assays, storage of virgins etc) utilised R1 
food (see below). Experimental crosses were set up on R2 (see below) supplemented with 
dried active yeast (Allinson), and unless otherwise stated, were incubated at 25 °C for the 
duration of the experiment. 
Fly food recipe 1 (R1) was made as follows: 6.4 g Agar (Fisher), 64 g glucose 
(Sigma), 16 g ground yellow corn and 40 g Brewer’s yeast (MP Biomed Europe) were 
mixed and cooked in 1 L (total volume) distilled water in a Systec MediaPrep steriliser. 
After cooling to below 60 °C, the preservative propionic acid (3 mL, Fisher), and 
antimicrobial agents methyl 4-hydroxybenzoate (1.8 g, Sigma) and ethanol (16 mL, 
Sigma) were added, and the mixture stirred for a further 10 minutes. The molten food was 
then dispensed into vials and bottles (Regina Industries Ltd), left to solidify, and stored 
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at 4 °C. Recipe 2 (R2) was identical in preparation, except for the addition of 80 g 
Brewer’s yeast in place of the 40 g contained within the less rich R1. 
2.2.1.1 Generation of fly stocks 
 
To generate stocks where the transgene of interest (TOI), e.g. a dsRNA hairpin against an 
ER UPR factor, was on the third chromosome (i.e. not the same chromosome as 
UAS-TFAM3M), male flies with the TOI were crossed to virgins from the multiple 
balancer stock w; Sco/Cyo; MKRS/TM6B. Male progeny of the genotype 
+/Cyo; TOI/MKRS were collected, and crossed to UAS-TFAM3M; Mef2/TM6B virgins. 
Virgin and male progeny from that cross were collected to form the stock 
UAS-TFAM3M/(Cyo); TOI/(TM6B). 
Homologous recombination in the female germline was harnessed to create stocks 
where the transgene of interest (TOI) resided on the same chromosome as UAS-TFAM3M 
(chromosome II). UAS-TFAM3M virgins were crossed to males with the TOI. 
UAS-TFAM3M/TOI virgins were collected from the progeny, and crossed to the double 
balancer stock Sco/Cyo. The progeny from this cross were examined for the presence of 
recombination. Flies heterozygous for the UAS-TFAM3M insert have orange eyes, and 
where the TOI also carried an eye colour marker, successful recombination could be 
judged by a darker combined eye colour. All recombinations were confirmed by PCR. 
Before genotyping by PCR, single males from the last cross, balanced over Cyo, were 
crossed to Sco/Cyo virgins. Males and virgins were collected from the progeny of this 
cross to create the final stock, and if the genotyping PCR was positive, the stock was kept. 
To genotype each line, a single male fly was homogenised with a pestle in 50 µL 
of squishing buffer (25 mM NaCl (Fisher), 10 mM Tris-HCl (Fisher) pH 8, 1 mM EDTA 
(Fisher) pH 8). The homogenate was pulsed down in a microfuge, 1 µL of 10 mg/mL 
Proteinase K (Thermo Fisher) was added and the tube incubated at 37 °C for one hour. 
The Proteinase K was then inactivated by transferring the tube to 95 °C for 3 minutes. 
After centrifugation at 13,000 RPM for 5 minutes, 2 µL of the supernatant was used as 
the DNA template in PCR reactions. 
For all genotyping, except the location of KK line hairpin RNA insertion sites (see 
below), the following PCR mix was used: 4 µL 5X Green GoTaq reaction buffer, 2 µL 8 
mM dNTPs, 0.1 µL GoTaq G2 DNA polymerase (all from Promega), 1 µL 10 mM 
forward primer, 1 µL 10 mM reverse primer, 2 µL DNA template (from squished fly), 
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9.9 µL ddH2O. See Table 2 for primers. The following program was then run on the 
PTC-200 Gradient Thermal Cycler PCR machine (MJ Research): 95 °C for 3 minutes, 
then 35 cycles of 95 °C for 30 seconds, 55 °C for 30 seconds and 72 °C for 90 seconds, 
followed by a final extension of 72 °C for 10 minutes. 
The KK library of RNAi lines was designed to provide integration of the RNA 
hairpins at a single site, 40D on chromosome 2L. However, during construction of the 
library, RNA hairpins were instead aberrantly inserted at the 30B locus (also on 
chromosome 2L) in all lines, and additionally at the 40D locus in some lines. Therefore, 
a subset of KK lines possess duplicated RNA hairpins. This was discovered in 2016 
(Vissers, Manning et al. 2016), and multiplex primers made available to test for the 
presence of these hairpins at 30B and 40D. Therefore KK line genotyping also included 
PCR to determine the presence or absence of the hairpins at 30B and 40D. The reaction 
mix was as follows: 4 µL 5X Green GoTaq reaction buffer, 2 µL 8 mM dNTPs, 0.1 µL 
GoTaq G2 DNA polymerase, 1 µL 10 mM C_Genomic_F primer OR 1 µL 10 mM 
NC_Genomic_F primer, 1 µL 10 mM pKC26_R primer, 1 µL pKC43_R primer, 2 µL 
DNA template (from squished fly), 8.9 µL ddH2O. The PCR program was: 95 °C for 3 
minutes, then 35 cycles of 95 °C for 30 seconds, 51 °C for 30 seconds and 72 °C for 90 














Stock/primer name Primer Sequence 
UAS-TFAM3M Fwd 5’-GAGTCGCGCAAGGAGATG-3’ 
UAS-TFAM3M Rvs 5’-GGATCGATAAGATTTCCGTGA-3’ 
Transgenic RNAi Project (TRiP) lines (from Bloomington): 
pVALIUM20 Fwd 5’-ACCAGCAACCAAGTAAATCAAC-3’ 
pVALIUM20 Rvs 5’-TAATCGTGTGTGATGCCTACC-3’ 


















For KK line RNA hairpin insertion site(s): 
C_Genomic_F Fwd 5'-GCCCACTGTCAGCTCTCAAC-3' 
NC_Genomic_F Fwd 5'-GCTGGCGAACTGTCAATCAC-3' 
pKC26_R primer Rvs 5’-TGTAAAACGACGGCCAGT-3’ 
pKC43_R primer Rvs 5’-TCGCTCGTTGCAGAATAGTCC-3’ 










2.2.2 Dissections and immunofluorescence 
 
All dissections for imaging experiments were performed on larvae at wandering late third 
instar stage.  
 
2.2.2.1 CNS dissections for immunofluorescence 
 
The relevant fly crosses were left to egg-lay at 25°C for 3 days. The adults were then 
removed and the embryos incubated at 29°C (to enhance Gal4 activity) until dissection at 
third instar larval stage. For fixed imaging of the central nervous system (CNS), larvae 
were removed from their vial, cleaned in ice-cold PBS (Oxoid, Thermo Scientific), and 
then transferred to a drop of PBS on a Sylgard plate. The larvae were bisected with forceps 
(Agar Scientific), and the mouth end retained in the PBS. The cuticle was then inverted 
by coaxing the open end of the larvae over forceps holding the mouth parts. After the 
viscera was removed, the inverted cuticle with attached CNS was transferred to a 0.5 mL 
Eppendorf and fixed for 25 minutes in 4% formaldehyde (Thermo Scientific)/PBS. After 
three 10-minute washes with 0.1% Triton X-100 (Sigma)/PBS (PBS-T), the samples were 
blocked for one hour in 5% normal goat serum (NGS) (Yorlab)/PBS-T. The relevant 
primary antibodies were applied in 5% NGS/PBS-T, and left rocking overnight at 4°C. 
Following three further 10-minute PBS-T washes, the samples were incubated with 
secondary antibody/PBS-T at room temperature for one hour, and then washed x2 with 
PBS-T and x1 with PBS (10 minutes per wash). The samples were then transferred in 
PBS onto SuperFrost Plus microscope slides (ThermoScientific), where the cuticle was 
removed and the CNS mounted dorsal side up in Vectashield (Vector Laboratories) under 
22 x 22 mm size 0 coverslips (Academy). The slides were stored at 4 °C in the dark. 
 
2.2.2.2 NMJ dissections for immunofluorescence 
 
For fixed imaging of the neuromuscular junction (NMJ), larvae were cleaned, stunned 
and placed in PBS on a Sylgard plate, as for the CNS. The head and tail ends of the larvae 
were then immobilised by micro-pin (Entomoravia) with the larvae dorsal side up, and 
the larvae cut open longitudinally with iridectomy scissors (Fine Science Tools). After 
the viscera was removed, two cuts perpendicular to the original central cut were made at 
each end to open up the larval cuticle into a rectangular fillet. The four corners of the 
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cuticle were pinned, and the PBS removed and replaced with 4% formaldehyde/PBS, in 
which the sample was fixed for 15 minutes. After fixation, the samples were transferred 
to 0.5 mL Eppendorfs in PBS-T, and the washes and primary/secondary antibody 
incubation proceeded as described for the CNS. Conjugated HRP antibodies were treated 
as secondary antibodies, and applied for one hour at room temperature (alongside any 
secondary antibodies relevant to the experiment). For mounting, samples were transferred 
cuticle side down to SuperFrost Plus microscope slides in PBS, the head and tail removed 
by iridectomy scissors, and the PBS replaced by Vectashield mounting medium. After 22 
x 22 mm size 0 coverslips were applied, the slides were stored at 4 °C in the dark. 
 
2.2.3 Microscopy and quantifications 
 
All fixed and live images were taken on a Zeiss LSM 710 confocal microscope with ZEN 
software (Version 6, 2010). Settings were resolution = 1024 x 1024 pixels, averaging = 2, 
and speed = 9, unless otherwise stated. Samples were aligned using a 10x objective 
(numerical aperture (NA) = 0.30), and then images were taken using a 40x oil immersion 
objective (NA = 1.30). z-stacks were taken with inter-section intervals of 1 µm and 
0.5 µm for the CNS and NMJ respectively. All image quantification was via the image 
processing software ImageJ (National Institutes of Health, USA). 
For calcium imaging, see Section 2.2.4. 
 
2.2.3.1 Quantification of mitochondrial morphology 
 
A single section through the centre of the motor neuron cell bodies was selected from 
each z-stack. The images were then thresholded in ImageJ, and binary masks created. 
Regions of interest containing seven cell bodies were selected via the freehand tool, and 
then the number of mitochondria, and the area and perimeter of each mitochondria, was 
obtained via Analyze > Analyze particles. The minimum size cut-off was 0.01 µm2 





2.2.3.2. Quantification of ER morphology 
 
Quantification of ER morphology was adapted from the method in (Yalçın, Zhao et al. 
2017). ER morphology in neuronal cell bodies was quantified in the dorsal medial motor 
neuron clusters. After maximum intensity z-projections across 3 consecutive sections 
through the centre of the cells were obtained, the cells in each projection were numbered, 
and then three were selected by random number generator. Three lines per selected cell 
were drawn orthogonally from the nuclear to plasma membrane according to one of four 
pre-defined patterns - also selected by random number generator - giving a total of nine 
quantified lines per sample. The fluorescence intensity profile along each line was 
obtained via Analyze > Plot profile, and these values were transferred to an Excel 
spreadsheet. The variance and mean intensity of the fluorescent signal were computed 
across rolling windows of 5 pixels (~346 nm) for BiP-sfGFP-HDEL and 
lyso-RFP-KDEL, and 7 pixels (~363 nm) for tdTomato-Sec61β, and combined into the 
quotient ‘Variance/mean intensity’ to provide a readout of local fluctuations in 
fluorescence normalised to the local intensity of the signal. To compute the overall 
‘Variance/mean intensity’ per sample, the mean of ‘Variance/mean intensity’ values per 
window (i.e. per 5 or 7 pixels) was calculated for each line, and then the mean of these 
nine values was obtained to give the final figure. To obtain the ‘Variance/mean intensity’ 
positional values, the ‘Variance/mean intensity’ for each successive window, from the 
nuclear membrane outwards, was averaged across all the lines drawn (giving n = 9 x no. 
of samples), and was plotted for all windows with n ≥ 20. (i.e. the mean ‘Variance/mean 
intensity’ of the first window across all n lines, followed by the mean ‘Variance/mean 
intensity’ of the second window across all n lines, and so on until fewer than 20 lines 
were long enough to have the ith window). ER morphology at the neuromuscular junction 
was quantified in type 1b NMJs, on muscle 4, abdominal segment 2, of third instar larvae. 
‘Variance/mean intensity’ was calculated along a segmented line that followed the 
contours of the axon from a terminal bouton to the junction of the axon with the segmental 
nerve. One line was drawn per sample. Overall ‘Variance/mean intensity’ and positional 






2.2.3.3. Quantification of ER-mitochondrial contacts 
 
For quantifications of ER-mitochondrial contacts in the cell bodies of dorsal medial motor 
neurons, single sections across the centre of the cells were selected from the acquired 
z-stacks. Nine lines per sample were drawn orthogonally from the nuclear to plasma 
membranes, using the same random selection procedure described for ER morphology 
quantification (2.2.3.1), and the fluorescence intensity profile was obtained for each line 
and transferred to an Excel spreadsheet. To accommodate the wide range of fluorescence 
intensities displayed by the tdTomato-Sec61β and lyso-RFP-KDEL reporters, local 
thresholding was applied to determine the boundaries of the ER along the lines. Firstly, 
the profiles were smoothed to reduce noise by two rounds of averaging across 5 pixel 
windows. After this smoothing, pixels that represented peaks in the signal were identified 
as those for which the immediately adjacent pixels either side had lower fluorescence 
intensities. Troughs were similarly identified as pixels whose two immediate neighbours 
both had higher fluorescence intensities. Pixels along the smoothed fluorescence intensity 
profiles were considered to fall within the ER if they had an intensity value greater than 
the average of their nearest peak and trough. The same thresholding was applied to the 
mitoGFP signal, with the addition of a minimum cut-off because the signal was cleaner. 
The distance (in pixels) between the boundaries of the two organelles was then calculated. 
At ER-mitochondrial contact sites, the distance between the two organelles is 10-25 nm 
(Csordás, Renken et al. 2006). 106.27 µm x 106.27 µm images of tdTomato-Sec61β and 
mitoGFP were taken in 2048 x 2048 pixel frames (so 1 pixel represents ~52 nm), and 
therefore 0 pixel gaps between the ER and mitochondrial boundaries were considered to 
represent candidate ER-mitochondrial contact sites (i.e. the thresholded boundary of each 
organelle was located in the same pixel). For quantification of ER-mitochondria contacts 
at the neuromuscular junction, fluorescent intensity profile plots from the terminal 
boutons to the junction of the axon with the segmental nerve were obtained as described 
for ER morphology. These profile plots were then processed as described above for ER-






2.2.3.4. Quantification of all other fluorescent images 
 
For experiments with either a nuclear (UAS-nlacz) or membrane marker 
(UAS-CD8-GFP), maximum intensity projections of z-stacks through the dorsal side of 
the VNC were obtained. 50 points in the nuclear or cytoplasmic region of interest were 
then selected in the marker channel (e.g. CD8-GFP) without reference to the channel of 
interest (e.g. P-eIF2α). The average fluorescence intensity of those 50 points was then 
obtained in the channel of interest. 
For experiments without nuclear or membrane markers, see Calcium imaging and 
quantifications (Section 2.2.4) 
 
2.2.4 Calcium imaging and quantifications 
 
2.2.4.1 Basal (unstimulated) calcium levels  
 
2.2.4.1.1 Cytosolic and mitochondrial GCaMP imaging 
Live imaging was performed for all experiments with the genetically encoded Ca2+ 
sensors, GCaMPs. Larvae were dissected in Schneider’s medium (Sigma) to allow the 
high glutamate concentration to reduce muscle twitching. Pinned flat-preparations were 
created as described for NMJ dissections in 2.2.2.2, but instead of fixing, the tail and 
mouth structures were removed, the CNS retained and the sample then transferred to a 
SuperFrost Plus microscope slide by forceps, taking care to preserve the integrity of the 
axonal bundles and neuromuscular junction contacts. A coverslip was applied with 15 µL 
of Schneider’s underneath to hydrate the sample. z-stacks were taken on the LSM710 
confocal using the 488 nm laser, with 0.5 µm and 1 µm inter-slice intervals for the NMJ 
and VNC respectively. Maximum intensity projections were created for quantification of 
both the cytosolic and mitochondrial GCaMPs. 50 points were selected in fluorescent 







2.2.4.1.2 Calcium modulated photoactivatable ratiometric integrator (CaMPARI) 
imaging 
 
Individual wandering third instar larvae were selected from a vial, washed in room 
temperature PBS, and then allowed to orient themselves in normal crawling posture 
dorsal side up on a 22 x 22 mm size 0 coverslip. A drop of PBS was applied to a 
SuperFrost Plus microscope slide, and the coverslip was then inverted onto the slide, 
placing the larvae ventral side up in PBS. The ventral head region was then exposed to 
30 seconds of UV epifluorescence, with the larvae tracked down the ocular to ensure that 
the CNS remained within the field of the laser for the duration of the UV exposure. Each 
larva was then immediately bisected, inverted and fixed in 4% formaldehyde/PBS for 25 
minutes (as described for CNS dissections in 2.2.2.1). After 3 x 10 minute washes in PBS-
T, and 1 x 10 minute wash in PBS, the CNS was mounted on a microscope slide in 
Vectashield, also as described in 2.2.2.1. The samples were imaged on the LSM 710 
confocal with the default (green) and photoconverted (red) isoforms excited using 488 
nm and 543 nm lasers respectively. For quantification, 50 points were selected in the cell 
bodies in the green channel of a maximum intensity projection of the dorsal half of the 
VNC. The average of those 50 points was then measured in both the green and red 
channels to give the red:green fluorescence ratio. 
 
2.2.4.2 Stimulated calcium level imaging 
 
After the removal of adults from the experimental cross, embryos were retained at 25 °C 
(i.e. not transferred to 29 °C) to avoid overactivation of TrpA1 channel. Wandering third 
instar larvae were bisected and the cuticle inverted (as described in 2.2.2.1) in 
hemolymph-like 3.1 (HL3.1) media (70 mM NaCl, 5 mM KCl (Fisher), 1.5 mM CaCl2 
(Sigma), 4 mM MgCl2 (Sigma), 10 mM NaHCO3 (Life Technologies), 5 mM Trehalose 
(Fisher), 115 mM sucrose (Sigma) and 5 mM HEPES (Alfa Aesar), from (Feng, Ueda et 
al. 2004)). The CNS was dissected from the inverted cuticle, and retained on the 
microscope slide in residual HL3.1. A 1 mm thick, 10 mm external diameter, rubber o-
ring was placed around the CNS to serve as a mould for the agarose that was used to 
immobilise the sample during imaging. The o-ring was flooded with molten 1% low-melt 
agarose (2-hydroxyethyl agarose (Sigma), in HL3.1 media) ejected from a P1000 pipette 
with sufficient force to carry the CNS to the surface of the agarose. The slide was then 
placed in the fridge for ~5 minutes to allow the agarose to set, after which the o-ring was 
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carefully removed and a 22 x 22mm size 0 coverslip placed directly onto the agarose. 
Activation of the TrpA1 channel was achieved via a peltier (Hebei TEC1-12706) secured 
flush underneath the microscope slide during imaging. The peltier was connected to the 
Thurlby Thandar PL154 powerpack (RS Components) and calibrated to ramp to a 
temperature of 25 °C using an infrared thermometer (GM320, L-FENG-UK) pointed at 
the surface of the peltier whilst the voltage was adjusted. Time series were taken at 2 Hz 
on the LSM710 confocal microscope using the 20x objective (NA = 0.50). The duration 
of peltier on/off intervals were timed using a standard laboratory timer. Times series were 
quantified by plotting the profile of 50 points (selected within the region of interest e.g. 
the cell bodies) across each frame.  
 
 
2.2.5 ATF4 antibody creation 
 
A 180 bp region common to all isoforms of Drosophila ATF4, but upstream of the 
conserved DNA binding domain, was cloned into the pGEX4T-2 (Amersham) vector to 
create a 60 amino acid region of ATF4 tagged with full-length glutathione-s-transferase 
(GST).  
 
Cloning procedure: the 180 bp insert was amplified by PCR from the Drosophila 
wild-type Oregon-R genome using primers 
ATATTGGATCCGAATGTCTTTTGGACCAAAAGGC (Fwd – BamHI site) 
AGCGACTCGAGAGCCATCATTGAGCTGGTAAT (Rvs – XhoI site) 
and the high fieldity Q5 polymerase (NEB) according to the manufacturer’s protocol. The 
PCR program was: 98 °C for 30 seconds, then 35 cycles of 55 °C for 30 seconds, 72 °C 
for 1 minute, 98 °C for 10 seconds, followed by a final extension of 72 °C for 5 minutes. 
The insert was purified using the Qiagen QIAquick Nucleotide Removal Kit and both 
insert and plasmid were double digested with BamHI and XhoI in the buffers 
recommended by the supplier (NEB). The digested fragments were purified with Qiagen 
QIAquick Gel Extraction Kit before being combined in a 1:3 vector:insert molar ratio 
with T4 DNA ligase (HC) (Thermo Fisher Scientific). After 6 days at 4 °C, 1 µL of the 
ligation mixture was used to transform One Shot TOP10 chemically competent E. coli 
(Thermo Fisher Scientific), which were then plated onto ampicillin-agar plates. After 
overnight incubation at 37 °C, colonies were miniprepped using the alkaline lysis method, 
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and tested for the presence of cloned plasmid by restriction enzyme digest. Positive preps 
were Sanger sequenced (Souce BioScience) to confirm correct cloning. 
 
Fusion protein (antigen) expression and purification: The pGEX-4T-2-ATF4 
plasmid was transformed into competent BL21 (DE3) cells (NEB) for protein expression. 
A 3 mL positive culture of BL21 (DE3)-pGEX-4T-2-ATF4 in LB broth (Fisher) was then 
grown at 37 °C and induced  by 0.1 mM (final concentration) IPTG (Sigma). After two 
hours the cells were pelleted, lysed and run on an SDS-PAGE gel (see 2.2.6) and stained 
with Coomassie (Pierce, Thermo Fisher Scientific) to confirm the solubility of the ATF4-
GST fusion. For larger scale production of the antigen, a 3mL starter culture in 2xTY 
media (1.6 g Bacto-Tryptone (Becton, Dickinson & Co.), 1 g yeast extract (Oxoid, 
Thermo Scientific) 0.5 g NaCl in 100 mL ddH2O, pH 7) was grown all day in a shaking 
incubator at 37 °C, and then 400 µL was used to innoculate a 20 mL 2xTY overnight 
culture. The following day, 10 mL of the overnight culture was used to innoculate a 
500 mL final culture of BL21 (DE3)-pGEX-4T-2-ATF4 in 2xTY. Protein expression was 
induced by 0.1 mM IPTG when the culture reached an OD600 of 0.8. The culture was 
left shaking at 37 °C for a further 5 hours after induction, and then decanted into 10 x 50 
mL Falcon tubes and pelleted at 4,000 g for 15 minutes. The pellets were combined and 
resuspended in 30 mL ice-cold lysis buffer (50 mM Tris, 50 mM NaCl, pH 7.5) and then 
sonicated on ice. The sonicated solutions were re-pelleted at 12,000 RPM, 4 °C, for 10 
minutes, the supernatant removed and saved, and the pellet resuspended in 20 mL lysis 
buffer. The 20 mL solution was re-sonicated, then re-pelleted (12,000 RPM, 4 °C for 10 
minutes) and the supernatant combined with the 30 mL saved from the first sonication to 
give 50 mL of supernatant containing cellular proteins. 0.75 mL (bed volume) of 
glutathione sepharose beads (4B, GE Healthcare), pre-washed x4 in ice-cold lysis buffer, 
were added to this supernatant and it was left rocking at 4 °C for three hours. The beads 
were then pelleted (2,000 RPM, 4 °C, for 2 minutes), the unbound proteins removed, and 
the beads washed three times with 50 mL lysis buffer (resuspended in lysis buffer, then 
re-pelleted at 2,000 RPM, 4 °C, for 2 minutes). The ATF4-GST fusion was eluted in 3 x 
1 mL elution buffer (PBS + 10 mM glutathione (Sigma)) by adding 1 mL of buffer, 
rocking at 4 °C for 10 minutes and then pelleting at 2,000 RPM, 4 °C for 2 minutes. 10 
µL of eluate was run on an SDS-PAGE gel alongside bovine serum albumin (BSA) 




Antibody production from the antigen: 2.5 mL of purified ATF4-GST was sent 
on ice to Envigo RMS UK Ltd, who immunised Sprague Dawley rats with the antigen 
alongside Freund’s Complete Adjuvant, performed three booster injections of the antigen 
with Freund’s Incomplete Adjuvant and then harvested the antisera, which was shipped 
to us at -20 °C. On arrival, 0.01% (final concentration) sodium azide was added, and the 
antibody stored at -20 °C. 
  
 
2.2.6 Translation assay and western blot analysis 
 
For each genotype, the CNS were dissected from 30 third instar larvae by bisection and 
inversion of the cuticle (as described in 2.2.2.1). Dissection was performed in room 
temperature Schneider’s medium, and the 30 CNS placed in a 1.5 mL Eppendorf 
containing 500 µL room temperature Schneider’s. The Schneider’s was then removed 
from the Eppendorf by a gel-loading pipette tip (VWR) - further narrowed by 
compression with forceps, to avoid removing the CNS alongside the media – and replaced 
with 24 µL of ice-cold solubilisation buffer (300 mM NaCl, 15 mM MgCl2, 15 mM 
Tris-HCl pH 7.5, 1% Triton-X100, 2 mM  DTT (Fisher Scientific), 100 µM puromycin 
(Sigma)) + 1.2 µL of 20 U/mL RiboLock RNAse inhibitor (Thermo Fisher Scientific). 
The samples were pipetted up and down 50 times with a P200 pipette to homogenise, and 
then left at 4 °C for 10 minutes to allow puromycin incorporation into nascent 
polypeptides. To quench the reactions and prepare the samples for sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 6 µL of 5x SDS loading buffer 
(30% glycerol (Sigma), 4.5% SDS (VWR), 250 mM Tris pH 6.8, trace of bromophenol 
blue (Fisher)) was added and the samples incubated at 95 °C for 10 minutes, before 
storage at -20 °C. 
 
 The incorporation of puromycin was assessed by western blot (the samples were 
run on an SDS-PAGE gel, transferred to a nitrocellulose membrane, and probed with an 
antibody to puromycin) as follows: 
 Creation of the SDS-PAGE gel: The 13% running gel was made by mixing 3.2 
mL 40% acrylamide (Fisher), 2.5 mL 1.5 M Tris pH 8.8, 0.15 mL 10% SDS and 4.15 mL 
ddH2O in a 15 mL Falcon. The polymerising agents 20 µL tetramethylethylenediamine 
(TEMED) (Sigma) and 70 µL 10% ammonium persulfate/ddH2O (APS) (Sigma) were 
then added and the gel poured between glass plates (Bio-Rad) set at 1 mm distance. A 
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layer of isopropanol was applied to level the top surface of the gel. After 30 minutes, the 
isopropanol was removed, the top of the gel rinsed with ddH2O and the inter-plate gap 
dried with filter paper. An 8% stacking gel was made by mixing 1 mL acrylamide, 
1.25 mL 0.5 M Tris pH 6.8, 0.05 mL 10% SDS and 2.7 mL ddH2O, then adding 7 µL 
TEMED and 45 µL APS. The stacking gel was poured on top of the polymerised running 
gel, and a 10-well comb added to create the wells for protein loading. 
 
 Electrophoresis: After the stacking gel was left to polymerise for 30 minutes, the 
comb was removed and the gel plates secured within the running module of a Bio-Rad 
electrophoresis cell, opposite a buffer dam. Running buffer (0.025 M Tris, 0.19 M 
glycine, 0.1 % SDS, pH 8.3) was added to the indicated level on the tank. Prior to loading, 
the samples were thawed, briefly microfuged, and the supernatant transferred to a new 
Eppendorf. 0.5 µL 1 M DTT was added and the samples re-incubated at 95 °C for 2 
minutes. After cooling, 25 µL of each sample was loaded into the gel and run at 70 V for 
30 minutes through the stacking gel, and then 100 V for two hours. 
 
 Transfer: Separated proteins were transferred to a 0.2 µm nitrocellulose 
membrane (GE Healthcare) via the Xcell SureLock transfer chamber at 25 V for 2 hours. 
Transfer buffer was 0.025 M Tris, 0.19 M glycine, 0.1 % SDS, 20% methanol, pH 8.3. 
 
 Antibody and imaging: After the blot was blocked in 10% 
dried milk (Marvel)/Tris-buffered saline (TBS), the primary anti-puromycin antibody 
was added 1:500 in 5% dried milk in Tween 20(Sigma)/TBS (TBS-T) and incubated 
overnight at 4 °C. The following morning the blot was washed four times in TBS-T (10 
minutes per wash) and then incubated with secondary antibody (Alexa Fluor 680) in 5% 
milk/TBS-T for one hour. After washes x2 with TBS-T and x2 with TBS, the blot was 
scanned on the Odyssey Imager (LI-COR).   
 
 
2.2.7 Assays of neuronal function 
 
2.2.7.1 Climbing assay 
 
Male flies of appropriate genotype were selected under CO2 anaesthesia, within 24 hours 
of eclosion. Assays were undertaken 24-48 hours later to allow the flies to recover from 
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the anaesthetic, 1-3 hours after morning illumination. Individual flies were aspirated from 
a vial into a 10 mL serological pipette (Falcon). Flies were relocated to the base of the 
pipette by tapping against the bench. The height obtained in three, continuous, 10 second 
climbs was measured for each fly, and the mean computed to give the data point for that 
insect (Fig. 2.2 A). Wandering (i.e. non-vertical) or discontinuous climbs were excluded. 
Climbing assays assessing the impact of XBP1 knock-down (line 25990) and 




2.2.7.2 Wing inflation assay 
 
All flies that eclosed from each cross were collected under CO2 anaesthesia, and stored 
at 25°C for ≥24 hours to ensure that an uninflated wing phenotype was not due to young 
age. The number of flies in each category - inflated, semi-inflated and uninflated 
(Fig. 2.2 B) - were then counted. Chi-squared tests were performed on the raw data (i.e. 










































Figure 2.2 Assays of neuronal function. (A) Schematic of the climbing assay. 
(B) Adult Drosophila with inflated, semi-inflated and uninflated wings. Photos 
courtesy of Olivia Duncan. 
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Before RNA sequencing was undertaken, qRT-PCR was performed to confirm that 
expression of dsRNA against ATF4 by RNAi line 25985 caused a knock-down of ATF4 
mRNA. The follow intron-spanning primers were used for ATF4 and the housekeeping 
gene Rpl4: 
 
ATF4 forward: 5’- ATTCACTGCTGCCGCAAAA-3’ 
ATF4 reverse:  5’-GTTCAACGTTGCCTTTTGGT-3’ 
Rpl4 forward:  5’-TCCACCTTGAAGAAGGGCTA-3’ 
Rpl4 reverse:  5’-TTGCGGATCTCCTCAGACTT-3’ 
 
RNAi line 25985 was driven ubiquitously by the Daughterless-Gal4 (Da-Gal4) 
driver. Control larvae were the progeny of Da-Gal4 crossed to w1118. After egg-laying for 
three days at 25 °C, the embryos were incubated at 29 °C until wandering third instar 
larval stage, when the larvae were homogenised for RNA extraction. 
 
Three larvae per replicate were homogenised with a pestle in 100 µL TRIzol (Life 
Technologies). The homogenate was left at room temperature for five minutes before the 
addition of 20 µL chloroform, followed by shaking for 15 seconds, and then another three 
minutes incubation at room temperature. After microcentrifuging at 12,000 g, 4 °C for 15 
minutes, the upper phase was decanted into a new Eppendorf. 50 µL of isopropanol was 
added (to the new tube) and the mixture vortexed for 10 seconds. After incubation at room 
temperature for 10 minutes, the samples were spun at 12,000 g, 4 °C for 10 minutes and 
the supernatant discarded. The RNA pellet was washed by the addition of 200 µL 
70% ethanol, spun at 12,000 g, 4 °C for five minutes, and the ethanol removed. The RNA 
was then resuspended in 34 µL RNAse-free water, the concentration of each replicate 
measured using the NanoDrop Spectrophotometer (Thermo Scientific), and each replicate 
diluted to 150 ng/µL. 
 
 DNAse I treatment was performed with the DNAse I Amplification Grade kit 
from Sigma-Aldrich. For each sample, 2 µL of reaction buffer and 2 µL of RNAse-free 
DNAse I were added to 16 µL of RNA, and the mixture incubated at room temperature 
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for 15 minutes before 2 µL of Stop solution was added and the samples then incubated at 
70 °C for 10 minutes.  
 
 cDNA was synthesised from 10 µL RNA via the Fermentas First Strand cDNA 
Synthesis kit. DNAse I-treated RNA was incubated in a PCR tube at 70 °C for five 
minutes with 1 µL 0.2 mg/mL random hexamer primers, then chilled on ice momentarily 
and briefly pulsed in the microfuge. 4 µL of 5X M-MuLV buffer, 1 µL 20 U/mL 
RiboLock RNAse inhibitor (Thermo Fisher Scientific), 2 µL 10 mM dNTPs and 2 µL (20 
U/µL) M-MuLV reverse transcriptase were then added, and place in the PTC-200 
Gradient Thermal Cycler PCR machine for the following program: 25 °C for 10 minutes, 
37 °C for one hour, 70 °C for 10 minutes. 
 
 The cDNA was tested for genomic DNA contamination by ‘normal’ PCR with the 
primers to be used for qRT-PCR (above). The reaction mixture was as follows: 5 µL 2X 
PCRBio Ultramix (PCR Biosystems), 0.5 µL 10 µM forward primer, 0.5 µL 10 µM 
reverse primer, 2µL cDNA, 2 µL ddH2O. The PCR program: 95 °C for 10 minutes, then 
35 cycles of 95 °C for 10 seconds, 60 °C for 15 seconds, 72 °C for 20 seconds. All 
samples were free of genomic DNA. 
 
 qRT-PCR was then performed on 30 ng/µL cDNA using the Roche Lightcycler 
480 Instrument II. Eight replicates of each condition (control and ATF4 knock-down) 
were run in triplicate. The mix per reaction was: 5 µL qPCRBIO Sygreen Mix Lo-ROX 
(PCRBiosystems), 0.4 µL forward primer, 0.4 µL reverse primer, 4.2 µL cDNA. The 
qPCR program was: 95°C for 10 minutes, then 45 cycles of 95 °C for 10 seconds, 60 °C 
for 15 seconds and 72 °C for 20 seconds, and then a ramp to 95 °C to obtain the melt 
curves. cDNA standards from 120 ng/µL to 1 ng/µL were made by serial dilution and run 
under the same protocol to assess the efficiencies of the ATF4 and control (Rpl4) primers, 
which were comparable. Relative gene expression was calculated by the 2-ΔΔCt method: 
the mean Ct value for Rpl was subtracted from the mean Ct value for ATF4 for each 
sample, giving ΔCt. The smallest of the ΔCt values was then subtracted from the other 
ΔCt values, giving ΔΔCt. Both the ATF4 and Rpl4 primers had efficiencies of ~100%, so 
it could be assumed that a ΔCt equal to 1 implied a two-fold decrease in expression level, 





2.2.8.2 RNA sequencing 
 
Fly crosses were carried out as described in 2.2.1, and incubated at 25 °C for the duration. 
For each replicate, 20 CNS were dissected from third instar larvae in cold PBS, and placed 
into 100 µL of lysis buffer + β-mercaptoethanol from the Absolutely RNA Microprep kit 
(Agilent Technologies) after excess PBS had been removed from the forceps by touching 
against a paper towel. The lysis buffer was kept on ice for the duration of the dissections, 
and each larval CNS was transferred individually to the lysis buffer immediately after 
dissection. Each genotype was prepared in quadruplicate. RNA was extracted from the 
CNS tissue using the Absolutely RNA Microprep kit according to the manufacturer’s 
protocol, and RNA quality was confirmed using the RNA Pico Chip (Agilent 
Technologies) by Dr David Chambers. The samples were sent to the NGS Laboratory at 
Glasgow Polyomics, where they prepared polyA cDNA libraries using the TruSeq 
Stranded mRNA kit (Illumina), and oversaw 75 bp single-end sequencing at a depth of 
25 million reads on the Illumina NextSeq 500. The raw unaligned reads were received in 
fastq format, and mapped to the Drosophila melanogaster genome by Bateman Lab 
postdoc Dr Ramya Ranganathan, using TopHat software (Trapnell, Roberts et al. 2012). 
Alignment quality was high, with ≥ 92% overall read alignment for all samples. I then 
analysed the BAM files containing the aligned reads via the remainder of the Tuxedo 
protocol (Trapnell, Roberts et al. 2012) (Fig. 2.2). Cufflinks software was first used to 
assemble the transcriptomes – to assign the mapped reads to specific transcripts – and 
these assemblies were then passed to the Cuffdiff program to analyse differential gene 
expression. Cufflinks and Cuffdiff were both accessed via the web-based user interface 
software Galaxy (usegalaxy.org). Volcano plots and heatmaps were created in R Studio 
















Figure 2.3 Overview of the Tuxedo protocol for RNA-Seq analysis. From (Trapnell, 
Roberts et al. 2012). Cuffmerge, which integrates replicate samples to produce one 
final merged assembly, is an optional step that was considered unnecessary in the 
analysis of my samples due to the high quality annotation of the Drosophila 
melanogaster genome, and the likelihood therefore that it would serve only to 
introduce or amplify assembly errors. 
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Cufflinks was run within Galaxy with the following parameters: 
 
Maximum intron = 300,000 bp. Fragments that appear to align either side of a putative 
intron ≥300,000 bp are ignored. 
Minimum isoform fraction = 0.1. Transcripts that appear to account for < 10% of the 
expression of a particular gene are ignored. 
Pre-mRNA fraction = 0.15. Intra-intronic transcripts that appear to account for < 15% of 
the expression of a particular gene are ignored. 
Use reference annotation = Yes. The August 2014 assembly of the Drosophila 
melanogaster genome (dm6) accessed from University of California Santa Cruz (UCSC) 
(https://genome-euro.ucsc.edu/) was used to guide transcript assembly. 
Perform bias correction = Yes. Corrections are made for positional biases introduced by 
library preparation i.e. the over-representation of fragments at certain locations within a 
transcript (Roberts, Trapnell et al. 2011). 
Use multi-read correct = Yes. Initial estimates of transcript abundance are made before 
reads that could be mapped to multiple locations in the genome are assigned fractional 
locations. For example, if multi-read correct is not enabled, and a read could map to four 
positions within the genome, each position would be assigned 0.25 of a read. With 
multi-read correct enabled, read fractions (e.g. 0.15, 0.2, 0.3 & 0.35) are assigned to each 
location based on transcript abundance estimates, corrections for fragment length and 
fragment bias. 
Apply length correction = Cufflinks effective length correction. Fragments per kilobase 
of transcript per million reads (FPKM) values for short transcripts are adjusted upwards 
in accordance with the overall size distribution of library fragments, to account for the 
fact that short transcripts will produce very few fragments above the minimum read 
length. 
 
Cuffdiff was run within Galaxy with the following parameters: 
 
Library normalization method = geometric. Geometric means of fragment counts for each 
replicate/library are calculated. FPKMs and fragment counts are then scaled via the 
median of the geometric mean for each replicate/library. 
Dispersion estimation method = pooled. Provides an estimate for dispersion by modelling 
how far the variance in the samples extends beyond that expected for a Poisson 
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distribution (where variance = mean). Pooled method averages the models for each 
replicate into one model for all conditions within the experiment. 
False discovery rate = 0.05. 
Minimum alignment count = 10. Significance tests to determine differential gene 
expression were conducted on all locuses with at least 10 alignments. 
Use multi-read correct = Yes. See parameters for Cufflinks. 
Perform bias correction = Yes. See parameters for Cufflinks. 
Apply length correction = Cufflinks effective length correction. See parameters for 
Cufflinks. 
 
The following thresholds were applied to the data output from Cuffdiff: A gene 
was considered to be meaningfully expressed if the average FPKM across the four 
replicates was ≥ 1 for at least one condition. A gene was considered to be significantly 
up- or downregulated if the fold-change was ≥ ± 1.5 (and the adjusted p value < 0.05). 
 
Gene ontology clustering was performed using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID), accessed at https://david.ncifcrf.gov, 
with guidance from (Huang da, Sherman et al. 2009). The significantly regulated genes 
in each condition (Control vs. TFAM overexpression, Control vs. ATF4 overexpression 
and TFAM overexpression vs. TFAM overexpression, ATF4 RNAi) were entered into 
DAVID in ‘Official gene symbol’ format (i.e. gene name), and the functional annotation 
clustering feature used with default settings. 
 
 
2.2.9 Statistical methods 
 
For RNA-Seq statistical methods see 2.2.8. 
 
All other statistical tests were performed in GraphPad Prism (Version 5.02, 2008, 
GraphPad Software Inc.). GraphPad Prism was also used to create all graphs, with the 
exception of the RNA-Seq heatmaps and volcano plots which were created in R Studio 
via the cummeRbund package.  
 
Pairwise comparisons were analysed via unpaired two-tailed t-test, with Welch’s 
correction applied if the variances of the samples was significantly different. Data 
requiring multiple comparisons (continuous data with three or more conditions) were 
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analysed by parametric one-way ANOVA with Tukey’s post-hoc test. Chi-squared tests 
were used to analyse categorical data. p values < 0.05 were considered significant 





























3. Investigating the impact of mitochondrial 




Mitochondrial retrograde signals communicate the functional status of the mitochondria 
to the nucleus. Mitochondrial dysfunction is strongly implicated in oncogenesis and 
metastasis, and therefore most retrograde signalling research has been performed in 
profilerating cell models. Given that mitochondrial dysfunction is also a hallmark of 
many neurodegenerative diseases, understanding mitochondrial retrograde signalling in 
neurons represents an important opportunity to identify novel therapeutic targets. 
 
 Mitochondria are not spatial or functional islands, they interact physically and 
functionally with many other organelles. In particular, significant areas of the ER are 
closely apposed to mitochondria, in regions termed mitochondria-associated membranes 
(MAMs). An array of protein tethering complexes secure the organelles together at sites 
within MAMs, and facilitate the performance of collective biological roles, including 
autophagy, lipid synthesis and Ca2+ handling (see main Introduction). 
 
 It has been extensively demonstrated that both lethal (apoptosis-inducing) and 
sub-lethal ER stressors cause changes to mitochondrial morphology and bioenergetics 
(for review see (Vannuvel, Renard et al. 2013)), but investigation of the reverse situation 
- mitochondrial dysfunction producing alterations to ER biology - has been neglected. I 
have hypothesised that neuronal mitochondrial dysfunction will alter aspects of ER 
biology, and that these changes will activate ER stress signalling that will communicate 
with the nucleus as a mitochondrial retrograde signal. In this chapter, I test the first part 
of my hypothesis, namely that neuronal mitochondrial dysfunction will cause changes to 
ER biology. I will use fluorescent reporters to examine mitochondrial morphology, ER 
morphology, ER-mitochondrial contacts and Ca2+ handling in a Drosophila model of 








In this chapter, I test the hypothesis that mitochondrial dysfunction in Drosophila motor 
neurons alters aspects of ER biology by: 
 
1) Investigating whether mitochondrial morphology is altered in neurons with 
mitochondrial dysfunction. 
2) Investigating whether ER morphology is altered in neurons with mitochondrial 
dysfunction. 
3) Assessing whether ER-mitochondrial contacts are altered in neurons with 
mitochondrial dysfunction. 



























3.2.1 Increased mitochondrial fragmentation in neurons with mitochondrial 
dysfunction. 
 
Mitochondria are physically and functionally coupled to the endoplasmic reticulum and I 
have therefore hypothesised that mitochondrial dysfunction will produce changes in ER 
biology. Given the physical apposition of the two organelles, it is likely that any 
alterations to mitochondrial morphology caused by mitochondrial dysfunction would 
impact upon ER morphology and/or ER-mitochondria contacts. I therefore began my 
investigation of ER biology in Drosophila neurons with mitochondrial dysfunction by 
assessing mitochondrial morphology. 
 
Overexpression of mitochondrial transcription factor A (TFAM) in Drosophila 
neurons causes mitochondrial dysfunction by suppressing mtDNA gene expression 
(Cagin, Duncan et al. 2015, Duncan, Granat et al. 2018). I chose to examine ER and 
mitochondrial biology in neurons whose function can be readily assayed (see next 
chapter), and therefore employed the D42-Gal4 driver, which is expressed in all motor 
neurons and some body wall sensory neurons (Sanyal 2009). Overexpression of TFAM 
alongside a mitochondrially-targeted GFP (mitoGFP) (Pilling, Horiuchi et al. 2006) by 
D42-Gal4 revealed a striking change to mitochondrial macromorphology in the motor 
neuron cell bodies of wandering late third instar larvae  (Fig. 3.1 A-B). Morphological 
parameters were quantified specifically in the dorsal medial motor neuron clusters in the 
ventral nerve cord (VNC). There was a non-significant enlargement of the total area of 
the mitochondrial network in the TFAM overexpression condition (Fig. 3.1 C). The 
number of mitochondria was increased by TFAM overexpression (p < 0.05, Fig. 3.1 D), 
and the median size of each mitochondrion significantly decreased (p < 0.001, Fig. 3.1 
E). The circularity of the mitochondria was unchanged between the control and 
mitochondrial dysfunction conditions (Fig. 3.1 F). The interconnectivity parameter 
(mean area/mean perimeter) (Dagda, Cherra et al. 2009) was significantly reduced by 
TFAM overexpression (p < 0.001, Fig. 3.1 G), in line with the increased mitochondrial 












































Figure 3.1 Increased mitochondrial fragmentation in the cell bodies of Drosophila 
motor neurons with mitochondrial dysfunction. (A, B) mitoGFP fluorescence in 
control (A) or TFAM overexpressing (B) dorsal medial motor neurons. (C) Total area 
of mitochondria per cell body (µm
2
), n = 12. (D) Number of mitochondrion per cell 




 scale. Box = interquartile 




 percentiles, + = mean, n = 1,213 (control) and 1,751 
(TFAM o/e). (F) Circularity (4π(area/perimeter
2
)) of each mitochondrion, n = 1,213 
(control) and 1,751 (TFAM o/e). (G) Interconnectivity (area/perimeter) of each 
mitochondrion, n = 1,213 (control) and 1,751 (TFAM o/e). (C, D, F, G) Means 
compared by two-tailed unpaired t-test. Bars = mean ± SEM. (E) Medians compared 
by two-tailed Mann-Whitney test. *p < 0.05, ***p < 0.001, n.s. = not significant. 
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3.2.2 Cell body ER morphology is altered by mitochondrial dysfunction in 
neurons. 
 
Having established that mitochondrial dysfunction in Drosophila neurons causes 
alterations to mitochondrial morphology, I next investigated whether ER morphology was 
also changed under conditions of mitochondrial dysfunction. I employed the TFAM 
overexpression model, and three fluorescent UAS reporter constructs that mark the ER. 
Two of the reporters were targeted to, and retained within, the ER by specific signal 
sequences; a superfolder GFP with the ER targeting sequence from chaperone BiP and 
the HDEL retention motif from calreticulin (BiP-sfGFP-HDEL) (Summerville, Faust et 
al. 2016), and RFP fused to hen’s egg lysozyme and the retention motif KDEL 
(lyso-RFP-KDEL) (Chowdhary, Tomer et al. 2017). The third reporter was an ER 
membrane marker comprised of the translocase subunit Sec61β fused to the fluorophore 
tdTomato (tdTomato-Sec61β) (Summerville, Faust et al. 2016). 
 
The constructs were driven in motor neurons by D42-Gal4, and ER morphology 
quantified in the cell bodies. Local variance in fluorescence normalised to the local mean 
fluorescence (variance/mean intensity) was computed along straight lines drawn 
orthogonally from the nuclear envelope to the plasma membrane, as per (Yalçın, Zhao et 
al. 2017). Overexpression of TFAM alongside the BiP-sfGFP-HDEL reporter resulted in 
a significant decrease in variance/mean intensity compared to control cells (p < 0.05, 
Fig. 3.2 A-C), suggesting that ER structure is less reticular in the mitochondrial 
dysfunction condition. This decrease was particularly marked in the perinuclear region 
(p < 0.001, Fig. 3.2 J), but persisted as a trend across most of the cytoplasm to the plasma 
membrane. Raw fluorescence intensity was also significantly decreased in the nuclear 
membrane and perinuclear region in the TFAM overexpression condition (p < 0.001, 
Fig. 3.2 K). These results were recapitulated when TFAM was overexpressed with 
tdTomato-Sec61β; there was a significant decrease in variance/mean intensity (p < 0.05, 
Fig. 3.2 D-F) that was most evident in the perinuclear region (p < 0.001 Fig. 3.2 L) and 
accompanied by a decrease in raw fluorescence intensity in the same region (p < 0.001, 
Fig. 3.2 M). By contrast, variance/mean intensity as reported by lyso-RFP-KDEL was 
unchanged across the cell body by TFAM overexpression (Fig. 3.2 G-I, N) and the 
reduction in raw RFP fluorescence intensity was almost uniform (Fig. 3.2 O).   
93 
 
Taken together, these results indicate that there are changes in ER morphology in 
the cell bodies of Drosophila motor neurons with mitochondrial dysfunction that may 








































Figure 3.2 Changes to ER morphology in Drosophila motor neuron cell bodies with 
mitochondrial dysfunction (A, B) BiP-sfGFP-HDEL fluorescence in control (A) or 
TFAM overexpressing (B) dorsal medial motor neurons. (D, E) tdTomato-Sec61β 
fluorescence in control (D) or TFAM overexpressing (E) dorsal medial motor neurons. 
(G, H) lyso-RFP-KDEL fluorescence in control (G) or TFAM overexpressing (H) 
dorsal medial motor neurons. (C, F, I) Variance in fluorescence intensity/mean 
fluorescence intensity (Variance/Mean intensity) was calculated across rolling 
windows of 5 pixels (BiP-sfGFP-HDEL, lyso-RFP-KDEL) or 7 pixels (tdTomato-
Sec61β), along lines drawn orthogonally from the nuclear to plasma membranes. (C, 
F, I) Variance/Mean intensity plotted as mean per sample. (J, L, N) Variance/Mean 
intensity plotted positionally from the nuclear membrane outwards as mean per pixel, 
for all pixels with n ≥20. (K, M, O) Raw fluorescence intensity computed across the 
same rolling pixel windows, and plotted positionally for all pixels with n ≥20. 
Significance in  J-N was determined by two-tailed unpaired t-test performed on the 
first 10 values (from the nuclear membrane outwards) in each condition. Significance 
in O was determined by two-tailed unpaired t-test performed on the first 10, and 
(separately) the last 10, values (from the nuclear membrane outwards) in each 
condition.  Means in C, F & I were also compared by two-tailed unpaired t-test. BiP-
sfGFP-HDEL: n = 17 larvae (=153 lines from nuclear to plasma membrane) for 
control, 18 (=162 lines) for TFAM o/e. tdTomato-Sec61β: n = 10 larvae (= 90 lines) 
for control, 12 (= 108 lines) for TFAM o/e. lyso-RFP-KDEL: n = 10 larvae (= 90 lines) 




Having identified morphological changes in the ER of motor neuron cell bodies 
caused by mitochondrial dysfunction, I examined ER shape at the neuromuscular junction 
(NMJ). The OK371-Gal4 P-element is inserted in the enhancer of the vesicular glutamate 
transporter, and therefore drives UAS transgenes in Drosophila motor neurons (Mahr and 
Aberle 2006). The tdTomato-Sec61β reporter was driven by this stronger motor neuron 
driver to provide robust expression at the distal end of the axon. Drosophila larval NMJs 
are highly stereotyped, and therefore the same synapse can be reliably located in each 
sample. Variance/mean intensity of tdTomato fluorescence was quantified in the type 1b 
NMJ on muscle four, abdominal segment 2, along a line that followed the contours of the 
synapse into the terminal. Overexpression of TFAM did not alter either the overall 
variance/mean intensity of tdTomato fluorescence in the NMJs (Fig. 3.3 A-C), or the 
spatial pattern of variance/mean intensity, which fluctuated around a constant level along 
the length of the synapse (Fig. 3.3 G). Raw fluorescence intensity gradually decreased 
towards the synaptic terminal in both the control and TFAM overexpression conditions 
(Fig. 3.3 H).  
 
 To verify the results of the tdTomato-Sec61β overexpression construct, I 
employed a reporter which utilises the endogenous transcriptional control of the ER 
shaping protein Reticulon-like-1 (Rtnl1). An artificial exon encoding YFP was inserted 
into an intron of Rtnl1 to create the fluorescent fusion Rtnl1∷YFP (Lowe, Rees et al. 
2014), and this has been shown to mark the ER in motor neuron terminals (O'Sullivan, 
Jahn et al. 2012). Replicating the results seen with the tdTomato-Sec61β reporter, 
overexpression of TFAM did not change either the overall variance/mean intensity of 
YFP fluorescence in the NMJs (Fig. 3.3 D-F), or the spatial patterning of the parameter, 
which again oscillated about a fixed level along the length of the axon (Fig. 3.3 I). Raw 
YFP fluorescence intensity also reproduced the results of the tdTomato-Sec61β fusion, 
showing progressive attenuation towards the synaptic boutons in both the control and 
TFAM overexpression conditions (Fig. 3.3 J). These results indicate that there are not 
gross changes in the morphology of the ER in the NMJs of Drosophila motor neurons 














































Figure 3.3 Unchanged ER morphology at the Drosophila neuromuscular junction in 
neurons with mitochondrial dysfunction. (A-B’’) tdTomato-Sec61β and HRP 
fluorescence in control (A-A’’) or TFAM overexpressing (B-B’’) NMJs. (D-E’’) 
Rtnl1::YFP and HRP fluorescence in control (D-D’’) or TFAM overexpressing (E-E’’) 
NMJs. (A, B, D, E) HRP. (A’, B’, D’, E’) Rtn1::YFP fluorescence. (A’’, B’’, D’’, E’’) 
Merged images. Variance in fluorescence intensity/mean fluorescence intensity 
(Variance/Mean intensity) was calculated across rolling windows of 7 pixels 
(tdTomato-Sec61β) and 4 pixels (Rtnl1::YFP), along segmented lines drawn outward 
from the axon terminal. (C, F) Variance/Mean intensity plotted as mean per sample. 
(G, I) Variance/mean intensity plotted positionally from the axon terminal outwards as 
mean per pixel, for all pixels with n ≥5. (H, J) Raw fluorescence intensity computed 
across the same rolling pixel windows, and plotted positionally for all pixels with n 
≥5. Means in C & F were compared by two-tailed unpaired t-test. tdTomato-Sec61β: 
n = 11 NMJs for control, 13 for TFAM o/e. Rtnl1::YFP: n = 18 NMJs for control, 15 
for TFAM o/e. Bars = mean ± SEM. n.s.= not significant. 
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3.2.3 Mitochondrial dysfunction alters ER-mitochondrial contacts in neurons. 
 
ER-mitochondria contacts enable the two organelles to share the performance of key 
biological functions. Having identified changes to mitochondrial and ER morphology that 
occur in Drosophila motor neurons under conditions of mitochondrial dysfunction, I 
hypothesised that ER-mitochondrial contacts may also be altered - either as a direct result 
of the morphological changes of the organelles, or another aspect of mitochondrial 
dysfunction. 
 
 To investigate ER-mitochondria contacts, I employed the tdTomato-Sec61β and 
lyso-RFP-KDEL reporters to label the ER, and mitoGFP to label the mitochondria. The 
constructs were driven by D42-Gal4, and ER-mitochondria distances were quantified in 
the motor neuron cell bodies of third instar larvae. To accommodate the wide range of 
fluorescence intensities displayed by the tdTomato-Sec61β and lyso-RFP-KDEL 
reporters, local thresholding was applied to determine the boundaries of the ER along 
lines drawn from the nuclear membrane to the plasma membrane (see Materials and 
Methods). After a similar thresholding was applied to the mitoGFP signal, the distance 
between the boundaries of the two organelles was computed. At ER-mitochondrial 
contact sites, the distance between the two organelles is 10-25 nm (Csordás, Renken et 
al. 2006). Images of the ER and mitochondrial reporters driven by D42-Gal4 were taken 
at a scale of 1 pixel = 52 nm, and therefore 0 pixel gaps between the ER and mitochondrial 
boundaries were considered to represent candidate ER-mitochondrial contact sites (i.e. 
the thresholded boundary of each organelle was located in the same pixel). Using this 
method, I found a significant increase in the number of candidate ER-mitochondria 
contacts in the TFAM overexpression condition when the ER was marked by either 
tdTomato-Sec61β (p < 0.001, Fig. 3.4 A-B’’’, E) or lyso-RFP-KDEL (p < 0.01, Fig. 3.4 
C-D’’’, E). Consistent with my finding that the perinuclear ER, as reported by 
tdTomato-Sec61β, appears less reticular in the TFAM overexpression condition - and 
therefore hypothetically presents fewer surfaces for ER-mitochondrial contacts - the mean 
distance of the candidate ER-mitochondrial contact sites from the nuclear membrane was 
significantly increased by TFAM overexpression when the ER was demarcated by 
tdTomato-Sec61β (p < 0.001, Fig. 3.4 F). Conversely, when the ER was marked by 
lyso-RFP-KDEL, the distribution of the candidate ER-mitochondria contacts was 
unchanged between control and TFAM overexpression conditions, in line with the 











































Figure 3.4 Changes to ER-mitochondria contacts in the cell bodies of Drosophila 
neurons with mitochondrial dysfunction. (A-B’’’) tdTomato-Sec61β and mitoGFP 
fluorescence in control (A-A’’’) or TFAM overexpressing (B-B’’’) dorsal medial motor 
neurons. (C-C’’’) lyso-RFP-KDEL and mitoGFP fluorescence in control (C-C’’’) or 
TFAM overexpressing (D-D’’’) dorsal medial motor neurons. (A, B) tdTomato-Sec61β 
fluorescence. (A’, B’) mitoGFP fluorescence. (A’’, B’’) Merged images. (A’’’, B’’’) 
Magnification of regions demarcated by white box in (A’’ & B’’). (C, D) lyso-RFP-
KDEL fluorescence. (C’, D’) mitoGFP fluorescence. (C’’, D’’) Merged images. (C’’’, 
D’’’) Magnification of regions demarcated by white box in (C’’ & D’’). ER and 
mitoGFP signals were locally thresholded to determine the boundaries of the 
organelles along lines drawn orthogonally from the nuclear to plasma membranes (see 
Materials & Methods), and ER-mitochondrial distances then computed. (E) Number 
of candidate ER-mitochondrial contacts identified (0 pixel gaps between the organelle 
boundaries). (F) Distance of the candidate ER-mitochondrial contacts from the nuclear 
membrane in pixels. Means in E & F compared by two-tailed unpaired t-test. 
tdTomato-Sec61β: n = 10 larvae (= 90 lines) for both conditions. lyso-RFP-KDEL: n 
= 10 larvae (= 90 lines) for control and 9 (= 81 lines) for TFAM overexpression. Bars 
= mean ± SEM. **p < 0.01, ***p < 0.001. n.s. = not significant. 
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results strongly suggest both an increase in the number of ER-mitochondrial contacts in 
the cell bodies of Drosophila motor neurons with mitochondrial dysfunction, and some 
relocation of these contacts in line with possible changes in the perinuclear morphology 
of the ER. 
 
Whilst I have observed alterations to ER morphology (Fig. 3.2) and 
ER-mitochondria contacts (Fig. 3.4) in the cell bodies of Drosophila motor neurons with 
mitochondrial dysfunction, I did not detect anomalies in ER morphology at the NMJ (Fig. 
3.3). TFAM overexpression is known to result in a dramatic loss of mitochondria from 
the synapse of motor neurons (Cagin, Duncan et al. 2015), and therefore the number 
and/or location of ER-mitochondrial contacts at the NMJ might be altered even in the 
absence of changes to ER morphology. To examine this proposal, I quantified ER-
mitochondrial (tdTomato-Sec61β-mitoGFP) distances along a segmented line drawn 
from a terminal bouton outwards to the junction of the single motor axon with the 
peripheral nerve. There was a significant reduction in the number (normalised to the 
length of axon sampled) of candidate ER-mitochondria contacts in the TFAM 
overexpression condition  (p < 0.001, Fig. 3.5 C), and the location of the candidate 
ER-mitochondria contacts was shifted significantly towards the nerve terminal (p < 0.05, 
Fig 3.5 D). These data indicate that changes in ER-mitochondrial contacts occur in both 


























































Figure 3.5 Changes to ER-mitochondria contacts at the neuromuscular junction of 
Drosophila neurons with mitochondrial dysfunction. (A-B’’’’) tdTomato-Sec61β, 
mitoGFP and HRP fluorescence in control (A-A’’’’) or TFAM overexpressing (B-B’’’’) 
neuromuscular junctions. (A,B) HRP. (A’,B’) tdTomato-Sec61β fluorescence (A’’,B’’) 
mitoGFP fluorescence. (A’’’,B’’’) Merged images. (A’’’’,B’’’’) Magnification of 
regions demarcated by white box in (A’’’ & B’’’). ER and mitoGFP signals were locally 
thresholded to determine the boundaries of the organelles along lines drawn outwards 
from the axon terminal (see Materials & Methods), and ER-mitochondrial distances 
then computed. (C) Number of candidate ER-mitochondrial contacts identified (0 pixel 
gaps between the organelle boundaries). (D) Relative distance of the candidate ER-
mitochondrial contacts from the axon terminal. Means in C & D compared by two-
tailed unpaired t-test, n = 8 NMJs for both conditions. Bars = mean ± SEM. * p < 0.05, 
***p < 0.001.  
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3.2.4 Mitochondrial Ca2+ levels are increased in neurons by mitochondrial 
dysfunction. 
 
ER-mitochondria contacts are important regulators of intracellular calcium 
homeostasis and signalling. Having established that both the number and spatial 
distribution of ER-mitochondria contacts are altered by mitochondrial dysfunction in 
Drosophila motor neurons, I hypothesised that Ca2+ handling would also be affected by 
mitochondrial dysfunction. 
 
To measure the basal levels of cytosolic Ca2+, I used the genetically encoded 
calcium indicator GCaMP6m under UAS control (Chen, Wardill et al. 2013). GCaMPs 
are chimeric proteins that undergo a structural rearrangement that activates GFP 
fluorescence upon the binding of Ca2+ to their calmodulin domain (Nakai, Ohkura et al. 
2001). I expressed GCaMP6m in motor neurons via the OK371-Gal4 driver. 
Quantification of live images revealed that TFAM overexpression did not alter the levels 
of cytosolic Ca2+ in either the cell bodies (Fig. 3.6 A-C) or NMJs (Fig. 3.6 H-J) of 
unstimulated motor neurons. A second reporter construct, CaMPARI, exhibits 
irreversible green-to-red photoconversion in the presence of both Ca2+ and UV light 
(Fosque, Sun et al. 2015). Replicating the results seen with GCaMP6m, TFAM 
overexpression driven alongside CaMPARI by OK371-Gal4 did not significantly alter 
the red:green fluorescence ratio in the cytosol of motor neuron cell bodies of larvae 
exposed to UV light (Fig. 3.6 D-G). By contrast, knock down of the store-operated Ca2+ 
entry facilitator, Stim (Liou, Kim et al. 2005, Roos, DiGregorio et al. 2005), resulted in 
significantly increased red:green fluorescence ratios (p < 0.001, Fig.3.6 D-G), indicating 
increased basal Ca2+ levels in this condition, and confirming that the dynamic range of 


















































Figure 3.6 Basal Ca
2+
 levels are unchanged in the cell bodies and NMJ of Drosophila 
motor neurons with mitochondrial dysfunction. GCaMP6m fluorescence in control (A) 
or TFAM overexpressing (B) dorsal medial motor neurons. (C) Quantification of 
GCaMP6m fluorescence in cell bodies, n = 22 larvae for control, 20 for TFAM o/e. 
(D-F’’) CaMPARI fluorescence in dorsal medial motor neurons of control (D-D’’), 
TFAM overexpressing (E-E’’) or Stim knock-down (F-F’’) larvae. (D, E, F) Green 
(default) channel. (D’, E’, F’) Red (photoconverted) channel. (D’’, E’’, F’’) Merged 
images. (G) Quantification of CaMPARI red/green fluorescence ratio in cell bodies, n 
= 34 larvae for control, 11 for control no UV, 37 for TFAM o/e, 11 for TFAM o/e no 
UV, 33 for Stim RNAi and 11 for Stim RNAi no UV. (H, I) GCaMP6 fluorescence in 
control (H) or TFAM overexpressing (I) NMJs. (J) Quantification of GCaMP6m 
fluorescence in NMJs, n = 36 NMJs for control, 37 for TFAM o/e. Means in C & J 
compared by two-tailed unpaired t-test. Means in G compared by one-way parametric 
ANOVA with Tukey’s post-hoc test. Bars = mean ± SEM. **p < 0.01, ***p < 0.001, 
n.s. = not significant. 
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Given the critical roles that mitochondria and the ER play in Ca2+ handling, and 
the alterations to ER morphology and ER-mitochondrial contacts caused by 
mitochondrial dysfunction, it was unexpected that cytosolic Ca2+ levels were unchanged 
by TFAM overexpression. To assess whether the anticipated Ca2+ defect was present 
within mitochondria, a mitochondrially-targeted GCaMP3 (mitoGCaMP) (Drago and 
Davis 2016) was driven in motor neurons by OK371-Gal4. Overexpression of TFAM 
resulted in a striking increase in Ca2+ levels within the mitochondria of motor neuron cell 
bodies (p < 0.001, Fig. 3.7). 
  
Mitochondria are integral regulators of wide-ranging, dynamic cellular processes 
via Ca2+ signalling. The increase in mitochondrial Ca2+ levels caused by TFAM 
overexpression therefore suggested that defects in cytosolic Ca2+ handling may only be 
apparent in stimulated neurons. Activation of Drosophila motor neurons by targeted 
expression of the heat-activated Transient Receptor Potential ion channel, dTrpA1 
(Hamada, Rosenzweig et al. 2008), revealed that TFAM overexpression causes a marked 
increase in cytosolic Ca2+ levels in the cell bodies of repeatedly stimulated neurons (Fig. 
3.8). There was no significant difference in GCaMP6m fluorescence between control and 
TFAM overexpression neurons after the first stimulation, but significant differences in 
GCaMP6m fluorescence upon second and third stimulations (p < 0.05 for differences in 
peak fluorescence, Fig. 3.8 A-C). This outcome was also seen in the axons - for which 
there was also a significant difference in GCaMP6m fluorescence minima (p < 0.01 for 
first trough, p < 0.05 for second trough, Fig. 3.8 D) – and neuropil (Fig. 3.8 E) of the 
samples. These results indicate that neuronal mitochondrial dysfunction causes alterations 
















Figure 3.7 Basal mitochondrial Ca
2+
 levels are significantly higher in the cell bodies 
of Drosophila motor neurons with mitochondrial dysfunction. mitoGCaMP 
fluorescence in control (A) and TFAM overexpressing (B) dorsal medial motor 
neurons. (C) Quantification of mitoGCaMP fluorescence. Means compared by two-











































Figure 3.8 Changes to dynamic cytosolic Ca
2+
 levels in Drosophila motor neurons 
with mitochondrial dysfunction. (A) Mean of traces for GCaMP6m fluorescence in 
dorsal medial motor neuron cell bodies as TrpA1 channels were activated by 20 second 
(s) on/off pulses of 25 °C heat, as indicated by the horizontal black lines below the 
graph (line = heat on, space = heat off). Control = black trace, TFAM overexpression 
= red trace. (B, C) Sample images of control (B) and TFAM overexpressing (C) 
samples showing change in GCaMP6m fluorescence over the three heat pulses (images 
are aligned to the graph in (A) and the black lines denoting heat on/off). (D, E) Mean 
traces for GCaMP6m levels in the axons (D) and neuropil (E). Lines and error bars in 
graphs are mean ± SEM. In the cell bodies and axons, for first heat on/off cycle (0-40 
seconds), n = 6 larvae for both conditions, for the second cycle onwards (41-120 
seconds), n = 5 for both conditions. In the neuropil, for first heat on/off cycle (0-40 
seconds), n = 6 larvae for control and 7 for TFAM o/e, for the second cycle onwards 
(41-120 seconds), n = 5 for control and 6 for TFAM o/e. (A, D, E) Significant 
differences in fluorescent peaks and troughs were assessed by two-tailed unpaired t-
test performed on the mean of the ten frames spanning the relevant peak or trough for 
each sample. *p < 0.05, **p < 0.01. Individual GCaMP6m fluorescent traces from 






Mitochondria are physically and functionally linked to the ER. I have therefore 
hypothesised that mitochondrial dysfunction causes changes to ER biology, that these 
changes activate ER stress signalling, and that this signalling communicates with the 
nucleus as a mitochondrial retrograde signal. In this chapter, I aimed to determine whether 
mitochondrial dysfunction does indeed alter aspects of ER biology in Drosophila motor 
neurons. I used a series of fluorescent reporters to examine the relationships between 
mitochondrial dysfunction and ER morphology, ER-mitochondrial contacts and Ca2+ 
handling. 
 
Overexpression of TFAM caused fragmentation of the mitochondrial network in 
the cell bodies of Drosophila neurons. I assessed ER morphology in the cell bodies of 
Drosophila motor neurons using the fluorescent ER membrane marker tdTomato-Sec61β, 
and two fluorescent reporters that are targeted to, and retained within, the ER; BiP-sfGFP-
HDEL and lyso-RFP-KDEL. For all three reporters, quantification of local variance in 
fluorescence intensity normalised to local mean fluorescence intensity, revealed a 
reduction in normalised variance in the mitochondrial dysfunction condition, suggesting 
that the ER had become less reticular. The decrease in normalised variance was 
particularly prominent in the perinuclear region, and was accompanied by a reduction in 
fluorescence intensity in the same area. 
 
ER morphology at the NMJ was assessed via the tdTomato-Sec61β construct and 
an exon trap fusion Rtnl1∷YFP, and did not recapitulate the changes seen in the motor 
neuron cell bodies. There was no difference in either the overall variance/mean intensity, 
or the spatial patterning of the parameter. 
  
There is extensive physical juxtaposition of mitochondrial and the ER, and this 
permits the organelles to jointly execute key biological functions. It has been shown that 
TFAM overexpression dramatically alters the morphology of the mitochondrial network 
in Drosophila motor neuron cell bodies. Having identified putative changes to ER 
morphology in those same cells,  I hypothesised that ER-mitochondrial contacts may also 




I examined ER-mitochondrial contacts in motor neuron cell bodies via a 
mitochondrially-targeted GFP and the tdTomato-Sec61β and lyso-RFP-KDEL reporters. 
There was a significant increase in the number of candidate ER-mitochondrial contacts 
(0 pixel gaps between the ER and mitochondrial boundaries). Consistent with the 
perinuclear changes to ER morphology indicated by the tdTomato-Sec61β reporter, the 
mean distance of the candidate ER-mitochondrial contacts from the nuclear membrane 
was significantly further in the mitochondrial dysfunction condition when the ER was 
demarcated by tdTomato-Sec61β. 
 
I did not identify morphological differences in the ER at the NMJ of motor 
neurons with mitochondrial dysfunction. However, in addition to modifying the 
macromorphology of mitochondria in motor neuron cell bodies, TFAM overexpression 
also results in a substantial loss of mitochondria at the synapse. Consistent with this, the 
number of ER-mitochondrial distances and candidate ER-mitochondria contacts at the 
NMJ was significantly reduced in the mitochondrial dysfunction condition. The location 
of the candidate ER-mitochondrial contact sites was shifted significantly towards the 
synaptic terminal by TFAM overexpression. 
 
Ca2+ handling is a key shared function of the mitochondria and ER. Having 
identified changes to ER-mitochondrial contact sites, I investigated levels of Ca2+ in the 
cytosol and mitochondria of unstimulated motor neurons. Basal Ca2+ was unchanged in 
the cytosol of motor neurons with mitochondrial dysfunction, as measured by two 
independent reporters. By contrast, levels of Ca2+ in the mitochondria and the cytosol of 
stimulated neurons were strikingly raised in the mitochondrial dysfunction condition. 
 
Overall, these data demonstrate clear affects of mitochondrial dysfunction on ER 










4. Investigating ER stress signalling in Drosophila 




In Chapter 3, I identified changes in ER morphology, ER-mitochondria contacts, and 
calcium handling that occur in Drosophila neurons with mitochondrial dysfunction. 
These changes suggest substantial alterations to ER biology, and I therefore hypothesise 
that ER stress signalling will be activated by mitochondrial dysfunction in Drosophila 
neurons, and that this signalling will modify the function of affected neurons. 
 
 Stress signalling from the ER occurs via the conserved ER unfolded protein 
response (UPR) (Fig. 4.1), that I describe more thoroughly in the main Introduction, but 
will also outline here. The ER UPR comprises three individual, but cross-regulated 
pathways that each culminate in the activation of a transcription factor. At the head of 
each pathway is an ER-resident transmembrane protein; the kinases PERK and IRE1 form 
homo-oligomers in response to unfolded protein stress in the ER, and subsequently 
undergo activation by trans-autophosphorylation of their cytoplasmic domains. A loss of 
ER proteostasis causes the transcription factor ATF6 to traffic from the ER to the Golgi 
complex where it is cleaved, and a cytosolic portion translocates to the nucleus to activate 
transcription of ER UPR genes. Whilst ATF6 itself forms one complete branch of the ER 
UPR, PERK and IRE1 have other downstream effectors. PERK phosphorylates the 
translation initiation factor eIF2α, leading to a broad reduction in translation, but the 
specific induction of a subset of proteins with novel 5’UTRs, including the ER UPR 
transcription factor ATF4, and phosphatase scaffold GADD34. In mammals, transcription 
of GADD34 is also upregulated by the ATF4 target CHOP, and GADD34 opposes PERK 
by targeting the PP1 phosphatase to eIF2α, thus forming a negative feedback loop within 
the ER UPR. Activated IRE1 acquires ribonuclease activity and, in addition to the 
targeted degradation of a subset of messenger RNAs, specifically catalyses the splicing 
of mRNA encoding the transcription factor XBP1 to create an active form of the protein. 
 
There is evidence from in vitro and non-neuronal in vivo experiments that 
mitochondrial dysfunction can activate the ER UPR. Dissipation of mitochondrial 
membrane potential by the protonophore carbonyl cyanide m-chlorophenyl hydrazine 
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(CCCP) resulted in ER stress in HEK293T and SH-SY5Y cells and activated ATF4 
(Bouman, Schlierf et al. 2011). The complex I inhibitor rotenone also triggered 
transcriptional regulation by ATF4 in SH-SY5Y cells (Wu, Luo et al. 2014), the ATP 
synthase inhibitor oligomycin was found to cause ER stress in a human liver cell line 
(Lim, Lee et al. 2009), and ER stress signalling activated by the antiretroviral Efavirenz 
was suppressed in human hepatoma cells lacking mtDNA (Apostolova, Gomez-Sucerquia 
et al. 2013). Disease pathogenesis driven by mitochondrial dysfunction also triggered ER 
stress pathways in a rat model of acute pancreatitis (Biczo, Vegh et al. 2018). To test for 
activation of the ER UPR in Drosophila neurons with mitochondrial dysfunction, I will 
employ a second model in addition to TFAM overexpression. Ubiquitous knock-down of 
the homologue of the Complex I subunit NDUFS1, the highly conserved ND-75 
(Fearnley and Walker 1992, Weidner, Geier et al. 1993) in adult fly heads causes a 
reduction in NADH oxidase-ferrireductase activity and reduced expression of other 
complex I subunits (Hegde, Vogel et al. 2014). If my conjecture that the ER UPR is 
activated by mitochondrial dysfunction in Drosophila neurons is correct, I will examine 
the consequences of this activation by assessing neuronal function via climbing and wing 














In this chapter, I test the hypothesis that mitochondrial dysfunction in Drosophila neurons 
activates ER stress signalling, and that this signalling has functional consequences for the 
affected neurons by: 
1) Determining whether components of the ER UPR are activated in models of 
mitochondrial dysfunction, and if there is a consequent reduction in global 
translation. 
2) Assessing the impact of genetic manipulation of ER UPR components in two 
































4.2.1 The PERK and IRE1 branches of the ER UPR are activated in models of 
mitochondrial dysfunction. 
 
In Chapter 3, I described changes to ER biology that occur in Drosophila neurons with 
mitochondrial dysfunction. Given these changes, I have hypothesised that neuronal 
mitochondrial dysfunction will activate ER stress signalling in the form of the ER UPR, 
and that this signalling will have functional consequences for the affected neurons. To 
test this proposal, I first examined the activation of components of the PERK and IRE1 
branches of the ER UPR in models of Drosophila neuronal mitochondrial dysfunction. 
 
 The kinase PERK is resident in the ER membrane. Classically, an overload of 
unfolded proteins within the lumen of the ER causes the oligomerisation and 
autophosphorylation of PERK. Once activated in this manner, the cytosolic domain of 
PERK directly phosphorylates the translation initiation factor eIF2α (Fig. 4.1). I used 
immunofluorescence staining in wandering third instar larvae to examine the extent of 
eIF2α phosphorylation in our models of mitochondrial dysfunction. Overexpression of 
TFAM and a membrane-targeted GFP were driven in motor neurons by OK371-Gal4. 
TFAM overexpression caused a significant increase in the level of phosphorylated eIF2α 
(P-eIF2α) in the cytosol of affected cells (p < 0.001, Fig. 4.2 A-C). This result was 
recapitulated by knock-down of the complex I subunit ND-75 in motor neurons (p < 0.01, 
Fig. 4.2 D-F). In mammals, eIF2 α is at the convergence of four pathways which comprise 
the integrated stress response, and can therefore be phosphorylated by three other kinases 
in addition to PERK. Only one of these additional kinases, GCN2, is conserved in 
Drosophila. The relative contribution of PERK and GCN2 to eIF2α phosphorylation 


















Figure 4.2 Levels of phosphorylated eIF2α are increased in Drosophila neurons with 
mitochondrial dysfunction. (A-B’) Immunofluorescence staining with P-eIF2α antibody in 
control (A-A’) or TFAM overexpressing (B-B’) dorsal medial motor neurons. (D-E’) 
Immunofluorescence staining with P-eIF2α antibody in control (D-D’) or ND-75 knock-down 
(E-E’) dorsal medial motor neurons.(A, B, D, E) P-eIF2α fluorescence. (A’, B’, D’ E’) Merged 
images of P-eIF2α (magenta) and membrane-targeted GFP (green). P-eIF2α staining 
quantified in C (TFAM overexpression, n = 8 larvae for control, 12 for TFAM o/e) and F (ND-
75 RNAi, n = 10 larvae for control and ND-75 RNAi). Bars = mean ± SEM. Means compared 





















Figure 4.3 Preliminary indication that pan-neuronal overexpression of TFAM does 
not affect the rate of translation in the Drosophila CNS. Western blot of CNS 
homogenate from control or TFAM overexpressing wandering late third instar 
larvae. (A) Ponceau staining. (B) Immunostaining for puromycin. 
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Phosphorylation of eIF2α is typically observed to cause a reduction in 
cap-dependent translation (Fig. 4.1). Having observed increased levels of P-eIF2α in the 
TFAM overexpression and ND-75 knock-down models, I conjectured that translation 
may be globally reduced in Drosophila neurons with mitochondrial dysfunction as a 
protective bioenergetic measure. To test this proposal, I used the peptide chain terminator 
puromycin (Nathans 1964) to examine the rate of translation. Immunostaining for 
puromycin reports on the rate of incorporation of the toxin into nascent polypeptides. No 
difference was detected in the levels of puromycin incorporation in CNS homogenate 
between control larvae and those with pan-neuronal TFAM overexpression driven by 
nSyb-Gal4 (Fig 4.3). Whilst there is obviously a glial contribution in the homogenate that 
could be confounding the result, these preliminary data indicate that TFAM 
overexpression does not cause a profound reduction in the rate of translation in 
Drosophila neurons. 
 
Canonically, whilst phosphorylation of eIF2α usually reduces the rate of global 
translation, it translationally upregulates the ER UPR transcription factor ATF4 by 
inducing the ribosome to skip initiation at a series of decoy uORFs in the ATF4 5’ UTR 
(see main Introduction). Therefore, I next examined ATF4 protein levels in Drosophila 
neurons with mitochondrial dysfunction by creating a polyclonal antibody directed at a 
60 amino acid region common to all known isoforms of Drosophila ATF4, but outside of 
the widely-conserved DNA binding domain. Immunostaining of CNS tissue from larvae 
overexpressing ATF4 isoform B in motor neurons via the OK371-Gal4 driver confirmed 
the specificity of the antibody; fluorescence was not detectable above background in the 
nuclei of motor neuron clusters in control VNCs, but was clearly visible in the ATF4-

















Figure 4.4 Validation of Drosophila ATF4 antibody. Immunofluorescence staining with 
ATF4 antibody, created as described in Materials and Methods 2.2.5, in control (A’-A’’) 
or ATF4 overexpressing (B-B’’) dorsal medial motor neurons. (A, B) Membrane-targeted 
GFP (UAS-CD8-GFP; green in A’’, B’’). (A’, B’) ATF4 antibody (magenta in A’’, B’’). 
(A’’, B’’) Merged images. (C) Quantification of ATF4 staining, n = 4 larvae for both 
control and ATF4 overexpression conditions. Bars = mean ± SEM. Medians compared by 
two-tailed Mann-Whitney test, *p = 0.0286. 
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The validated antibody was then used to test whether ATF4 is upregulated in our 
models of mitochondrial dysfunction. Strong ATF4 staining was seen in the nuclei of 
motor neurons of flies overexpressing TFAM (p < 0.001, Fig. 4.5 A-C) or ND-75 RNAi 
(p < 0.001, Fig. 4.5 D-F) via OK371-Gal4, indicating that ATF4 is indeed upregulated by 
mitochondrial dysfunction in Drosophila motor neurons. Once again, membrane-targeted 
GFP was used to mark the cells in which the genetic manipulation had taken place. 
 
Having established that proteins that can form components of the PERK branch 
of the ER UPR are activated by neuronal mitochondrial dysfunction in Drosophila, I next 
examined the IRE1 pathway. Like PERK, IRE1 is a transmembrane ER protein which 
oligomerises and autophosphorylates in response to unfolded protein stress in the ER. 
Unlike PERK, IRE1 acquires ribonuclease activity upon autophosphorylation, and splices 
mRNA of the transcription factor XBP1 to produce an active form of the protein (Fig. 
4.1). To assess activation of XBP1 in our models of mitochondrial dysfunction, I used a 
UAS reporter construct that has EGFP subcloned downstream of the IRE1 splice site in 
XBP1 (Ryoo, Domingos et al. 2007). The EGFP encoded by the reporter is in frame only 
when XBP1 is spliced to its active form (Fig. 4.6 A). XBP1-EGFP and nuclear-targeted 
β-galactosidase (β-gal) were driven in motor neurons by OK371-Gal4. In control larvae, 
EGFP fluorescence was largely undetectable (Fig. 4.6 B’, E’). However, when TFAM 
was overexpressed alongside the reporters, EGFP was clearly visible and colocalised with 
β-Gal, demonstrating that the XBP1-EGFP fusion protein had been targeted to the nucleus 
as expected for an active transcription factor (Fig. 4.6 C-C’’). The increase in EGFP was 
significant compared to control larvae (p < 0.001, Fig. 4.6 D). Knock-down of the 
complex I subunit ND-75 in motor neurons resulted in even stronger EGFP expression 
compared to controls (p < 0.001, Fig. 4.6 F-F’’, G). Taken together, these results indicate 


























Figure 4.5 Levels of ATF4 are increased in Drosophila neurons with mitochondrial 
dysfunction (A-B’) Immunofluorescence staining with ATF4 antibody in control (A-
A’) or TFAM overexpressing (B-B’) dorsal medial motor neurons. (D-E’) 
Immunofluorescence staining with P-eIF2α antibody in control (D-D’) or ND-75 
knock-down (E-E’) dorsal medial motor neurons. (A, B, D, E) ATF4 fluorescence. (A’, 
B’, D’ E’) Merged images of ATF4 (magenta) and membrane-targeted GFP (green). 
ATF4 staining quantified in C (TFAM overexpression, n = 13 larvae for control and 
TFAM o/e) and F (ND-75 RNAi, n = 23 larvae for control and 20 for ND-75 RNAi). 




Figure 4.6 Splicing of XBP1 mRNA to produce an active form of the protein is increased in 
Drosophila neurons with mitochondrial dysfunction. (A) EGFP is in frame only when XBP1 
mRNA is spliced to encode an active form of the protein, from (Ryoo, Domingos et al. 2007). 
(B-C’’) XBP1-EGFP fluorescence and nuclear-targeted β-Gal in control (B-B’’) or TFAM 
overexpressing (C-C’’) motor neurons. (E-F’’) XBP1-EGFP fluorescence and nuclear-targeted 
β-Gal in control (E-E’’) or ND-75 knock-down (F-F’’) motor neurons. (B, C, E, F) 
Immunofluorescence staining with β-Gal antibody. (B’, C’, E’, F’) XBP1-EGFP fluorescence. 
(B’’, C’’, E’’, F’’) Merged images. (D) Quantification of EGFP fluorescence in control and 
TFAM overexpressing motor neurons (n = 6 larvae for control, 11 for TFAM o/e). (G) 
Quantification of EGFP fluorescence in control and ND-75 knock-down motor neurons (n = 13 
larvae for control and 19 for ND-75 RNAi). Bars = mean ± SEM. Means compared by two-




4.2.2 Genetic manipulation of ER UPR components in Drosophila motor neurons 
with mitochondrial dysfunction affects neuronal function. 
  
I have demonstrated that components of the stress signalling ER UPR are activated in 
Drosophila models of neuronal dysfunction. To test the second part of my hypothesis - 
that this signalling will have functional consequences for the affected neurons - I 
performed two functional assays on all elements of the canonical ER UPR. 
 
Adult Drosophila display negative geotaxis; when forcibly relocated to a base 
point they reflexively climb back upwards against gravity (Carpenter 1905). This 
behaviour enables us to use the climbing assay - a schematic of which is shown in 
Materials and Methods Fig. 2.2 A - to assess the motor system of the fly. Overexpression 
of TFAM in motor neurons by the D42-Gal4 driver reduces the distance climbed by adult 
flies to about 50% of the control value (p < 0.001, Fig. 4.7 A), confirming that 
mitochondrial dysfunction can cause functional deficits in Drosophila neurons. Knock-
down of ND-75 in motor neurons is pupal lethal and so was not used for ER UPR genetic 
interaction assays. Knock-down of PERK in conjunction with TFAM overexpression 
caused a significant exacerbation of the climbing phenotype (p < 0.01, Fig 4.7 A) when 
the knock-down was mediated by RNAi line 16427. PERK knock-down by a second 
RNAi line, 35162, resulted in a non-significant exacerbation of the climbing impairment 
induced by TFAM overexpression and a third RNAi line, 42499, was pupal lethal when 
combined with TFAM overexpression (both Appendix 8.2.1). Knock-down of PERK 
alone by the three RNAi lines did not cause any reduction in climbing ability compared 
to control flies (Fig.4.7 A and Appendix Fig. 8.2.1). Overexpression of PERK by 
D42-Gal4 was lethal both alone, and in combination with TFAM overexpression at both 
25 °C and 20 °C. 
 
A second functional assay examines the status of the adult wing. Flies eclose from 
their pupal casing with folded wings (Materials and Methods Fig. 2.2 B). Secretion of the 
neurohormone buriscon from a population of crustacean cardioactive peptide (CCAP)-
expressing neurons in the abdominal ganglion of the VNC controls the inflation that 
results in the flat wing of the mature adult (Luan, Lemon et al. 2006). Genetic 
manipulation of the amyotrophic lateral sclerosis-associated protein TDP-43 by both the 
CCAP-Gal4 and D42-Gal4 drivers (independently) results in adult flies with uninflated 
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wings (Vanden Broeck, Naval-Sánchez et al. 2013), likely due to the expression pattern 
of D42-Gal4 overlapping that of CCAP/bursicon in the abdominal ganglion. 
Overexpression of TFAM via the D42-Gal4 driver also results in approximately 50% of 
mature adult flies with uninflated wings (Fig. 4.7 B). Having determined that PERK 
knock-down exacerbates the climbing phenotype of TFAM-overexpressing flies, I 
examined the effect that knock-down of the protein has on wing inflation. In line with the 
climbing assay results, both of the PERK RNAi lines that were non-lethal when combined 
with TFAM overexpression caused a significant increase in the number of flies with 
uninflated wings in the mitochondrial dysfunction condition (p < 0.001 for both, Fig. 
4.7 B & Appendix 8.2.1). 
 
Subsequent examination of each of the remaining ER UPR elements via climbing 
and wing inflation assays suggested diverse functional implications for each of the 
components, with the unifying theme that knock-down of the transcription factors at the 
end of each UPR branch appears functionally beneficial. These results are described 


































































Figure 4.7 Functional consequences of genetic manipulation of components of the PERK 
ER UPR pathway (PERK, eIF2α and GADD34) in Drosophila motor neurons with TFAM 
overexpression. (A, B) Climbing (A) and wing inflation (B) assays with PERK knock-
down (line 16427). (C, D) Climbing (C) and wing inflation (D) assays with eIF2α knock-
down (line 44449), flies incubated at 20 °C for the duration of the assay (25 ° C for all 
other climbing and wing inflation assays). (E, F) Climbing (E) and wing inflation (F) 
assays with eIF2α overexpression. (G, H) Climbing (G) and wing inflation (H) assays with 
GADD34 knock-down (line 33011). (I, J) Climbing (I) and wing inflation (J) assays with 
GADD34 overexpression. TFAM overexpression and all ER UPR RNAi and 
overexpression lines were driven by D42-Gal4. Wing inflation assay: number of flies per 
genotype displayed at the base of each column. Climbing assays: n = 15 for all genotypes 
in A, n = 13 for all genotypes in C, n = 20 for E & G, and n = 11 for I. Bars = mean ± 
SEM. Means were compared by one-way parametric ANOVA with Tukey’s post-hoc test. 
Wing inflation: significance was tested by Chi-squared test on the raw data. n.s. = not 
significant, * p < 0.5, **p < 0.01, ***p < 0.001. 
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Knock-down of eIF2α caused a substantial reduction in viability, even at 20 °C, 
and highly significant climbing and wing inflation impairments compared to control flies 
(p < 0.001, Fig. 4.7 C & D). When combined with TFAM overexpression, knock-down 
of eIF2α was pupal lethal. Overexpression of eIF2α alone also reduced climbing ability 
compared to control flies, and when combined with TFAM overexpression increased the 
number of flies with uninflated wings (p < 0.05, Fig. 4.7 F) compared to the TFAM 
overexpression condition, but did not significantly affect the TFAM-overexpression 
climbing phenotype (Fig. 4.7 E). 
 
GADD34 recruits a phosphatase that functions in a negative feedback loop within 
the UPR to oppose the action of PERK, by dephosphorylating eIF2α (Fig. 4.1). Two 
GADD34 RNAi lines generated inconsistent outcomes; line 33011 suppressed the 
TFAM-overexpression functional deficits (p < 0.05 (climbing), p < 0.001 (wing), Fig 4.7 
G & H), whilst line 107545 did not alter the climbing ability of TFAM-overexpressing 
flies (Appendix 8.2.1), but did cause a significant increase in the number of flies with 
uninflated wings (p < 0.001, Appendix  Fig 8.2.1). Overexpression of GADD34 
exacerbated the climbing deficiencies of the mitochondrial dysfunction flies (p < 0.001, 
Fig 4.7 I), but did not significantly alter the number of flies with uninflated wings (Fig. 
4.7 J). 
 
Knock-down of ATF4 by RNAi line 25985 slightly reduced climbing ability 
compared to control flies (p < 0.001), but produced a significant suppression of both the 
TFAM-overexpression climbing and wing inflation phenotypes (p < 0.001 for both, Fig. 
4.8 A & B). Knockdown of ATF4 by another RNAi line, 2935, resulted in impaired 
climbing versus control flies (p < 0.05), but had no significant effect when combined with 
TFAM overexpression in either the climbing or wing inflation assays (Fig. 4.8 C & D). 
Overexpression of ATF4 also resulted in a climbing deficit compared to control flies (p 
< 0.01, Fig. 4.8 E), and, in this case, also exacerbated the TFAM-overexpression climbing 















Figure 4.8 Functional consequences of genetic manipulation of ATF4 in Drosophila motor 
neurons with TFAM overexpression. (A, B) Climbing (A) and wing inflation (B) assays 
with ATF4 knock-down (line 25985). (C, D) Climbing (C) and wing inflation (D) assays 
with ATF4 knock-down (line 2935). (E, F) Climbing (E) and wing inflation (F) assays 
with ATF4 overexpression. TFAM overexpression and all ATF4 RNAi and 
overexpression lines were driven by D42-Gal4. Wing inflation assay: number of flies per 
genotype displayed at the base of each column. Climbing assays: n = 20 for all genotypes. 
Bars = mean ± SEM. Means were compared by one-way parametric ANOVA with Tukey’s 
post-hoc test. Wing inflation: significance was tested by Chi-squared test on the raw data. 
n.s. = not significant, * p < 0.5, **p < 0.01, ***p < 0.001. 
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Knock-down of IRE1 at the head of the second ER UPR pathway produced 
inconsistent results. One RNAi line (35253) significantly suppressed both the climbing 
and wing inflation deficits of TFAM-overexpressing flies (p < 0.001, Fig. 4.9 A & B), 
whilst another line, (62156) precipitated an increase in these impairments (p < 0.5 for 
climbing, p < 0.001 for wing inflation, Appendix 8.2.2). Flies heterozygous for the 
(homozygous lethal) loss-of-function mutant IRE1f02170 displayed a small, but non-
significant, improvement in climbing ability, and a significantly improved wing inflation 
ability (p < 0.001 Appendix 8.2.2). Overexpression of IRE1 did not alter the climbing 
ability of flies with neuronal mitochondrial dysfunction, but did significantly reduce the 
number of flies with uninflated wings (p < 0.01, Fig. 4.9 D). 
 
Knock-down of XBP1 by two RNAi lines consistently suppressed the climbing 
and wing inflation impairments of TFAM-overexpressing flies (p < 0.05 for line 36755 
climbing, p < 0.001 for all other comparisons, Fig. 4.9 E & F and Appendix 8.2.2). 
Overexpression of the C-terminally truncated XBP1-EGFP fusion that was used to test 
activation of XBP1 caused a non-significant exacerbation of the TFAM-overexpression 
climbing phenotype (Fig. 4.9 G) and a significant increase in the number of flies with 
uninflated wings (p < 0.001, Fig. 4.9 H). 
 
The transcription factor ATF6 comprises the third branch of the mammalian ER 
UPR (Fig. 4.1). Knock-down of ATF6 suppressed the climbing and wing inflation 
phenotypes of TFAM-overexpressing flies (p < 0.001 for both, Fig. 4.10 A & B). 
Overexpression of ATF6 did not significantly impact the climbing or wing inflation 






















































Figure 4.9 Functional consequences of genetic manipulation of the IRE1 ER UPR 
pathway in Drosophila motor neurons with TFAM overexpression. (A, B) Climbing 
(A) and wing inflation (B) assays with IRE1 knock-down (line 35253). (C, D) 
Climbing (C) and wing inflation (D) assays with IRE1 overexpression. (E, F) 
Climbing (E) and wing inflation (F) assays with XBP1 knock-down (line 25990). 
Performed by Rhian Ford. (G, H) Climbing (G) and wing inflation (H) assays with 
XBP1-EGFP overexpression. Performed by Jordan Briscoe. TFAM overexpression 
and all ER UPR RNAi and overexpression lines were driven by D42-Gal4. Wing 
inflation assay: number of flies per genotype displayed at the base of each column. 
Climbing assays: n = 20 for all genotypes. Bars = mean ± SEM. Means were 
compared by one-way parametric ANOVA with Tukey’s post-hoc test. Wing 
inflation: significance was tested by Chi-squared test on the raw data. n.s. = not 























Figure 4.10 Functional consequences of genetic manipulation of ATF6 in 
Drosophila motor neurons with TFAM overexpression. (A, B) Climbing (A) and 
wing inflation (B) assays with ATF6 knock-down (line 26211). (C, D) Climbing 
(C) and wing inflation (D) assays with ATF6 overexpression. TFAM 
overexpression and ATF6 RNAi and overexpression lines were driven by D42-
Gal4. Wing inflation assay: number of flies per genotype displayed at the base of 
each column. Climbing assays: n = 20 for all genotypes. Bars = mean ± SEM. 
Means were compared by one-way parametric ANOVA with Tukey’s post-hoc test. 
Wing inflation: significance was tested by Chi-squared test on the raw data. n.s. = 
not significant, **p < 0.01, ***p < 0.001. 
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V 16427  ↓  ↓ 
BM 35162    ↓ 
BM 42499  Lethal  Lethal 
O/e Δ Lethal Lethal Lethal Lethal 
eIF2α 
RNAi BM 44449 ↓ Lethal ↓ Lethal 
O/e F 001282 ↓   ↓ 
ATF4 
RNAi 
BM 25985 ↓ ↑  ↑ 
V 2935 ↓    
O/e F 000106 ↓ ↓  ↓ 
GADD34 
RNAi 
BM 33011  ↑  ↑ 
V 107545    ↓ 
O/e F 003018 ↓ ↓   
IRE1 
RNAi 
BM 35253 ↓ ↑  ↑ 
BM 62156  ↓  ↓ 




BM18520    ↑ 
XBP1 
RNAi 
BM 25990 ↓ ↑  ↑ 
BM 36755 ↓ ↑  ↑ 
O/e BM 60730    ↓ 
ATF6 
RNAi BM 26211  ↑  ↑ 
O/e F 000476     
Table 3. Summary of climbing and wing inflation phenotypes produced by genetic 
manipulation of ER UPR components in Drosophila motor neurons. TFAM overexpression 
and all ER UPR lines were driven by D42-Gal4. Flies were incubated at 25 °C for the 
duration of all assays except for eIF2α RNAi and PERK o/e which were lethal alone at 25 
°C, and therefore incubated at 20 °C throughout. ‘vs. control’ = comparison of ER UPR line 
(expressed alone) with control flies. ‘vs. TFAM o/e’ = comparison of ER UPR line 
expressed with TFAM overexpression, with flies overexpressing TFAM alone. O/e = 
overexpression. ↓ on red background = significantly reduced. ↑ on green background = 
significantly increased. Yellow background = no significant difference. BM = Bloomington 
Drosophila Stock Center, V = Vienna Drosophila Resource Center, F = FlyORF (Zurich 







In the previous chapter, I outlined alterations to ER biology that occur in Drosophila 
neurons with mitochondrial dysfunction. These changes suggest that the ER may be 
subject to stress under conditions of mitochondrial dysfunction, and I therefore 
hypothesised that 1) the ER UPR stress signalling pathway may be activated by 
mitochondrial dysfunction in Drosophila neurons, and 2) that this activation would have 
functional consequences for the affected neurons. In this chapter, I tested these 
hypotheses by a series of immunofluorescence and functional assays.  
 
The ER UPR kinase PERK phosphorylates the translation factor eIF2α when 
activated by ER stress. Immunofluorescence staining revealed that levels of P-eIF2α were 
increased in both tested models of mitochondrial dysfunction – overexpression of TFAM, 
and knock-down of the complex I subunit ND-75. Canonically, phosphorylation of eIF2α 
causes a reduction in global translation, and I therefore hypothesised that translation may 
be decreased in our models of mitochondrial dysfunction. Immunostaining for the peptide 
chain terminator puromycin gave preliminary indications that this conjecture is false; 
there was no significant difference in puromycin incorporation between control brains, 
and those with pan-neuronal overexpression of TFAM. 
 
Whilst phosphorylation of eIF2α normally reduces cap-dependent translation, it 
specifically upregulates translation of the ER UPR transcription factor ATF4. Consistent 
with the finding that mitochondrial dysfunction caused an increase in P-eIF2α, levels of 
ATF4 were also upregulated in motor neurons with TFAM overexpression and ND-75 
knock-down. 
 
In a second branch of the ER UPR, the transmembrane protein IRE1 becomes a 
ribonuclease upon activation, and splices mRNA of the transcription factor XBP1 to 
encode an active form of the protein. Use of an XBP1-EGFP fusion construct 
demonstrated that splicing of XBP1 to its active form also occurs in Drosophila motor 
neurons with TFAM overexpression and ND-75 knock-down. 
 
Having determined that components that can comprise the PERK and IRE1 
branches of the ER UPR are activated in Drosophila neurons with mitochondrial 
dysfunction, I examined the functional consequences of this activation via climbing and 
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wing inflation assays. Whilst there was some variation in the results produced by the 
replicate RNAi lines, some reliable observations were made; knockdown of PERK 
resulted in an exacerbation of the climbing and wing inflation impairments caused by 
TFAM overexpression whilst, conversely, knockdown of the transcription factors at the 
end of each UPR branch – ATF4, XBP1 and ATF6 – generally resulted in the suppression 
of the TFAM-overexpression phenotypes. 
 
In this chapter, I have established that components of the ER UPR are activated 
in Drosophila neurons with mitochondrial dysfunction, and that this activation has 

































5. Investigating the role of the ER UPR as a 





In Chapter 4, it was demonstrated that components of the IRE1 and PERK branches of 
the ER UPR are activated by mitochondrial dysfunction in Drosophila neurons. Genetic 
manipulation of the UPR modified the function of neurons with mitochondrial 
dysfunction in climbing and wing inflation assays. In particular, knock down of the 
transcription factors at the terminus of each branch partially suppressed the neuronal 
functional deficits caused by TFAM overexpression, suggesting that these proteins may 
be key therapeutic targets in neurodegenerative diseases associated with mitochondrial 
dysfunction. 
 
I have hypothesised that the ER UPR is a mitochondrial retrograde signalling 
pathway in Drosophila neurons. For my conjecture to be correct, at least one of the UPR 
transcription factors must regulate nuclear gene transcription under conditions of 
mitochondrial dysfunction. The basic leucine zipper transcription factor ATF4 is the final 
element of the PERK branch of the ER UPR. Analysis of microarray data from human 
neuronal precursor cells treated with the mitochondrial complex I inhibitor MPP+, 
identified ATF4 as the master regulator of transcriptional changes induced by the toxicant 
(Krug, Gutbier et al. 2014). ATF4 itself was transcriptionally upregulated in a mouse 
neocortical culture treated with another Complex I inhibitor, rotenone (Yap, Chen et al. 
2013), and N2a neuroblastoma cells treated with MPP+ (Mazzio and Soliman 2012). In 
addition, CHOP, a transcriptional target of mammalian ATF4, was highly upregulated in 
the cortex of mice with knockout of the mitochondrial serine protease HtrA2 (Moisoi, 
Klupsch et al. 2008). In Drosophila, ATF4 was discovered to be a regulator of the 
transcriptional response to mutations in the mitochondrial quality control factors pink1 
and parkin in whole fly heads (Celardo, Lehmann et al. 2017). Whilst these studies were 
mostly in vitro, or not specific to neuronal cells, they suggest that ATF4 is a strong 
candidate to regulate transcription in our in vivo models of mitochondrial dysfunction in 
Drosophila neurons. In this chapter, I will test the hypothesis that ATF4 is a 
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transcriptional regulator in our TFAM-overexpression model of mitochondrial 
dysfunction using RNA-Seq analysis. 
 
 Control of ATF4 expression is canonically at the level of translation, and is 
mediated by phosphorylation of the translational initiation factor eIF2α (see main 
Introduction). In mammalian cells, eIF2α can be phosphorylated by four kinases – 
including the ER UPR kinase PERK – that collectively form the integrated stress response 
(ISR). A multi-omics study of four disparate mitochondrial dysfunction models in HeLa 
cells identified the ISR as the key co-ordinator of the stress response (Quiros, Prado et al. 
2017). Two of the four ISR kinases (PERK and GCN2) are conserved in Drosophila 
(Malzer, Szajewska-Skuta et al. 2013), and I will therefore also examine the extent to 
which upregulation of ATF4 is controlled by PERK and GCN2 in the TFAM-



























In this chapter, I test the hypothesis that the ER UPR is a mitochondrial retrograde 
signalling pathway in Drosophila neurons by: 
1) Determining whether ATF4 expression is controlled by the kinases PERK and 
GCN2 under conditions of mitochondrial dysfunction. 
2) Investigating the putative role of ATF4 as a regulator of the transcriptional 
response to mitochondrial dysfunction by RNA-Seq analysis. 




































5.2.1 Determining whether ATF4 expression is controlled by the kinases PERK 
and GCN2 under conditions mitochondrial dysfunction. 
 
I have shown in Chapter 4 that ATF4 is upregulated in Drosophila motor neurons under 
conditions of mitochondrial dysfunction, and hypothesised that this activation is mediated 
by the ER UPR. However, in mammalian cells, eIF2α is also the target of three other 
kinases that, together with PERK, comprise the ISR. Of the ISR kinases, only GCN2 is 
conserved alongside PERK in Drosophila. To establish the extent to which ATF4 
expression in Drosophila neurons is co-ordinated by PERK and GCN2 under conditions 
of mitochondrial dysfunction, I performed a series of knock-down experiments. 
 
Overexpression of TFAM, alongside knock-down of either PERK or GCN2, was 
driven in motor neurons by the glutamatergic driver OK371-Gal4. Affected cells were 
marked by co-expression of membrane-localised GFP (UAS-CD8-GFP). I used 
immunofluorescence in wandering third instar larvae to assess levels of ATF4 expression, 
employing an antibody to the protein, production and validation of which is described in 
the previous chapter. 
 
Knock-down of PERK by RNAi line 16427 did not change levels of ATF4 in the 
nucleus of affected cells compared to control larvae (Fig. 5.1 A-B’, E). However, knock-
down of PERK in conjunction with TFAM overexpression resulted in a significant 
decrease in ATF4 expression when compared to TFAM overexpression alone 
(p < 0.05, Fig. 5.1 C-D’, E), suggesting that ATF4 is regulated by PERK under 
conditions of mitochondrial dysfunction. This result was recapitulated by a second RNAi 
line against PERK; knock-down of PERK by RNAi line 42499 in concert with TFAM 
overexpression produced a significant reduction in ATF4 levels (p < 0.001, Fig. 5.1 H-J), 
but did not alter basal levels when expressed alone (Fig. 5.1 F-G’, J). By contrast, 
expression of RNAi line 35355 against GCN2 did not alter levels of ATF4 in either 
control or mitochondrial dysfunction conditions (Fig. 5.2 A-E). Knock-down of GCN2 
by an alternative RNAi line, 103976, resulted in a trend towards decreased ATF4 levels 
when TFAM was overexpressed (Fig. 5.2 F-J), but this was not significant. Taken 
together, these results suggest that in Drosophila motor neurons with TFAM 































Figure 5.1 ATF4 is regulated by PERK under conditions of TFAM overexpression 
in Drosophila motor neurons. Membrane-targeted GFP (CD8-GFP), PERK RNAi 
and TFAM overexpression (o/e) driven in motor neurons of the VNC by 
OK371-Gal4. (A-A’, F-F’) control larvae, (C-C’ and H-H’) TFAM overexpression, 
(B-B’) PERK RNAi line 16427, (D-D’) TFAM overexpression and PERK RNAi 
16427 combined, (G-G’) PERK RNAi line 42499 and (I-I’) TFAM overexpression 
and PERK RNAi 42499 combined. (A,B,C,D and F,G,H,I) Immunofluorescence 
staining with ATF4 antibody (white). (A’,B’,C’,D’ and F’,G’,H’,I’) Merged images 
of GFP (green) and ATF4 fluorescence (magenta). ATF4 staining for PERK RNAi 
16427 quantified in (E), n = 17 (control larvae), 14 (PERK RNAi 16427), 16 
(TFAM o/e) and 18 (TFAM o/e, PERK RNAi 16427). ATF4 staining for PERK 
RNAi 42499 quantified in (J), n = 12 (control larvae), 8 (PERK RNAi 42499), 12 
(TFAM o/e) and 12 (TFAM o/e, PERK RNAi 42499). Bars = mean ± SEM. Means 
compared by one-way parametric ANOVA with Tukey’s post-hoc test. *p < 0.05, 































Figure 5.2 ATF4 is not regulated by GCN2 under conditions of TFAM 
overexpression in Drosophila motor neurons. Membrane-targeted GFP (CD8-
GFP), GCN2 RNAi and TFAM overexpression (o/e) driven in motor neurons of 
the VNC by OK371-Gal4. (A-A’, F-F’) control larvae, (C-C’ and H-H’) TFAM 
overexpression, (B-B’) GCN2 RNAi line 35355, (D-D’) TFAM overexpression 
and GCN2 RNAi 35355 combined, (G-G’) GCN2 RNAi line 103976 and (I-I’) 
TFAM overexpression and GCN2 RNAi 103976 combined. (A,B,C,D and F,G,H,I) 
Immunofluorescence staining with ATF4 antibody (white). (A’,B’,C’,D’ and 
F’,G’,H’,I’) Merged images of GFP (green) and ATF4 (magenta) fluorescence. 
ATF4 staining for GCN2 RNAi 35355 quantified in (E), n = 12 (control larvae), 11 
(GCN2 RNAi 35355), 12 (TFAM o/e) and 11 (TFAM o/e, GCN2 RNAi 35355). 
ATF4 staining for GCN2 RNAi 103976 quantified in (J), n = 12 (control larvae), 
11 (GCN2 RNAi 103976), 12 (TFAM o/e) and 12 (TFAM o/e, GCN2 RNAi 
103976). Bars = mean ± SEM. Means compared by one-way parametric ANOVA 





5.2.2 Investigating the putative role of ATF4 as a regulator of the transcriptional 
response to mitochondrial dysfunction. 
 
I have proposed that ATF4 is a key regulator of the transcriptional retrograde response to 
mitochondrial dysfunction in Drosophila neurons. To test this hypothesis, RNA 
sequencing (RNA-Seq) was performed on CNS tissue from wandering third instar larvae. 
Overexpression of TFAM, overexpression of ATF4, and overexpression of TFAM 
combined with ATF4 RNAi, were driven by the pan-neuronal driver nSyb-Gal4. Control 
larvae were the progeny of nSyb-Gal4 flies crossed to w1118. Since we do not detect the 
ATF4 protein in control larvae, ATF4 RNAi was omitted as a condition. Before 
proceeding to the RNA-Seq experiment, I performed qRT-PCR to confirm that expression 
of the ATF4 RNAi line (25985) reduced ATF4 mRNA abundance; ATF4 mRNA was 
reduced by ~90% in whole larvae with ATF4 RNAi line 25985 driven ubiquitously 
(Fig. 5.3).   
  
 To control for differing transcript lengths – a long transcript will produce more 
sequencing fragments than a shorter one – and variation in sequencing depth between 
runs, gene abundance in RNA-Seq analysis is presented as the normalised quantity 
‘fragments per kilobase of transcript per million reads’ (FPKM). In all the following 
analyses, genes were considered meaningfully expressed if the average FPKM across the 
quadruplicate samples was ≥ 1 for at least one condition. This threshold was applied 
alongside minimum fold change cut-offs of 1.5 for upregulated genes, 0.67 (equivalent to 
a -1.5 fold change) for downregulated genes, and an adjusted p value cut-off of 0.05. 
  
With the above thresholds applied, the expression of 63-169 genes were 
significantly changed between each pair of conditions (Fig. 5.4 and Table 4). The 
transcriptional retrograde response to the TFAM-overexpression model of mitochondrial 
dysfunction can be seen by considering the ‘TFAM overexpression vs Control’ pairing; 
36 genes were significantly upregulated, and 63 significantly downregulated. Heatmaps 
showing expression of the genes up- and downregulated by TFAM overexpression can 









Figure 5.3 Expression of ATF4 RNAi line (25985) reduces ATF4 mRNA abundance. 
ATF4 RNAi line 25985 was driven ubiquitously by Da-Gal4, and qRT-PCR was 
performed on cDNA synthesised from RNA extracted from wandering third instar 
larvae. Abundance was normalised to the housekeeping gene Rpl4. Means compared 








Control TFAM o/e ATF4 o/e  
99 
36 genes ↑ (36%)   
TFAM o/e 
63 genes ↓ (64%)   
169 
35 genes ↑ (21%) 
68 
13 genes ↑ (19%)  
ATF4 o/e 
134 genes ↓ (79%) 55 genes ↓ (81%)  
71 
20 genes ↑ (28%) 
63 
20 genes ↑ (32%) 
88 
53 genes ↑ (60%) TFAM o/e, 
ATF4 RNAi 51 genes ↓ (72%) 43 genes ↓ (68%) 35 genes ↓ (40%) 
Table 4. Number of genes significantly regulated in each pairwise condition, as 
determined by RNA-Seq analysis. Comparisons are Y versus X, for example, the 36 
upregulated genes in the top left are increased in the TFAM overexpression condition 
compared to Control. Thresholds were ≥ ±1.5 fold change in expression, mean FPKM 




Figure 5.4 Volcano plots of pairwise gene expression changes as determined by RNA-
Seq analysis. Expression changes are Y versus X, for example, the top left panel is 
TFAM overexpression versus Control. Significantly changed genes (p-adj <0.05) are 

















Figure 5.5 Heatmap of genes upregulated by TFAM overexpression. 36 genes 
upregulated by TFAM overexpression, compared to Control, as determined by 
RNA-Seq analysis using Cuffdiff software. As per the scale bar, expression 
(colour) is shown proportional to fragment counts normalised to transcript length 




Figure 5.6 Heatmap of genes downregulated by TFAM overexpression. 63 genes 
downregulated by TFAM overexpression, compared to Control, as determined by 
RNA-Seq analysis using Cuffdiff software. As per the scale bar, expression (colour) is 
shown proportional to fragment counts normalised to transcript length and number of 
mapped reads (FPKM). 
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If ATF4 is to be considered an important regulator of the retrograde response to 
mitochondrial dysfunction in Drosophila neurons, then (1) ATF4 overexpression would 
be expected to replicate some of the transcriptional changes caused by TFAM 
overexpression, and (2) knock-down of ATF4 in conjunction with TFAM overexpression 
would be expected to reverse some of the transcriptional changes caused by TFAM 
overexpression. 
 
Comparison of genes differentially expressed in the TFAM overexpression and 
ATF4 overexpression conditions (both relative to control) revealed striking similarities 
(Fig. 5.7 A); 10/36 (28%) genes upregulated by TFAM overexpression were also 
upregulated by ATF4 overexpression (see Appendix 8.3.1 for list), whilst 47/63 (77%) of 
genes downregulated by TFAM overexpression were also downregulated by ATF4 
overexpression (Appendix 8.3.2). The direction of regulation was reversed for only two 
genes (ImpL3 and Arc1), whose expression was increased by TFAM overexpression, but 
decreased by ATF4 overexpression (Appendix 8.3.1). Genes that were differentially 
expressed in both TFAM and ATF4 overexpression conditions were significantly 
correlated when analysed by linear regression (Y = 0.80X ± 0.06, R2 = 0.72, p < 0.0001) 
(Fig. 5.7 B).  
 
Qualitative inspection of the heatmaps in Figures 5.5 and 5.6 indicates that 
knock-down of ATF4 reverses many of the transcriptional changes induced by TFAM 
overexpression. To quantitatively characterise these transcriptional alterations, I 
identified the significantly regulated genes in the pairwise comparison 
‘TFAM overexpression, ATF4 RNAi vs TFAM overexpression’ and compared them to 
the transcriptional changes in ‘TFAM overexpression vs Control’ (Fig. 5.7 C); 17/36 
(47%) genes upregulated by TFAM overexpression (vs Control) were downregulated by 
co-expression of ATF4 RNAi (vs TFAM overexpression alone) (Appendix 8.3.3), the 
expression of 13/63 (21%) genes downregulated by TFAM overexpression was also 
reversed by ATF4 RNAi (Appendix 8.3.4). The TFAM transcriptional phenotype was 
exacerbated by ATF4 knock-down for only two genes – one gene upregulated by TFAM 
overexpression was further upregulated by simultaneous ATF4 knock-down (Hsp70Bb) 
(Appendix 8.3.4), and one gene downregulated by TFAM overexpression was further 
downregulated by ATF4 knock-down (CG14566) (Appendix 8.3.3). There was a 
significant negative correlation between the expression of genes regulated in both 












Figure 5.7 Quantitative analysis of transcriptional regulation by ATF4 in the TFAM-
overexpression model of mitochondrial dysfunction. Area-proportional Venn diagrams 
showing (A) the number of commonly regulated genes in the TFAM overexpression 
(vs Control) and ATF4 overexpression (vs Control) conditions as determined by RNA-
Seq, and (C) the number of commonly regulated genes in the TFAM overexpression, 
ATF4 RNAi (vs TFAM overexpression alone) conditions as determined by RNA-Seq. 
↑ = upregulated, ↓ = downregulated. Only significantly expressed genes (≥ ±1.5 fold 
change in expression, mean FPKM ≥1 for at least one condition, and adjusted p < 0.05) 
were included. In (B) and (D), graphs show gene expression correlations between the 
same pairings of conditions. All genes plotted were significantly regulated in their 
respective conditions. Axis labels indicate the genotype that was compared to the 
control condition, apart from where otherwise stated (D, Y-axis). Lines of best-fit were 
determined by least squares linear regression analysis and their equations displayed on 
the graphs. R
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Of the 57 genes commonly regulated by TFAM overexpression and ATF4 
overexpression (i.e. up- or downregulated in both conditions), the expression of 13 was 
also reversed by ATF4 knock-down (vs TFAM overexpression) (Appendix 8.3.5, grey 
shading).  
 
To gain insight into the function of the genes regulated by ATF4 in Drosophila 
neurons with mitochondrial dysfunction, I performed functional annotation clustering via 
the gene ontology software DAVID. Functional terms for each significantly regulated 
gene can be found in Appendix 8.3.5. To enable the software to discover clusters of 
relevance to the nervous system, 19 genes with solely structural roles elsewhere in the 
larvae – and whose presence in the list of significantly regulated genes very likely 
represents tissue contamination in a sample - were removed from the analysis  (Appendix 
8.3.6). Only one significantly enriched cluster, centred around ATP- and nucleotide 
binding, was identified for the genes signficantly regulated by TFAM overexpression vs 
control (p = 0.038, Fig. 5.8 B). The output from DAVID contains all identified clusters 
regardless of the significance of enrichment, and the same cluster also appeared in the 
output for ATF4 overexpression vs control, and TFAM overexpression, ATF4 RNAi vs 
TFAM overexpression alone, although neither was significantly enriched (p = 0.067 and 
0.66 respectively, Fig. 5.8 B). One further cluster, which centred around oxidoreductase 
activity and heme/iron binding, was both common to all three conditions and significantly 
enriched in at least one condition (ATF4 overexpression vs control, p = 0.002, 
Fig. 5.8 A). Three highly enriched clusters, focused upon neurohormone signalling (p = 
0.0006, Fig. 5.9 A), oxidative phosphorylation (p = 0.028, Fig. 5.9 B) and glutathione 
metabolism (p = 0.08, Fig. 5.9 C), were uniquely identified for the ATF4 overexpression 
vs control condition. One cluster containing Hsp20 chaperones was significantly enriched 
solely in the TFAM overexpression, ATF4 RNAi vs TFAM overexpression alone 
condition (Fig. 5.9 D). There were no significantly enriched clusters common to two (but 
not all three) conditions. 
 
My results indicate that ATF4 has fulfilled the criteria to be considered a regulator 
of mitochondrial retrograde signalling in the Drosophila nervous system: (1) ATF4 
overexpression replicated some (58%) of the transcriptional changes caused by TFAM 
overexpression, and (2) knock-down of ATF4 in conjunction with TFAM overexpression 
reversed some (30%) of the transcriptional changes caused by TFAM overexpression. 
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This strongly suggests that ATF4 is a key regulator of the transcriptional response to 









































Figure 5.8 Functional annotation clusters common to the TFAM o/e, ATF4 o/e (both 
versus control) and TFAM o/e, ATF4 RNAi compound (versus TFAM o/e alone) 
conditions as determined by DAVID gene ontology software. (A) Cluster centred 
around oxidoreductase activity and heme/iron binding. (B) Cluster centred around 
ATP- and nucleotide binding. (A, B) The clustering for each condition was processed 
independently, and then combined into the grids (i.e. the list of genes significantly 
regulated by ATF4 o/e was not input into the software at the same time at the list of 
genes significantly regulated by TFAM o/e). DAVID outputs all detected clusters 
regardless of the calculated level of significance of the enrichments. Clusters displayed 
here are those which were identified for all three conditions, and where the terms 
within the cluster were significantly enriched in at least one of the conditions. 
Enrichment score is the negative logarithm of the geometric mean of the p values of 
each term within the cluster (so overall p = 10-enrichment score). *p < 0.05, **p < 0.01. 
(C) Key for clusters in (A) and (B). Green = gene significantly regulated and placed 
within cluster in TFAM o/e versus control, pink = gene significantly regulated and 
placed within cluster in ATF4 o/e versus control, blue = gene significantly regulated 
















































Figure 5.9 Functional annotation clusters unique to ATF4 overexpression (versus 
control) or TFAM overexpression, ATF4 RNAi (versus TFAM overexpression alone) as 
determined by DAVID gene ontology software. (A) Cluster centred around 
neurohormone signalling. (B) Oxidative phosphorylation cluster. (C) Cluster centred 
around glutathione metabolism. (D) Heat shock cluster. (A-C) Clusters unique to ATF4 
o/e vs control. (D) Cluster unique to TFAM o/e, ATF4 RNAi vs TFAM o/e. (A-D) 
Enrichment score is the negative logarithm of the geometric mean of the p values of 
each term within the cluster (so overall p = 10-enrichment score). *p < 0.05, **p < 0.01, 
***p < 0.001.  
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5.2.3 Validation of RNA-Seq analysis using an independent method. 
 
One of the genes whose expression was significantly upregulated by TFAM 
overexpression and reversed by ATF4 knock-down in my RNA-Seq analysis was Thor, 
which encodes the Drosophila homologue of the cap-dependent translation repressor 
4E-BP1. I used immunofluorescence to explore the transcriptional regulation of Thor by 
an independent method. An OK371-Gal4, UAS-CD8-GFP driver line that also possesses 
a Thor transcriptional reporter (a lacz insertion downstream of the Thor promoter) was 
used to drive ATF4 RNAi (Fig. 5.10) alongside TFAM overexpression in motor neurons. 
Levels of Thor transcription were assessed by quantification of β-Gal 
immunofluorescence staining in the cell bodies of targeted neurons, as demarcated by 
GFP expression. Transcription of Thor was significantly increased by TFAM 
overexpression (Fig. 5.10 C-C’’, E, p < 0.001 ), slightly decreased by ATF4 RNAi alone 
(Fig. 5.10 B-B’’, E, p <0.01), and also decreased to that same level when ATF4 was 
knocked down in conjunction with TFAM overexpression (Fig. 5.10 D-D’’, E, p < 0.001). 
This result confirms that ATF4 regulates Thor transcription in Drosophila motor neurons 









































Figure 5.10 ATF4 regulates transcription of Thor under conditions of TFAM 
overexpression in Drosophila motor neurons. Membrane-targeted GFP (CD8-
GFP), ATF4 RNAi (in B-B’’), TFAM overexpression (o/e) (in C-C’’) and TFAM 
overexpression, ATF4 RNAi combined (D-D’’) driven in motor neurons of the 
VNC by OK371-Gal4. (A,B,C,D) GFP fluorescence (white). (A’,B’,C’,D’) 
Immunofluorescence staining with for β-Gal (white). (A’’,B’’,C’’,D’’) Merged 
images (GFP green, β-Gal magenta). β-Gal staining quantified in (E), n = 21 
(control larvae), 21 (ATF4 RNAi), 15 (TFAM o/e) and 12 (TFAM o/e, ATF4 
RNAi). Bars = mean ± SEM. Means compared by one-way parametric ANOVA 





In this chapter I aimed to establish whether the ER UPR is a mitochondrial retrograde 
signalling pathway in Drosophila neurons. 
 
In Chapter 4, I demonstrated that components of the PERK branch of the ER UPR 
are activated in our models of mitochondrial dysfunction. In particular, I showed that 
phosphorylation of the translational regulator eIF2α is increased by TFAM 
overexpression, and that levels of the ATF4 protein also increase. In this chapter, to 
investigate whether the PERK branch of the ER UPR is indeed the pathway responsible 
for the upregulation of ATF4, I performed immunofluorescence knock-down 
experiments. Two RNAi lines demonstrated that PERK regulates the expression of ATF4 
under conditions of TFAM overexpression; PERK knock-down in conjunction with 
TFAM overexpression significantly reduced ATF4 levels compared to overexpression of 
TFAM alone. Conversely, knock-down of the ISR kinase GCN2  - which can also 
phosphorylate eIF2α - by two independent RNAi lines did not significantly alter ATF4 
levels in either control or mitochondrial dysfunction conditions. Taken together, these 
results strongly suggest that the ER UPR, with limited or no contribution from GCN2, 
regulates ATF4 expression in Drosophila motor neurons in the TFAM-overexpression 
model of mitochondrial dysfunction. 
 
To be a mitochondrial retrograde signalling pathway, the ER UPR must alter 
nuclear gene transcription in response to mitochondrial dysfunction. Having confirmed 
that ATF4 is regulated by the ER UPR when TFAM is overexpressed in motor neurons, 
I performed RNA-Seq analysis on larval CNS tissue with pan-neuronal TFAM 
overexpression to investigate the putative role of the protein in transcriptional regulation. 
 
The expression of 99 genes was significantly altered by overexpression of TFAM 
compared to control samples. This retrograde transcriptional signature was substantially 
replicated by overexpression of ATF4; 57/99 (58%) genes that underwent transcriptional 
changes in the TFAM overexpression condition were similarly regulated by ATF4 
overexpression. Only 2/99 (2%) genes displayed inverted regulation – they were 




Knock down of ATF4 in conjunction with TFAM overexpression reversed the 
transcriptional changes induced by TFAM overexpression for 30/99 (30%) genes. ATF4 
RNAi enhanced the effects of TFAM overexpression - further increased or decreased 
expression - for just 2/99 (2%) genes. Enriched functional clusters for the genes 
significantly regulated by TFAM and/or ATF4 included ATP- and nucleotide binding, 
oxidoreductase activity, neurohormone signalling, oxidative phosphorylation and 
molecular chaperones. 
 
The Drosophila 4E-BP1 homologue, Thor, was amongst the genes regulated by 
ATF4 in my RNA-Seq analysis; expression of Thor was upregulated by TFAM 
overexpression and suppressed by co-expression of ATF4 RNAi. This pattern was 
replicated in immunofluorescence experiments which utilised a lacz reporter downstream 
of the Thor promoter, thus confirming that ATF4 can control nuclear gene transcription 
under conditions of neuronal mitochondrial dysfunction, and suggesting that the ER UPR 

























6.1 Alterations to mitochondrial and ER biology in Drosophila neurons 
with mitochondrial dysfunction 
 
6.1.1 Alterations to Ca2+ handling 
 
I detected dramatically elevated mitochondrial Ca2+ levels in the cell bodies of TFAM 
overexpressing motor neurons. This is in line with some other models of mitochondrial 
dysfunction, including instances of oxidative stress (Hawkins, Irrinki et al. 2010), 
Complex II inhibition (Nasr, Gursahani et al. 2003, Mbaya, Oulès et al. 2010), and PINK1 
mutation in Drosophila (Lee, Huh et al. 2018). Retention of the facility to import 
significant Ca2+ suggests that any putative reduction in membrane potential caused by 
TFAM overexpression, may be overcome by the high Ca2+ microdomains at expanded 
ER-mitochondrial contacts. 
 
The mitochondrial enzymes pyruvate dehydrogenase, isocitrate dehydrogenase 
and α-ketoglutarate dehydrogenase are known to be activated by Ca2+ ions (Denton and 
McCormack 1980), and therefore raised mitochondrial Ca2+ could facilitate an increase 
in the conversion of pyruvate to acetyl-CoA, and its subsequent oxidation in the Krebs 
cycle. However, RNA-Seq analysis indicated that lactate dehydrogenase (ImpL3) was 
upregulated ~3-fold by TFAM overexpression, and it is therefore likely that the excess 
pyruvate consumed for conversion to lactate (with concomitant oxidation of NADH), 
would prevent any meaningful increase in acetyl-CoA supply to the Krebs cycle.  
 
 Ca2+ overload can also activate pathological pathways within the mitochondria. 
Mitochondrial permeability transition (MPT) is the sudden increase in IMM permeability 
that permits the efflux of molecules ≤ 1.5 kDa into the intermembrane space (Haworth 
and Hunter 1979), usually followed by mitochondrial swelling and sometimes by OMM 
rupture and the release of apoptotic factors such as cytochrome c. Raised mitochondrial 
Ca2+ can trigger MPT (Chalmers and Nicholls 2003), but TFAM overexpression in 
Drosophila motor neurons does not cause cell loss in third instar larvae (Cagin, Duncan 
et al. 2015), so it is unlikely that MPT is occuring in this model. This could be due to a 
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lack of other pro-MPT/apoptotic signals such as ceramide (Szalai, Krishnamurthy et al. 
1999).  
 
 Cytosolic GCaMP and CaMPARI reporters indicated that TFAM overexpression 
does not change the level of cytosolic Ca2+ in Drosophila motor neurons. Larvae 
expressing CaMPARI were exposed to UV whilst crawling, implying that their motor 
neurons were activated when Ca2+ levels were being recorded by photoconversion of the 
CaMPARI reporter. Repeated neuronal stimulation via the heat-activated TrpA1 channel 
did however lead to increased Ca2+ levels in TFAM overexpressing neurons, suggesting 
subtle elevations in cytosolic Ca2+ caused by TFAM overexpression that could only be 
detected by hyper-stimulation. 
 
 An increase in cytosolic Ca2+ could lead to the activation of myriad pathways, 
many of which could only be discovered by analysis of post-translational modifications, 
and would not be obviously detectable by RNA-Seq analysis of the transcriptional 
changes caused by TFAM overexpression. The kinase ERK is activated by TFAM 
overexpression in Drosophila motor neurons, and knock-down of components of the 
Ras-ERK-ETS pathway suppressed the climbing and wing inflation impairments of 
TFAM overexpressing flies (Duncan, Granat et al. 2018). Phosphorylation (activation) of 
ERK is Ca2+-dependent and can be regulated by both CaMKs (Enslen, Tokumitsu et al. 
1996, Schmitt, Wayman et al. 2004) and calcineurin (Dougherty, Ritt et al. 2009), 
suggesting that elevated cytosolic Ca2+ could be the activator of the counterproductive 
ERK-mediated retrograde signalling in Drosophila motor neurons with mitochondrial 
dysfunction. 
 
6.1.2 Alterations to mitochondrial morphology 
 
I did not assess any direct parameters of mitochondrial function in this thesis, but did 
investigate the morphology of mitochondria in Drosophila neurons with TFAM 
overexpression. The morphology of purified mitochondria from whole young (15 day 
old) flies is remarkably homogeneous; a subset of only 10% of isolated mitochondria 
displayed greater elongation or widened cristae. By contrast, the morphology of 
mitochondria extracted from aged (70 day old) flies was diverse and included abnormally 
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thin and branched mitochondria, suggesting that the mitochondrial uniformity seen in the 
young adults was not an artefact of the isolation procedure, and that mitochondrial 
structure may be similar across diverse tissues in the young fly (Brandt, Mourier et al. 
2017). In support of this, in vivo imaging of the Drosophila embryo revealed a reticular 
network highly similar in appearance to that which I imaged in Drosophila motor neurons 
(Macchi, El Fissi et al. 2013). Overexpression of TFAM in Drosophila motor neurons 
caused significant changes to the morphology of the mitochondrial network in the cell 
bodies. Whilst the total area of mitochondria remained unchanged, the number of 
mitochondria increased and the average size decreased, suggesting increased 
fragmentation and a tip of the fission/fusion balance towards fission. 
 
In rat liver cells, mitochondrial fragmentation was found to be dependent on 
mitochondrial Ca2+ influx and components of the OMM scission machinery, Drp1 and 
Fis1. The fragmentation could be reversed if the elevated level of mitochondrial Ca2+ was 
transient, but became permanent if mitochondrial Ca2+ levels were persistently raised 
(Hom, Gewandter et al. 2007). Recently, two independent groups have found that 
Drp1-independent constrictions of the IMM occur during mitochondrial fission (Cho, 
Cho et al. 2017, Chakrabarti, Ji et al. 2018). These constrictions are dependent on 
enhanced mitochondrial Ca2+ uptake which, when examined, was mediated by increased 
ER-mitochondrial contacts (Chakrabarti, Ji et al. 2018). Knockdown of the VDAC-to-IP3 
receptor linker GRP75 in an oxidative stress model reduced mitochondral fragmentation, 
lending weight to the idea that excess Ca2+ transfer from the ER to the mitochondria could 
underly at least some fragmentation (Honrath, Metz et al. 2017). 
 
Whilst Ca2+-induced pathological fragmentation is probably occuring in 
Drosophila neurons with TFAM overexpression, a proportion of the smaller 
mitochondrial units could also be mitochondria-derived vesicles (MDVs). MDVs 
transport damaged mitochondrial components for degradation, and are proposed to limit 
the need for mitophagy in tissues with a high energy demand, such as cardiac muscle and 
the nervous system (Roberts, Tang et al. 2016). MDV formation is regulated, with specific 
cargo and structure, and increased by oxidative stress or ETC inhibition (Soubannier, 
McLelland et al. 2012). Single-membrane MDVs canonically contain the OMM proteins 
TOM20 and VDAC, and lack IMM and matrix components. Double-membrane MDVs 
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have been found to contain pyruvate dehydrogenase and a subunit of Complex III, but not 
VDAC or TOM20 (Soubannier, McLelland et al. 2012, Soubannier, Rippstein et al. 
2012). Double-membrane MDVs are targeted to the lysosome (McLelland, Soubannier et 
al. 2014). Single-membrane MDVs are also targeted to the lysosome unless they are of a 
subset that is enriched for the OMM SUMO E3 ligase mitochondrial-anchored protein 
ligase (MAPL) and lack TOM20, in which case the peroxisome is the destination 
(Neuspiel, Schauss et al. 2008). 
 
Formation of the double-membrane MDVs which traffick damaged IMM and 
matrix proteins for degradation, requires wild-type PINK1 and parkin in mammalian cell 
culture (McLelland, Soubannier et al. 2014). In Drosophila heads, a proportion of the 
PINK1/parkin-dependent turnover of ETC components is independent of mitophagy, but 
a role for MDVs was not explored (Vincow, Merrihew et al. 2013). In PINK1 and parkin 
loss-of-function or knock-down models, reports of mitochondrial morphology conflict. 
Both mitochondrial fragmentation (Yang, Gehrke et al. 2006, Lutz, Exner et al. 2009) and 
enlargement (Poole, Thomas et al. 2008, Lee, Huh et al. 2018) or branching (Mortiboys, 
Thomas et al. 2008) have been observed. It is clear that the morphological outcome is 
context specific, and it may be that in cases where elevated mitochondrial Ca2+ is not 
sufficient to cause fragmentation by excess fission or MPT-induced rupture – perhaps due 
to the absence of a co-factor - that swelling or branching is seen due to impaired MDV 
formation.  
 
6.1.3 Alterations to ER morphology 
 
As with mitochondria, the morphology of the ER is dynamic (Lee and Chen 1988). I used 
three fluorescent fusion constructs to record snapshots of ER morphology under control 
and mitochondrial dysfunction conditions. The luminal diameter of Drosophila ER sheets 
is approximately 30 nm (Shibata, Shemesh et al. 2010), well below the resolution limits 
of green (λ ≈ 500 nm, NA  = 1.3, therefore d ≈ 190 nm as per (Abbe 1873)) and red (λ ≈ 
600 nm, d ≈ 230 nm) light in standard confocal microscopy, so the fluorescent constructs 
report only an approximation of ER morphology, but are nevertheless useful tools for 
preliminary investigations. The putative reduction in ER reticulation suggested by two of 
the reporters merits follow-up with higher resolution techniques such as electron 
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microscopy, and the perinuclear localisation of the most pronounced changes may guide 
these investigations and others that utilise antibodies against subcellular compartments.  
 
Each of the three fluorescent reporters had different targeting and retention 
sequences, and therefore the potential to mark distinct regions of the ER. Whilst animal 
cells make almost exclusive use of the KDEL retention motif, Drosophila proteins utilise 
HDEL and KDEL in roughly equal proportion (Abrams, Cheng et al. 2013). The identity 
of the retention signal has been shown to impact the intra-ER localisation of proteins in 
plant and animal cells (Napier, Fowke et al. 1992, Gilham, Alam et al. 2005), although 
not in a predictable manner; in both cases the KDEL motif correlated with restricted 
distribution of its allied proteins, but one was to perinuclear ER and the other sub-cortical. 
In addition, structures and/or sequences outside of the known targeting and retention 
motifs seem to play a role in trafficking to ER subdomains in a cell-type specific manner. 
Remarkably, a DsRed-KDEL fusion marked solely ER-derived vesicles in hippocampal 
neurons, whilst a second construct (GFP-KDEL), that differed only in the identity of the 
fluorophore, displayed reticular patterning. In COS-7 cells, both reporters were reticular 
(Bannai, Inoue et al. 2004). Sec61β is a subunit of the complex that transports nascent 
polypeptides into the ER lumen (Gorlich and Rapoport 1993), and therefore the 
tdTomato-Sec61β construct should demarcate the rough ER membrane, however 
fluorescent fusions with human Sec61β were seen throughout the ER (Shibata, Voss et 
al. 2008) and did not integrate into translocon complexes (Snapp, Hegde et al. 2003), 
again suggesting that subdomain targeting is a function of the complete protein. Given 
these findings, further investigation would be required to establish the intra-ER 
localisation of the three fusion constructs I used to examine ER morphology. However, 
since the BiP-sfGFP-HDEL and tdTomato-Sec61β reporters both indicated extremely 
similar changes to ER morphology, it is likely there is substantial overlap in their 
localisation. The lyso-RFP-KDEL reporter also exhibited reticular patterning, but did not 
recapitulate the results seen with the other constructs, suggesting that it localised to a 
different, although potentially overlapping, subset of ER domains. Taken together the 
results indicate that morphological changes of neuronal ER caused by mitochondrial 
dysfunction may be more acute in some ER domains, and that alterations are not restricted 
to the external structure of the organelle, but may also include a functional reassignment 
of internal ER regions. A caveat to these observations is that overexpression of 
ER-targeted fluorescent chimeras has been reported to alter ER morphology (Snapp, 
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Hegde et al. 2003), however any such changes should have occurred in both the control 
and mitochondrial dysfunction conditions, and therefore does not invalidate the 
preliminary conclusion that mitochondrial dysfunction alters ER morphology in the cell 
bodies of Drosophila neurons.   
 
A reduction in the reticular nature of the ER in response to mitochondrial 
dysfunction may correspond to an increase in sheet content, classically associated with 
the rough ER and protein synthesis. Recently, a paradigm-shifting examination of ER 
morphology using high resolution microscopy techniques has proposed that regions of 
the ER previously classified as sheets are in fact dense matrices of tubules, the voids in 
which could not be distinguished by lower resolution imaging (Nixon-Abell, Obara et al. 
2016). If corroborated, this finding will have wide-ranging implications in the field of ER 
dynamics, but may not revolutionise the concept that ‘sheets’ are the site of protein 
synthesis, given that ribosomes have been extensively imaged on these regions and the 
proposed tubular densities would also present regions of reduced curvature that can 
accommodate the ribosome. 
 
Removal of the 40S subunit from actively synthesising ribosomes on the ER 
caused the immediate loss of interphase ER sheets in CHO-K1 cells (Puhka, Vihinen et 
al. 2007). The authors speculated that Ca2+ leakage from the remaining 60S-translocon 
complex may signal the rearrangement of ER structure via the highly conserved EF-hand 
protein, p22. Regulation of ER morphology during the cell cycle seems not to be 
conserved between mammals and flies (Bobinnec, Marcaillou et al. 2003) and, although 
possible, increased ribosome occupancy of the ER is an unlikely response to neuronal 
mitochondrial dysfunction given the phosphorylation of eIF2α that canonically reduces 
global translation. Therefore, it seems improbable that the hypothetical ER sheet 
expansion seen in the TFAM overexpression condition is due to stabilisation by 
ribosomes. 
 
Increased cytosolic Ca2+ concentration has been shown to increase the number of 
ER-plasma membrane contacts (Chang, Hsieh et al. 2013, Giordano, Saheki et al. 2013) 
and induce dramatic fragmentation of the ER (Subramanian and Meyer 1997, Ribeiro, 
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McKay et al. 2000). In addition, Ca2+ activation of p22 increases ER network formation 
(Andrade, Zhao et al. 2004), indicating that it is also unlikely that a reduction in ER 
reticulation would be mediated by the increased levels of cytosolic Ca2+ seen in stimulated 
Drosophila neurons with mitochondrial dysfunction.  
 
Expansion of ER sheets in yeast has been observed in response to treatment with 
the reducing agent DTT and glycolsylation inhibitor tunicamycin, and attributed to 
activation of lipid biosynthesis by the ER UPR protein IRE1 (Schuck, Prinz et al. 2009). 
Cell survival was increased by ER sheet expansion, independently of chaperone 
activation. IRE1 is also required for the increase in ER sheets in the developing 
photoreceptor cells of Drosophila (Xu, Chikka et al. 2016). It has been demonstrated that 
increased lipid packing density activates the ER UPR in yeast and mammals (Volmer, 
van der Ploeg et al. 2013, Halbleib, Pesek et al. 2017). The mechanism determined in 
yeast was a mechano-sensitive amphipathic helix in the IRE1 transmembrane domain that 
is conserved in fellow ER UPR sensor PERK, and across species (Halbleib, Pesek et al. 
2017). Coupled with my results, these findings suggest a mechanism for ER sheet 
expansion whereby mitochondrial dysfunction disturbs lipid homeostasis causing 
aberrant ER membrane composition that activates the UPR, which then augments the 
initial changes to ER morphology.  
 
6.1.4 Alterations to ER-mitochondrial contacts 
 
At the NMJ, TFAM overexpression decreased the number of candidate ER-mitochondrial 
contact sites. TFAM overexpression results in a significant loss of mitochondria from the 
NMJ, and the alteration to candidate ER-mitochondria contact sites may therefore simply 
be a reflection of this reduction – particularly given that I did not detect changes to ER 
morphology at the NMJ. In the motor neuron cell bodies, my results indicate that TFAM 
overexpression increased the number of candidate ER-mitochondrial contact sites, and 
this may reflect changes in the morphology of both organelles. In recent years, altered 
ER-mitochondrial contacts have been found to be a common characteristic of many 
diverse diseases. The changes to MAMs have not been consistent, either in their extent, 




Recently it was demonstrated in neurons from Drosophila parkin mutants that 
increased ER-mitochondrial contacts diminish ER phosphatidylserine (PS) content by 
augmented transfer of PS from the ER to mitochondria, where it is converted to 
phosphatidylethanolamine and the drive to continued PS transfer maintained (Valadas, 
Esposito et al. 2018). Similar lipid dysregulation in the motor neuron cell bodies of TFAM 
overexpressing flies, could explain the activation of the ER UPR and suggests that 
perturbed lipid homeostasis may constitute part of the MAM-to-ER leg of the retrograde 
signal from the mitochondria to the nucleus. PS supplemented food rescued the sleep 
abnormalities of parkin mutant flies indicating that PS could represent a viable oral 
therapy for neurological diseases associated with increased ER-mitochondrial contacts. 
 
 Dysregulated Ca2+ signalling may also contribute to the MAM-to-ER signalling 
of mitochondrial dysfunction in Drosophila neurons. An amyotrophic lateral sclerosis 
(ALS)-associated mutation in the mitochondrial tethering protein VAPB, results in 
extended MAM formation and increased Ca2+ transfer from the ER to the mitochondria 
in cell lines and rat cortical neurons (De Vos, Mórotz et al. 2012). Similarly, in 
Drosophila, mutation of the PD-associated PINK1 increases ER-mitochondria contacts 
in dopaminergic neurons leading to elevated mitochondrial Ca2+ and cell death (Lee, Huh 
et al. 2018). Both studies indicate that enhanced ER-mitochondrial Ca2+ transfer is 
detrimental to neuronal health. This idea is supported by the finding that knock-down of 
the VDAC-IP3 receptor linker, GRP75, protects hippocampal HT22 cells from oxidative 
stress, putatively by reducing mitochondrial Ca2+ overload (Honrath, Metz et al. 2017). 
In addition, GRP75 overexpression exacerbated the deleterious affects of rotenone 
treatment in rat mesencephalic cells (Jin, Hulette et al. 2006). However, mutations in the 
sigma-1 receptor, which has roles in both ER-mitochondrial lipid and Ca2+ transfer, 
underly some cases of ALS. Knockout of the sigma-1 receptor disturbed 
ER-mitochondrial contacts, exacerbated locomotor phenotypes (Bernard-Marissal, 
Medard et al. 2015) and hastened death in a mouse model of motor neuron disease 
(Mavlyutov, Epstein et al. 2013), whilst sigma-1 receptor activation has been shown to 
be beneficial in both in vivo and in vitro ALS models (Mancuso, Oliván et al. 2012, Ono, 
Tanaka et al. 2014). This is contradictory to the idea that reducing Ca2+ and lipid transfer 
in neuronal disease is beneficial, and indicates that much work remains to uncover the 
context-specific factors that determine whether increased ER-mitochondria contacts have 
ameliorative or pathological consequences. 
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6.2 Communicating mitochondrial dysfunction from the ER to the 
nucleus in Drosophila neurons. 
 
6.2.1 Communication via the ER lumen 
 
I have shown that the ER UPR is activated in response to mitochondrial dysfunction in 
Drosophila motor neurons, and conveys a retrograde signal to the nucleus via the 
cytoplasm. However, the ER is continuous with the outer nuclear membrane, and hence 
the ER lumen is continuous with the intermembrane space of the nuclear envelope. 
Therefore, it is conceivable that mitochondrial dysfunction could also send signals that 
are carried internally via the ER lumen to the nucleus. 
 
 The nucleoplasmic reticulum (NR) is the name given to invaginations of the 
nuclear envelope that protrude into the nucleoplasm, and has been widely observed in a 
variety of species. Two types of NR invaginations have been described; those that involve 
only the inner nuclear membrane are classified as type I, whilst those that comprise both 
the inner and outer nuclear membranes and hence create cul-de-sacs of cytosol wending 
into the nucleus – or sometimes tunnels completely traversing the nucleus (Fricker, 
Hollinshead et al. 1997) - are designated type II (Malhas, Goulbourne et al. 2011). 
 
Type II invaginations retain some of the molecular features of the ER, including 
the presence of protein disulfide isomerase, glucose-6-phosphatase (Fricker, Hollinshead 
et al. 1997) and calreticulin (Goulbourne, Malhas et al. 2011). Therefore the changes to 
perinuclear ER morphology suggested by two of the fluorescent reporters, may extend to 
altered NR morphology. As already discussed, the putative expansion of ER sheets and 
increase in ER-mitochondrial contacts suggest altered lipid synthesis in Drosophila 
neurons with mitochondrial dysfunction. Activity of CTP:phosphocholine 
cytidyltransferase (CCT), the rate-limiting enzyme in the synthesis of 
phosphatidylcholine (PC), is regulated by its localisation. The soluble 
cytosolic/nucleoplasmic CCT fraction is inactive. A reduction in membrane PC content 
prompts the insertion of CCT into the membrane, and its activation via the necessary 
conformational change. Overexpression of the nuclear-targeted isoform CCTα, caused 
proliferation of type II NR in CHO cells, an effect that was separately mediated by both 
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membrane insertion and PC synthesis (Lagace and Ridgway 2005). Thus disturbed PC 
levels in Drosophila neurons with mitochondrial dysfunction could cause changes to NR 
morphology. 
 
In HeLa cells, mitochondria have been shown to cluster around the cytoplasmic 
entrance to the type II invaginations, and remarkably, to shuttle in and out of the channels, 
buffering Ca2+ whilst inside (Lui, Chan et al. 2003). Further, the sigma-1 receptor, a 
component of MAMs, was found to localise to the NR in a murine motor neuron-like cell 
line (Mavlyutov, Yang et al. 2017), raising the possibility that ER-mitochondrial contacts 
continue into the nuclear domain, creating a very direct communication of the 
mitochondria with the nucleus. Alongside the increase in ER-mitochondrial contacts in 
Drosophila neurons detected by both fluorescent reporters in response to TFAM 
overexpression, the tdTomato-Sec61β reporter indicated a relocation of these contacts 
away from the perinuclear region. Whilst this finding was not recapitulated by the 
lyso-RFP-KDEL reporter, it does suggest that at least in some ER domains, mitochondrial 
dysfunction may alter the relationship between mitochondria and the NR, possibly 
leading to increased Ca2+ levels in the NR invaginations. 
 
 NR Ca2+ concentration is extremely relevant in a signalling context. Both a 
Na+/Ca2+ exchanger for the extrusion of Ca2+ from the nucleoplasm (Galva, Artigas et al. 
2012), and the IP3 and RyR (Marius, Guerra et al. 2006) receptors for the influx of Ca
2+, 
have been found in the NR, suggesting fully functional Ca2+ regulation in the nucleus. In 
mouse cardiomycocytes, Ca2+ release into the nucleoplasm by agonist activation of the 
IP3 receptor altered the transcription of cardio-related genes (Garcia, Shah et al. 2004). 
Several transcription factors are known to be regulated by nuclear (rather than cytosolic) 
Ca2+, including CREB (Chawla, Hardingham et al. 1998) and Elk-1 (Pusl, Wu et al. 
2002). In hippocampal neurons, a signalling programme involving transcriptional 
changes to >150 genes is regulated by nuclear Ca2+ changes in response to synaptic 
activity (Zhang, Zou et al. 2009). Also in hippocampal neurons, ATF3 is upregulated by 
CREB in a nuclear Ca2+-dependent manner, and mediates a neuroprotective response to 




 The ends of type II NR invaginations are substantially associated with nucleoli 
(Bourgeois, Hemon et al. 1979, Fricker, Hollinshead et al. 1997) – the sites of ribosome 
and signal recognition particle (SRP) biogenesis - suggesting a direct way in which global 
and ER-targeted translation could be modulated to maintain ER proteostasis, either 
through Ca2+ release into the nucleoli microdomain, or perhaps the interaction of NR 
transmembrane proteins or lamins with components of the nucleoli. 
 
Lamins are members of the intermediate filament family which form a meshwork 
under the inner nuclear membrane. The structure of chromatin within the nucleus has 
been shown to regulate the formation of the NR, with both condensation (Bozler, Nguyen 
et al. 2015), dispersal (Dellaire, Kepkay et al. 2009) and an increase in actively 
transcribed chromatin (Galiova, Bartova et al. 2008) shown to cause NR expansion, 
hypothetically via lamin-chromatin contacts and the mechanical forces exterted by 
chromatin reorganisation. Sequestration by lamin at the periphery of the nucleoplasm has 
been shown to repress the transcription of hundreds of Drosophila genes, including 
members of the cytochrome P450 family (Pickersgill, Kalverda et al. 2006), indicating 
that the extent and morphology of the NR could play an active role in gene expression in 
a number of physiological contexts, including mitochondrial dysfunction. 
 
6.2.2 Activation of the ER UPR 
 
6.2.2.1 Functional consequences of IRE1 and XBP1 activation 
 
The IRE1 branch of the ER UPR was upregulated by TFAM overexpression in 
Drosophila motor neurons, as indicated by increased splicing of the XBP1 transcription 
factor to its active form. Knock-down of IRE1 produced varying modifications to the 
climbing and wing inflation ability of flies with neuronal mitochondrial dysfunction – 
one RNAi line exacerbated the functional impairments, whilst another suppressed them. 
This inconsistency was also seen in RNAi lines targeting GADD34 and could be due to 
off-target effects or differing levels of knock-down – a small reduction in mRNA 
abundance may perhaps be beneficial, whilst a substantial knockdown could be 
detrimental to neuronal function. The efficiency of the RNAi lines will need to be assayed 
before any conclusions can be drawn. XBP1 knock-down produced largely beneficial 
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alterations to climbing and wing inflation ability, indicating that despite the hypothesised 
beneficial role in enhanced lipid synthesis, activation of the IRE1 pathway in Drosophila 
neurons with mitochondrial dysfunction is, on balance, functionally damaging. 
 
Reports of the detrimental effects of IRE1 activation are mostly restricted to the induction 
of apoptosis, however we do not see cell loss in the TFAM overexpression model, 
indicating that the suppression of the mitochondrial dysfunction phenotypes by IRE1 
knock-down is not due to a reduction in cell death. In models of atherosclerosis, IRE1 
upregulates the transcription of deleterious proinflammatory cytokines and chemokines 
(Tufanli, Telkoparan Akillilar et al. 2017). My RNA-Seq analysis of TFAM 
overexpressing neurons does not reveal any significant regulation of inflammatory 
markers or mediators. Knock-out of XBP1 beneficially upregulated autophagy in a 
murine ALS model (Hetz, Thielen et al. 2009), but further work will be needed to 
establish whether suppressed autophagy is the counterproductive element of IRE1 
pathway activation in TFAM overexpressing neurons. 
 
6.2.2.2 Activation of the PERK branch 
 
I identified increased levels of phosphorylated eIF2α (P-eIF2α) in the cytoplasm of motor 
neurons with both TFAM overexpression and ND-75 knock-down, which according to 
canonical UPR signalling would suggest downstream activation of ATF4. However, in 
human patients with nonalcoholic fatty liver or steatohepatitis, liver histology revealed 
increased phosphorylation of eIF2α, but unchanged ATF4 protein and mRNA levels 
(Puri, Mirshahi et al. 2008). A rat model of brain-wide ischaemia-reperfusion injury also 
detected increased P-eIF2α without upregulation of the ATF4 protein (Kumar, Krause et 
al. 2003). In both reports, the authors attributed hepatocyte and neuron death in part to 
failure to activate the protective elements of the downstream ER UPR. Having observed 
elevated levels of P-eIF2α in our models of mitochondrial dysfunction, dysregulation of 
the downstream components of the ER UPR would be a feasible mechanism to explain 
the association of mitochondrial dysfunction with neurodegenerative disease and 
premature organismal death, however I detected robust upregulation of ATF4 protein 
levels, indicating that the canonical P-eIF2α-ATF4 axis is operating in Drosophila motor 




In mammals, eIF2α can be phosphorylated by four kinases that constitute 
upstream arms of the integrated stress response. Of those four kinases, only GCN2 and 
PERK are conserved in Drosophila. GCN2 is typically considered to mediate the 
response to amino acid starvation, but has been shown to be the kinase responsible for 
eIF2α phosphorylation in oligomycin-induced mitochondrial dysfunction in gastric 
(Wang, Chen et al. 2016) and colon (Martínez-Reyes, Sánchez-Aragó et al. 2012) cancer 
cells, and two in vivo genetic models of mitochondrial dysfunction in C. elegans (Baker, 
Nargund et al. 2012). An extensive multiomics study of four drug-induced models of 
mitochondrial dysfunction in HeLa cells concluded that all four ISR kinases could 
redundantly phosphorylate eIF2α in response to treatment with the ionophore carbonyl 
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), since individual knock-down of 
the kinases had no effect on ATF4 induction. However, the authors examined only ATF4 
mRNA – and not protein – levels, and their reasoning is therefore incomplete (Quirós, 
Prado et al. 2017). In our TFAM overexpression model of mitochondrial dysfunction, 
levels of ATF4 were significantly reduced by knock-down of PERK, but unaltered by 
GCN2 knock-down, indicating that it is solely the ER UPR arm of the ISR that is 
regulating ATF4 in Drosophila motor neurons with mitochondrial dysfunction. In the 
oligomycin-treated gastric cancer cells, and both the C. elegans models, addition of an 
antioxidant reduced the GCN2-mediated phosphorylation of eIF2α, implying that reactive 
oxygen species (ROS) were activating this arm of the ISR, and suggesting therefore that 
ROS do not play a role in mitochondrial retrograde signalling via ATF4 in Drosophila 
neurons.  
 
6.2.2.2.1 Other pathways to ATF4 activation 
 
Knock-down of PERK in Drosophila neurons with mitochondrial dysfunction did 
not return ATF4 to control levels, and whilst this could simply be because the knock-
down was inefficient or only low levels of PERK are required for meaningful 
phosphorylation of eIF2α, it raises the possibility that ATF4 is also controlled by 
pathways unrelated to eIF2α. Canonically, ATF4 is regulated at the level of translation, 
but instances of transcriptional control that can bypass or enhance the effects of P-eIF2α 
have been noted: UV radiation increased phosphorylation of eIF2α in mouse embryonic 
fibroblasts (MEFs), but also reduced ATF4 mRNA levels and thus negated activation of 
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the protein via the usual translational mechanism. In the same cells, the 
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin increased 
both ATF4 mRNA and P-eIF2α levels (Dey, Baird et al. 2010). I did not detect significant 
up- or downregulation of ATF4 mRNA levels by TFAM overexpression in my RNA-Seq 
analysis. This is consistent with previous observations that ATF4 was not significantly 
altered in microarrays of Drosophila CNS tissue with pan-neuronal overexpression of 
TFAM or knock-down of ATP synthase subunit F6 (Cagin, Duncan et al. 2015), which 
strongly indicates that ATF4 is not regulated by transcriptional mechanisms in 
Drosophila neurons with mitochondrial dysfunction. 
 
In many cases, eIF2α-independent regulation of ATF4 has been documented, but 
the underlying mechanism not elucidated. ATF4 protein expression was uncoupled from 
both P-eIF2α and ATF4 transcript levels in mouse sarcomas (Lehman, Ryeom et al. 2015) 
and lymphoma cell lines (Ishizawa, Kojima et al. 2016). The authors of the former study 
excluded variations in copy number and mutations that would have changed ATF4 
expression, and speculated that altered regulation of  ATF4 degradation (β-TrCP and 
PHD3) and/or stabilisation (p300) factors may be responsible. I did not detect changes in 
the transcript abundance of the fly homologues of these proteins (slmb, Hph & nej) in my 
RNA-Seq experiment, but it is possible that they undergo post-transcriptional regulation 
and the dynamics of ATF4 degradation may be changed in Drosophila neurons with 
mitochondrial dysfunction. In the lymphoma cell study, the mechanism of ATF4 
activation was suggested to be post-transcriptional and similar to the uORF system, but 
was examined by a GFP reporter construct in MEFs, without the authors confirming that 
the fibroblasts regulated ATF4 in the same eIF2α-independent way as the lymphoma 
cells. 
 
Of particular interest to ATF4 in the nervous system, application of brain-derived 
neurotrophic factor (BDNF) to cultures of rat cortical and hippocampal neurons produced 
an elevation in both ATF4 mRNA and protein that was entirely independent of eIF2α, 
and instead mediated via tropomyosin receptor kinase B (TrkB) signalling and as yet 
undiscovered factors (Liu, Amar et al. 2018). Once again, I did not detect transcriptional 




Whilst I have not detected gene changes corresponding to the above studies, a 
gene that was not only significantly upregulated by TFAM overexpression, but also 
upregulated by ATF4 overexpression and reversed by ATF4 RNAi was the cap-
dependent translation repressor Thor (4E-BP in mammals). Phosphorylation of 4E-BP1 
by the nutrient sensor mTOR prevents the binding of 4E-BP1 to the translation initiation 
factor eIF4E, and permits cap-dependent translation to proceed. Inhibition of mTOR 
activity was recently shown to reduce ATF4 translation in a 4E-BP-dependent manner 
(Park, Reyna-Neyra et al. 2017). Increased levels of active (unphosphorylated) 4E-BP 
and the resultant reduction in cap-dependent translation were hypothesized to lead to an 
increase in the availability of ternary complexes (eIF2-GTP-tRNAiMet) that allowed the 
ribosome to initiate at the 5’UTR decoy uORFs, rather than the start codon, of ATF4. The 
transcriptional upregulation of 4E-BP1 by ATF4 in Drosophila neurons with 
mitochondrial dysfunction could therefore represent a novel negative feedback loop 
within the ER UPR pathway. 
 
It is known that the Drosophila homologue of hypoxia-inducible factor 1α 
(HIF-1α) is a key player in the regulation of mitochondrial retrograde signalling in the 
nervous system (Cagin, Duncan et al. 2015). Excitingly, a recent discovery could explain 
the eIF2α-independent regulation of ATF4 in many of the above studies, and tantalisingly 
suggests how the ISR, response to hypoxia and nutrient sensing could all simultaneously 
converge upon ATF4 in response to mitochondrial dysfunction. Translation of ATF4 
mRNA in response to amino acid starvation was shown to be controlled by methylation 
of adenosine (m6A) in the uORF proximal to the translational start site (uORF2) (Zhou, 
Wan et al. 2018). The presence of methylation impeded ribosome scanning and caused 
translation to initiate at uORF2 in preference to the overlapping ATF4 coding sequence. 
Knock-down of the m6A methyltransferase complex components METTL3 and 
METTL14 led to a substantial increase in ATF4 protein levels above those already 
induced by P-eIF2α, whilst knock-down of the m6A demethylases ALKBH5 and FTO 
largely abrogated the upregulation of ATF4 by eIF2α phosphorylation. ALKBH5 is 
induced by hypoxia in multiple cancer cell lines, in a HIF-1α-dependent manner 
(Thalhammer, Bencokova et al. 2011, Zhang, Samanta et al. 2016), suggesting that 
regulation of transcription by stabilised HIF-1α could impinge upon ATF4 translation. 
METTL3, METTL14 and the YTH domain family of m6A reading proteins are conserved 
in Drosophila, but neither homologues of ALKBH5 and FTO, nor alternative m6A 
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demethylases have been identified in the fly genome (Lence, Soller et al. 2017), indicating 
that much works remains to determine whether ATF4 mRNA marks the intersection of 







6.2.3 Functional consequences of ER UPR activation 
 
6.2.3.1 Functional consequences of PERK activation 
 
Knock-down of PERK exacerbated the neuronal functional deficits of TFAM 
overexpressing flies. It has recently been demonstrated that PERK acts to protect 
mitochondrial integrity in response to ER stress. Knock-out or inhibition of PERK 
increased mitochondrial fragmentation in MEFs treated with the ER stressors 
tunicamycin or thapsigargin, and this fragmentation was accompanied by decreased 
respiratory capacity. The protection by PERK was unaffected by knockout of ATF4, or 
inhibition of the IRE1 and ATF6 pathways, but did require the phosphorylation of eIF2α 
(Lebeau, Saunders et al. 2018). Also in MEFs, PERK has been detected within MAMs. 
PERK knockout reduced the number of ER-mitochondria contacts and the induction of 
apoptosis in response to ER stress mediated by (ER localised) ROS, suggesting that 
PERK and ER-mitochondrial tethering were required to communicate stress from the ER 
to the mitochondria (Verfaillie, Rubio et al. 2012). Similarly in rat cardiomyocytes, PERK 
– but not IRE1 or ATF6 – was discovered in MAMs and knock-down of the protein again 
protected against ROS-induced apoptosis, however ER-mitochondria contacts were not 
quantified (Liu, Zhu et al. 2013). These results raise the possiblity that the increased 
numbers of ER-mitochondrial contacts seen in the TFAM overexpression condition may 
be dependent on PERK. 
 
Fascinatingly, in mammalian cells, elevated cytosolic Ca2+ has been found to 
cause the expansion of ER-plasma membrane contacts via PERK-regulated changes to 
the actin cytoskeleton. These changes required the interaction of PERK with the actin 
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crosslinker Filamin A, but not PERK kinase activity. The increased ER-plasma 
membrane contacts served as expanded platforms for oligomerised STIM to trigger store-
operated Ca2+ entry and hypothetically replenish the intraluminal Ca2+ concentration of 
the ER (van Vliet, Giordano et al. 2017). Remarkably, IRE1 has also been shown to 
interact with Filamin A in diverse models including Drosophila hemocytes, functioning 
as a scaffold that governed cell motility (Urra, Henriquez et al. 2018).  
 
 
6.2.3.2 Functional consequences of ATF4 activation 
 
Although downstream of PERK, in Drosophila neurons with mitochondrial dysfunction, 
knock-down of ATF4 was able to suppress the neuronal functional deficits displayed in 
climbing and wing inflation assays. This suggests both that mitochondrial retrograde 
signalling is responsible for some neuronal functional pathology in addition to the original 
mitochondrial insult, and more specifically that activation of ATF4 is detrimental in 
neurons with mitochondrial dysfunction. The pathological element of retrograde 
signalling is in agreement with the previous finding that knock-down of HIF-1α also 
suppressed the mitochondrial dysfunction phenotype in Drosophila neurons (Cagin, 
Duncan et al. 2015), but the consequences of ATF4 activation as a stress responder in the 
nervous system have been an enigma. 
 
The normal physiological role of ATF4 in unstressed neurons appears to be the 
facilitation of synaptic plasticity and memory (Liu, Pasini et al. 2014, Hu, Levine et al. 
2015, Pasini, Corona et al. 2015). It should be noted that - in keeping with the divisive 
nature of ATF4 - conflicting reports have suggested that it inhibits plasticity (Chen, 
Muzzio et al. 2003, Costa-Mattioli, Gobert et al. 2007, Kandel 2012, Trinh, Kaphzan et 
al. 2012), however these studies drew conclusions solely from phosphorylation of eIF2α, 
or relied upon broad-spectrum inhibitors of the entire CREB family, and are therefore 
considered less reliable than the investigations that utilised direct manipulation of ATF4 
and described a positive role in plasticity. In the CNS of control Drosophila, I detected 
ATF4 protein solely in three bilaterally paired loci of the VNC, which I speculate may 
represent leg precursor regions. However, knock-down of ATF4 resulted in a slight 
decrease of β-Gal expression driven by the Thor promoter, suggesting that there may be 
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levels of ATF4 in the Drosophila CNS that were below the detection window of the ATF4 
antibody, and indicating that the protein may also have functional roles in the unstressed 
fly CNS. 
 
Several studies have identified ATF4 as a protective factor in response to 
mitochondrial dysfunction. Activating mutations in ATF4 increased resistance to 
oxidative stress in hippocampal HT22 and pheochromocytoma PC12 cell lines 
(Lewerenz, Sato et al. 2012). Dissipation of mitochondrial membrane potential by the 
protonophore carbonyl cyanide m-chlorophenyl hydrazine (CCCP) resulted in ER stress 
in HEK293T and SH-SY5Y neuroblastoma cells (Bouman, Schlierf et al. 2011). In these 
models, the parkin was a direct transcriptional target of ATF4, and its upregulation 
mediated cell survival in response to the CCCP treatment. Parkin was also the effector of 
ATF4-mediated protection of PC12 cells following application of MPP+ or 6-OHDA 
(Sun, Liu et al. 2013), and SH-SY5Y cells after rotenone treatment (Wu, Luo et al. 2014). 
Interestingly, whilst parkin is convincingly the agent of cellular preservation in these 
proliferating cell line models, it was not upregulated in my RNA-Seq experiments with 
TFAM overexpression, either of two Drosophila ex vivo microarrays - also with pan-
neuronal TFAM expression - (Cagin, Duncan et al. 2015, Duncan, Granat et al. 2018), 
nor in the cortex of mice with knockout of the mitochondrial serine protease HtrA2 
(Moisoi, Klupsch et al. 2008). These observations, combined with my finding that ATF4 
knock-down can partially suppress the neuronal deficits of TFAM-overexpressing flies, 
suggest that parkin does not play the same protective role in non-proliferating cells, and 
indicates contrasting roles for ATF4 in proliferating cells and terminally differentiated 
neurons. Consistent with this idea, a number of investigations in primary neurons have 
reported a detrimental role for ATF4 in response to stress. ATF4-/- murine primary cortical 
neurons were more resistant to oxidative stress induced by the glutamate analogue 
homocysteate (HCA) (Lange, Chavez et al. 2008), and apoptosis induced by the ER 
stressors tunicamycin and thapsigargin (Galehdar, Swan et al. 2010), with the latter 
protection stemming from reduced induction of PUMA via an ATF4-CHOP axis. Further, 
intra-axonal translation of ATF4 spread Alzheimer’s-associated Aβ1-42 pathology in 
murine brains, causing neuron loss that was abolished by siRNA targeting ATF4 or its 
downstream effector CHOP (Baleriola, Walker et al. 2014). To date, the only primary 
neuronal model of mitochondrial or mitochondria-related dysfunction to demonstrate 
protection by parkin was 6-OHDA treatment of ventral midbrain neurons (Sun, Aime et 
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al. 2018). The role of ATF4 in the regulation of parkin, and in vivo protection mediated 
by guanabenz, a small-molecule inhibitor of GADD34, was inferred from studies in 
proliferating cells. The authors also reported that ATF4 knockout substantially reduced 
the neuroprotective effect of guanabenz in primary cortical neuron cultures treated with 
the DNA-damage inducing agent camptothecin. This is in partial agreement with a 
previous study that showed ATF4 overexpression protected murine cortical neurons 
against camptothecin, but also demonstrated unchanged levels of the ATF4 protein in 
response to treatment with the toxin (Galehdar, Swan et al. 2010). Frustratingly, the 
authors of the guanabenz study were unclear as to the species of their primary cells, 
preventing direct comparison between the camptothecin results. Drosophila do not have 
a homologue of CHOP. Therefore, if my conjecture that absence of proliferation is the 
switch that changes the role of ATF4 from good to bad in neuronal mitochondrial 
dysfunction models is correct, it will not simply be the case that upregulation of parkin 
(good) in proliferating cells switches to upregulation of CHOP (bad) in terminally 
differentiated neurons, and may instead be a complex remodelling of the cells’ metabolic 
needs. 
 
6.2.4 ATF4 as a regulator of mitochondrial retrograde signalling 
 
There was substantial overlap in the genes regulated by TFAM overexpression and ATF4 
overexpression in Drosophila neurons. In addition, knock-down of ATF4 in conjunction 
with TFAM overexpression reversed many of the transcriptional changes caused by 
overexpression of TFAM. Whilst my RNA-Seq analysis requires further validation by 
qRT-PCR, taken together these findings indicate that ATF4 is a regulator of 
mitochondrial retrograde signalling in the Drosophila nervous system. 
 
 Interestingly, whilst ATF4 is well characterised in the UPR pathway downstream 
of ER stress, overexpression of ATF4 in Drosophila neurons resulted in the 
downregulation of a number of ETC Complex I subunits. Transcriptional regulation of 
the ETC enzymes was less pronounced by TFAM overexpression, and unaffected by 
knock-down of ATF4 alongside TFAM overexpression, suggesting that ATF4 may have 
the facility to regulate mitochondrial function in the Drosophila nervous system, but does 
not predominantly do so in the context of mitochondrial dysfunction. Instead, gene 
expression changes regulated by ATF4 are largely targeted to pathways that alter the 
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molecular or functional outcome of mitochondrial dysfunction, rather than to ‘fixing’ the 
mitochondrial defect.  
6.2.4.1 Glycolysis 
 
ATF4 is known to upregulate glycolytic genes in Drosophila S2 cells in response to ER 
stress induced by the reducing agent dithiothreitol (DTT) (Lee, Oney et al. 2015). 
However, it has not been demonstrated before that ATF4 can regulate glycolysis in the 
neurons of any organism. My results show that overexpression of ATF4 in Drosophila 
neurons downregulated expression of lactate dehydrogenase (ImpL3) and transaldolase 
(Taldo), the linker enzyme between the pentose-phosphate and glycolytic pathways, 
suggesting a concerted effort to maintain the supply of pyruvate to the Krebs cycle. 
TFAM overexpression caused the significant upregulation of Hexokinase A and ImpL3, 
whilst knock-down of ATF4 in conjunction with TFAM overexpression downregulated 
these genes, the trehalose transporter (Tret1-1), and the mitochondrial isoform of 
phosphoenolpyruvate carboxykinase 2 (Pepck2/CG10924). Trehalose, a disaccharide of 
glucose, is the predominant sugar in insects (Wyatt and Kale 1957), and Tret1-1 mediates 
its uptake into cells (Kanamori, Saito et al. 2010) prior to its hydrolysis into two glucose 
molecules by trehalase (Yoshida, Matsuda et al. 2016). Pepck2 catalyses the conversion 
of oxaloacetate to phosphoenolpyruvate via the elimination of CO2, an irreversible step 
in gluconeogenesis (Ashmore, Wagle et al. 1964). These changes indicate that ATF4 
upregulates gluconeogenesis and glycolysis in response to neuronal mitochondrial 
dysfunction caused by TFAM overexpression, hypothetically as a protective measure to 
counter reduced ATP production by the compromised ETC/Complex V. Upregulation of 
ImpL3 suggests that an increased proportion of the NADH produced by glycolysis is re-
oxidised in the cytosol, rather than transferred to the mitochondria for oxidation by the 
ETC. 
 
6.2.4.2 Oxidative stress and apoptosis 
 
Several cytochrome p450 proteins were downregulated by ATF4 overexpression. Two of 
those proteins were also downregulated by TFAM overexpression, and the expression of 
one was reversed by ATF4 knock-down, suggesting that ATF4 mediates a 
downregulation of members of the cytochrome P450 family in response to neuronal 
mitochondrial dysfunction. Cytochrome P450s are oxidases that function to metabolise 
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endogenous substances and xenobiotics, but are also constitutive producers of ROS even 
in the absence of substrates (reviewed in (Zangar, Davydov et al. 2004)). Coupled with 
the downregulation of Complex I subunits (mostly in the absence of mitochondrial 
dysfunction) by ATF4, this suggests a protective transcriptional programme to reduce 
oxidative stress, and possibly the consequent apoptosis. This idea is supported by the 
ATF4-mediated downregulation of cytochrome c distal (cyt-c-d) in response to TFAM 
overexpression. Drosophila possess two cytochrome c proteins, cyt-c-d and cytochrome 
c proximal (cyt-c-p). cyt-c-p is highly expressed in somatic cells of the fly throughout 
development and adulthood, whilst cyt-c-d transcripts are low (Arama, Bader et al. 2006). 
However, whilst cyt-c-p functions predominantly in the ETC, cyt-c-d promotes apoptosis 
in both the testes (where it is abundant) (Arama, Bader et al. 2006) and the developing 
retina (Mendes, Arama et al. 2006). In the retina, cyt-c-p is unable to fulfill the pro-
apoptotic role in the absence of cyt-c-d. This suggests that downregulation of cyt-c-d by 
ATF4 protects Drosophila neurons from apoptosis in response to TFAM overexpression. 
Paradoxically, ATF4 also appeared to downregulate a number of 
glutathione S-transferase (GST) enzymes in Drosophila neurons, both with and without 
TFAM overexpression. These proteins can function as anti-oxidants (Yang, Cheng et al. 
2001, Singhal, Singh et al. 2015), and have not been reported to generate ROS, so it is 
unclear why reducing their expression would be beneficial, and it may be that 
downregulation of the GST proteins is one of the functionally detrimental affects of ATF4 
that is alleviated by its knock-down. 
 
6.2.4.3 Molecular chaperones 
 
 A canonical aspect of the ER UPR is the upregulation of molecular chaperones to 
alleviate protein stress within the ER. Indeed, transcriptional upregulation of BiP 
(Drosophila Hsc70-3) is frequently used as a marker of ER UPR activation. Surprisingly 
BiP was not significantly regulated by either TFAM overexpression or ATF4 
overexpression, nor were any other ER-resident chaperones. Instead, the expression of 
Hsp22, which is known to be a mitochondrial chaperone (Morrow, Inaguma et al. 2000), 
and Hsc70-2, which is predicted to be a mitochondrial protein from sequence analysis 
(Sardiello, Licciulli et al. 2003), were upregulated by TFAM overexpression in a manner 
that appeared to be dependent on ATF4 (was reversed by ATF4 RNAi). This suggests 
that in Drosophila neurons with mitochondrial dysfunction, ATF4 ameliorates unfolded 
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protein stress by regulating the mtUPR, rather than the ER UPR. Given that TFAM 
overexpression would be expected to cause an unfolded protein burden in the 
mitochondria, caused by both mis-assembled ETC complexes and the stress of its own 
folding on the mitochondrial machinery, this suggests the existence of an unknown trigger 
that is able to switch ATF4 chaperone regulation in response to the main location of the 
unfolded protein overload. 
 
 The regulation of cytosolic chaperones is more complicated. Hsp67Bc, which is 
known to promote autophagy in Drosophila (Carra, Boncoraglio et al. 2010), was 
downregulated by ATF4 knock-down in the TFAM overexpression condition, suggesting 
that it is upregulated by ATF4 in response to TFAM overexpression, and that ATF4 may 
promote autophagy in Drosophila neurons with mitochondrial dysfunction.   
 
Three members of the cytosolic Drosophila Hsp70 family were also significantly 
regulated in my RNA-Seq analysis, however these genes inhabit a fascinating niche in 
the evolutionary landscape. Six Hsp70 genes exist in two clusters on chromosome 3. The 
Hsp70A genes (Hsp70Aa and Hsp70Ab) comprise one cluster, and the Hsp70B genes 
(Hsp70Ba, Hsp70Bb, Hsp70Bbb and Hsp70Bc) the other (Gong and Golic 2006). 
Remarkably, there are no fixed nucleotide differences between the members of each 
cluster, and therefore within each cluster all the members have identical amino acid 
sequences. Additionally, despite the duplication event that created the Hsp70B cluster 
from the Hsp70A loci occurring 12-15 million years ago (Bettencourt and Feder 2002), 
the chaperones of the two clusters differ by only six amino acids. Unsurprisingly, the six 
Hsp70 genes appear to be functionally equivalent. (Gong and Golic 2006). Whilst all the 
genes have near identical 5’UTRs and coding sequences, the clusters can be distinguished 
by the different sequences in their 3’UTRs, and in-situ hybridisation has suggested that 
the clusters can be separately regulated in response to heat shock (Lakhotia and Prasanth 
2002). The output from my RNA-Seq analysis reports that Hsp70Aa and Hsp70Bbb were 
downregulated, and Hsp70Bb upregulated by TFAM overexpression and/or ATF4 
overexpression, however it is extremely unlikely that the reads from the Hsp70 family 
could be definitively aligned to the gene from which they originated. ‘Multi-read correct’ 
was enabled in the transcript assembly software Cufflinks and therefore, at least 
theoretically, ambiguous Hsp70 reads could have been distributed according to a 
weighting of the reads from the 3’UTRs. However, it is likely that Cufflinks was 
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hamstrung by the upstream software Bowtie2, which performs the initial alignment 
procedure within the mapping software TopHat, and randomly assigns multi-mapped 
reads to one of the matching locations in the genome. Therefore, it is likely that on average 
the Hsp70 chaperones were not significantly regulated by either TFAM overexpression 
or ATF4 overexpression. 
 
 
6.2.4.4 Anabolic pathways 
 
Upregulation of one-carbon metabolism and the related nucleotide salvage 
pathway have previously been shown to occur in Drosophila pink1 and parkin mutants, 
and to protect these flies against dopaminergic neuron loss (Tufi, Gandhi et al. 2014, 
Celardo, Lehmann et al. 2017). Upregulation of the one-carbon metabolism genes, 
SHMT2 and MTHFD2, that are required for the synthesis of formylmethionine for 
mitochondrial proteins, was shown to be dependent on ATF4 (Celardo, Lehmann et al. 
2017). In my RNA-Seq analysis, ATF4 overexpression suppressed the transcription of 
dihydrofolate reductase (Dhfr), an upstream enzyme in tetrahydrofolate synthesis, but 
otherwise one-carbon metabolism and nucleotide salvage genes were not significantly 
regulated. This may be because in TFAM overexpressing neurons, functional pink1 and 
parkin would permit the recycling of dysfunctional mitochondria via MDV formation and 
mitophagy, hypothetically leading to the continual supply of formylmethionine and other 





Csas, encoding CMP-sialic acid synthetase, was downregulated by both TFAM 
overexpression and ATF4 overexpression. Co-expression of ATF4 RNAi increased Csas 
expression an average 1.4 fold versus TFAM overexpression alone, but this change was 
not significant (p = 0.00395, adjusted p  = 0.335). CMP-sialic acid is the activated 
substrate of the transferases which sialylate the terminal glycans of both proteins and 
lipids. Drosophila Csas mutants display locomotor defects and are paralysed at elevated 
temperatures. These phenotypes can be explained by a dose-dependent reduction in 
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evoked excitatory junction potentials (EJPs) – null mutants had a stronger impairment 
than hypomorphs – that was caused by decreased neuronal excitability rather than defects 
in synaptic transmission (Islam, Nakamura et al. 2013). Downregulation of Csas by 
TFAM or ATF4 overexpression is therefore likely to be functionally adverse, but is 
probably explained by the drive to produce and conserve ATP; synthesis of sialic acid 
consumes pyruvate (Roseman 1962) – reducing its availability for conversion to lactate 
by ImpL3, with the concomitant reoxidation of NADH to be used in the glycolytic 
pathway  - and it’s conjugation to CMP consumes a molecule of CTP.  
 
The function of sialylation in the nervous system is complex, but it appears to 
mask healthy neurites from microglial surveillance, whilst desialylated processes undergo 
phagocytosis (Linnartz, Kopatz et al. 2012, Linnartz-Gerlach, Schuy et al. 2016). A loss 
of neurites may explain the reduced neuronal excitability seen in Csas mutant flies, and 
some of the impairments to neuronal function in TFAM overexpressing flies. Sialylation 
is central to the processing of the Alzheimer’s-associated protein amyloid-β, with both 
positive and negative affects on neurotoxicity reported (Nakagawa, Kitazume et al. 2006, 
Patel, Henry et al. 2007, Nolan, McHale-Owen et al. 2017). 
 
Whilst my results show that knock-down of PERK is detrimental in Drosophila 
neurons with mitochondrial dysfunction, important work from the Mallucci lab has 
determined that the ER UPR is activated in mouse models of prion disease, and inhibition 
of PERK or the downstream effects of eIF2α phosphorylation reduces prion-mediated 
neurodegeneration (Moreno, Radford et al. 2012, Moreno, Halliday et al. 2013, Halliday, 
Radford et al. 2015). Interestingly, loss of sialylation from the pathogenic configuration 
of the prion protein, PrPSc, promotes enhanced amplification of PrPSc, removal of the 
cross-species barrier to infection, and increased neuroinflammation (Katorcha, Makarava 
et al. 2014, Katorcha, Makarava et al. 2015, Srivastava, Katorcha et al. 2018). Knockout 
of neuronal sialidases (neuramidases) did not affect the sialylation status of PrPSc 
(Katorcha, Klimova et al. 2015), indicating that it is the rate of sialyl transfer that controls 
sialylation levels of PrPSc. If ATF4 also downregulates the transcription of Csas in the 
mammalian nervous system, and thus hypothetically reduces levels of sialylation, this 
may explain why inhibition of PERK or P-eIF2α, with consequent reduction in ATF4, 
was therapeutic in murine prion disease models. In our Drosophila model of 
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mitochondrial dysfunction, it is likely that the benefits of increased sialylation from 
knock-down of PERK would be outweighed by the putative increase in mitochondrial 




6.3 Conclusions and Future Directions 
 
I hypothesised that mitochondrial dysfunction in Drosophila neurons would cause 
alterations to ER biology, activate ER stress signalling, and that this signalling would 
regulate nuclear gene transcription. In addition, I began my investigation by assessing 
mitochondrial morphology, and my work has therefore spanned from the source of the 
mitochondrial dysfunction, across contacts with, and changes to, the intervening ER, to 
the nucleus. My results show that ER stress signalling was activated in Drosophila 
neurons by mitochondrial dysfunction, and the breadth of my investigation has allowed 
me to place the activation of ER UPR components in a wider context. 
 
Whilst knock-down of many UPR proteins was functionally beneficial, knock-
down of PERK exacerbated the climbing and wing inflation deficits of TFAM 
overexpressing flies. My characterisation of fragmented mitochondria, increased numbers 
of candidate ER-mitochondria contacts and altered cytosolic Ca2+ allow me to speculate 
that PERK is a key player in the response to neuronal mitochondrial dysfunction, and that 
the seemingly beneficial presence of PERK is independent of its role within canonical 
UPR signalling. PERK has been shown to protect mitochondrial respiration and 
morphology in response to ER stress – suggesting a possible loop whereby mitochondrial 
dysfunction causes ER stress which then activates mitochondrial defense mechanisms – 
to be enriched at MAMs, and to modulate ER-plasma membrane contacts in response to 
elevated cytosolic Ca2+, putatively to restore luminal ER Ca2+ via store-operated Ca2+ 
entry. 
 
When characterising the role of PERK in response to neuronal mitochondrial 
dysfunction, it will first be necessary to confirm the changes to mitochondrial 
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morphology and increase in ER-mitochondria contacts via higher-resolution techniques 
such as electron microscopy, then whether PERK is also present at Drosophila neuronal 
MAMs and if PERK knock-down reduces these contacts. Verfaillie, Rubio et al. 2012 
established that expression of a kinase-dead PERK in PERK-/- MEFs was sufficient to 
maintain ER-mitochondrial contacts, whilst a cytoplasmic deletion mutant of PERK was 
not. Creation of similar Drosophila tools would allow us to dissect the contribution of 
PERK to ER-mitochondrial contacts away from its role in ER UPR signalling – which 
requires the kinase activity of PERK to phosphorylate eIF2α. 
 
To examine the putatively beneficial regulation of ER-plasma membrane contacts 
by PERK, further work first needs to be done to fully characterise the Ca2+ dynamics in 
Drosophila neurons with mitochondrial dysfunction. In particular, we need to know 
whether ER Ca2+ is depleted in the TFAM overexpression model in both resting and 
stimulated neurons, as theoretically PERK activity raises the intra-luminal ER Ca2+ 
concentration, and therefore may be detrimental if ER Ca2+ is abnormally high. 
Development of in vivo ER Ca2+ sensors derived from mammalian ER-GCaMPs (de Juan-
Sanz, Holt et al. 2017) or Calcium-measuring organelle-entrapped protein indicators 
(CEPIAs) (Suzuki, Kanemaru et al. 2014) will require the optimisation of Kds and 
dynamic ranges suitable for Drosophila neurons, but would be extremely useful in this 
characterisation. Live imaging of cytosolic Ca2+ levels in neurons stimulated by the heat-
activated TrpA1 channel required immobilisation of the CNS in agarose to reduce 
movement caused by heating of the surrounding media. Live imaging of Ca2+ in the 
reticular mitochondrial network could not be achieved via this method as the residual 
movement of the CNS was too great to keep single mitochondria in the focal plane. New 
techniques, probably utilising electrophysiology, will therefore have to be developed to 
image Ca2+ fluctuations in the ER and mitochondria of stimulated Drosophila neurons. 
  
Whilst PERK knock-down was detrimental, ATF4 knock-down suppressed the 
functional deficits of TFAM overexpressing neurons. This presents a therapeutic conflict 
between the head and tail of the PERK ER UPR branch that is unlikely to be solved by 
strategies targeting the intermediary eIF2α; the repression of global translation that is 
usually mediated by phosphorylation of eIF2α may meaningfully reduce the energetic 
burden on neurons with compromised ATP supply. The effect of eIF2α phosphorylation 
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on translation in neurons with mitochondrial dysfunction may be assessed without glial 
contamination by used of a tagged ribosomal subunit expressed via the Gal4-UAS system 
(Thomas, Lee et al. 2012). Tagged ribosomes can be pulled down, and the associated 
mRNA content assessed by sequencing. Inhibition of ATF4 itself would be a blunt 
therapeutic approach to neurological diseases associated with mitochondrial dysfunction, 
that risked reducing the hypothetically neuroprotective upregulation of glycolysis and 
decrease in ROS production that I have identified. Interventions directed at selected 
transcriptional targets of ATF4 that have been identified to be pathological may therefore 
represent better therapies. 
 
Transcription of CMP-Sialic acid synthetase (Csas) was downregulated by both 
TFAM overexpression and ATF4 overexpression in Drosophila neurons, with putatively 
damaging effects. I have discussed how the hypothetical modulation of sialylation by 
PERK may reconcile my observation that PERK knock-down exacerbates the TFAM 
overexpression phenotype, with the suppression of prion disease in murine models by 
PERK inhibition. With the caveat that further investigation of PERK be undertaken, the 
breadth of my work, which spans both the proximal and distal effects of PERK activation, 
enables me to suggest a two-pronged therapeutic strategy for diseases with mitochondrial 
dysfunction whereby PERK is activated to boost its hypothetically protective effects on 
mitochondrial morphology and Ca2+ homeostasis, but the transcriptional regulation of 
selected downstream targets by ATF4 is reversed. In particular, methods to block the 
downregulation of Csas or increase the activity of its encoded protein may protect 
otherwise healthy neurites from phagocytosis and enhance neural transmission. In the 
short-term, it should be established whether overexpression of Csas can suppress the 
functional deficits of TFAM overexpressing neurons, and if so, further experiments 
should then be undertaken to determine the role of sialylation in neuronal mitochondrial 
dysfunction, including examination of the number and morphology of neurites, and 
neuronal excitability in flies with genetic manipulations of Csas and TFAM.  
 
Alongside the activation of ER stress signalling, I also detected the hypothesised 
changes to ER biology in Drosophila neurons with mitochondrial dysfunction. In 
particular, two fluorescent ER markers suggested a reduction in the reticulation of the ER 
that was most profound in the perinuclear region. It has been established that knockout of 
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mitofusin (de Brito and Scorrano 2009), and mutation of the OMM fusion regulator 
SLC25A46 (Janer, Prudent et al. 2016), lead to altered ER morphology, however 
mitofusin and SLC25A46 are MAM components, and it is therefore not surprising that 
their absence affects ER morphology. My results are the first preliminary confirmation 
that dysfunctional mitochondria – as opposed to dysfunctional regulators of mitochondria 
such as mitofusin – can alter the shape of the ER, and the first demonstration that specific 
subdomains of the ER may be more acutely altered. It is likely that ER morphology has 
been underinvestigated in vivo due to an absence of suitable tools, and indeed electron 
microscopy or higher resolution fluorescence microscopy will be needed to verify the 
alterations to ER morphology suggested by the fluorescent BiP-sfGFP-HDEL and 
tdTomato-Sec61β reporters. The IRE1 and ATF6 branches (Maiuolo, Bulotta et al. 2011) 
of the ER UPR have been shown to regulate the lipid synthesis that drives the ER sheet 
expansion that could explain the hypothetical loss of reticulation in TFAM 
overexpressing flies. 
 
In addition to creating changes to ER lipid composition, the ER UPR can also be 
activated by altered ER lipid density. Increased ER-mitochondrial contacts in Drosophila 
parkin mutants detrimentally enhance the transfer of phosphatidylserine (PS) to the 
mitochondria, resulting in depletion of PS from the ER. PS has been widely and 
successfully trialled as an orally administered agent for improving the cognitive function 
in older adults with subjective memory complaints (Kato-Kataoka, Sakai et al. 2010, 
Richter, Herzog et al. 2010, Vakhapova, Cohen et al. 2010, Richter, Herzog et al. 2013, 
Moré, Freitas et al. 2014, Vakhapova, Cohen et al. 2014). PS supplementation also 
improved the memory performance of patients with the more severe classification ‘age-
associated memory impairment’ in two studies (Crook, Tinklenberg et al. 1991, 
Schreiber, Kampf-Sherf et al. 2000), but not in a third (Jorissen, Brouns et al. 2001) and 
has been shown to significantly improve the vocabulary and picture recall of Alzheimer’s 
patients, albeit very mildly (Zhang, Yang et al. 2015). In addition, PS has improved 
cognitive performance in an extensive range of animal models (reviewed in (Reddan, 
White et al. 2018)). These studies demonstrate that enhanced consumption of PS can 
positively impact the function of the nervous system, but the benefits have been largely 
linked to protection from oxidative stress or inflammation. If PS supplementation is 
shown to improve the climbing and/or wing inflation impairment of TFAM 
overexpressing flies, it will be important to determine whether the benefits were mediated 
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by changes in ER lipid composition and consequently reduced activation of the ER UPR. 
Regardless, if ROS are increased in the cell bodies of Drosophila motor neurons by 
TFAM overexpression, PS therapy could represent an effective neuroprotective strategy 
for reduction of oxidative damage.  
 
Whilst abnormal lipid handling is merely a candidate for transferring the 
retrograde signal from ER-mitochondrial contacts to the ER in response to mitochondrial 
dysfunction in Drosophila neurons, it is clear that the ER UPR represents at least part of 
the signal over the next leg from the ER to the nucleus. I characterised the transcriptional 
changes regulated by ATF4 in response to TFAM overexpression in Drosophila neurons, 
however knock-down of the the other UPR transcription factors ATF6 and XBP1 was 
also functionally beneficial in climbing and wing inflation assays. XBP1 has been shown 
to form heterodimers with ATF6 and ATF4 in response to ER stress (Yamamoto, Sato et 
al. 2007, Cho, Lee et al. 2008) to mediate combined regulation of target genes. It will be 
important to analyse the transcriptional regulation mediated by ATF6 and XBP1 in 
TFAM overexpressing neurons, as genes commonly regulated by all three ER UPR 
transcription factors would be prime candidates to underly the adverse effects of ER UPR 
activation, and represent novel therapeutic targets. 
 
The ER is continuous with the outer nuclear membrane, and it is therefore 
conceivable that ER stress signals could also be communicated internally through the ER 
lumen to the nucleoplasmic reticulum (NR), and thence into the nucleoplasm. Intra-ER-
to-nucleus signalling is a fascinating and underexplored topic. In order to determine the 
role, if any, of the NR in mitochondrial retrograde signalling in Drosophila neurons, it 
will first be required to establish whether invaginations of the nuclear envelope occur in 
either control or TFAM overexpressing neurons, and their relative frequency and extent. 
Given that mitochondria can be found within the type II NR channels, an initial 
experiment would be to examine the overlap of mitoGFP expression with that of a nuclear 
marker such as nuclear-targeted β-Gal. However, this would be merely a proxy for NR 
formation, and establishing a staining protocol for the ER/NR marker concanavalin A in 
Drosophila neurons would facilitate examination of the NR directly, and assessment of 
any localisation with the nucleoli by simultaneous use of DAPI staining. It will be 
important to include the nucleus in electron micrograph analysis of TFAM 
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overexpressing neurons, to determine at higher resolution whether there are alterations to 
NR morphology or the invasion of mitochondria into the channels formed by type II 
invaginations. Investigation of a functional role for NR Ca2+ handling in mitochondrial 
retrograde signalling could be undertaken by genetic manipulation of the Ca2+-dependent 
transcriptional regulator CaMKIV, which is only active within the nucleus (Lemrow, 
Anderson et al. 2004). Further analysis of NR function in response to mitochondrial 
dysfunction would likely require knowledge of the protein components that constitute the 
hypothetical NR-mitochondrial contacts, or are enriched in the NR. Theoretically this 
could be achieved by isolating the nuclear fraction of the cells, pulling down proteins 
associated with e.g. VDAC, and then performing mass spectrometry. However, it may be 
difficult to demonstrate that mitochondrial components pulled down from the nuclear 
fraction were not simply contaminants. 
 
In this thesis, I have demonstrated that mitochondrial dysfunction in Drosophila 
neurons alters mitochondrial morphology, ER morphology, ER-mitochondrial contacts 
and cellular Ca2+ handling, and that the ER stress signalling UPR is activated and 
regulates nuclear gene transcription. I have speculated that the retrograde signal from the 
mitochondria to the nucleus is conveyed from ER-mitochondria contacts to the ER by 
dysregulated lipid synthesis and/or Ca2+ handling, and from the ER to the nucleus by the 
ER UPR or, as yet undiscovered, intra-luminal pathways. How the initial signal from the 
mitochondria results in increased ER-mitochondrial contacts remains a very open 
question. In other models, PERK plays a pivotal role in the maintenance of mitochondrial 
morphology and ER-mitochondrial contacts independently of its function within the ER 
UPR, and therefore is a candidate for translating mitochondrial dysfunction into an 
augmented ER-mitochondrial interface – by an unknown mechanism. Elevated Ca2+ 
within one or more cellular compartments may also underly the increase in ER-
mitochondrial contacts, but again the mechanism is presently unclear. My work has been 
conducted in vivo in the nervous system, and its breadth has permitted me to suggest 
further investigation of therapeutic strategies for diseases associated with neuronal 
mitochondrial dysfunction that span the length of the retrograde signal from the 
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8.1 Individual GCaMP6m traces  
 
Traces of GCaMP6m fluorescence for each sample in dorsal medial motor neuron cell 
bodies (A), axons (B) and neuropil (C) as TrpA1 channels were activated by 20 second 
(s) on/off pulses of 25 °C heat, as indicated by the horizontal black lines below the graph 
(line = heat on, space = heat off). Control samples = black traces, TFAM overexpression 




8.2 Supplementary climbing and wing inflation assays 
 
8.2.1 Functional consequences of genetic manipulation of components of the PERK 
ER UPR pathway (PERK and GADD34) in Drosophila motor neurons with TFAM 
overexpression. 
 
(A, B) Climbing (A) and wing inflation (B) assays with PERK knock-down (line 35162). (C, D) 
Climbing (C) and wing inflation (D) assays with PERK knock-down (line 42499). (E, F) Climbing 
(E) and wing inflation (F) assays with GADD34 knock-down (line 107545). TFAM 
overexpression and all ER UPR RNAi and overexpression lines were driven by D42-Gal4. Wing 
inflation assay: number of flies per genotype displayed at the base of each column. Climbing 
assays: n = 20. Bars = mean ± SEM. Means were compared by one-way parametric ANOVA with 
Tukey’s post-hoc test. Wing inflation: significance was tested by Chi-squared test on the raw data. 
n.s. = not significant, ***p < 0.001. 
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8.2.2 Functional consequences of genetic manipulation of the IRE1 ER UPR 
pathway in Drosophila motor neurons with TFAM overexpression 
 
(A, B) Climbing (A) and wing inflation (B) assays with IRE1 knock-down (line 62156). (C, D) 
Climbing (C) and wing inflation (D) assays with IRE1 mutant f02170. (E, F) Climbing (E) and 
wing inflation (F) assays with XBP1 knock-down (line 36755). TFAM overexpression and all ER 
UPR RNAi and overexpression lines were driven by D42-Gal4. Wing inflation assay: number of 
flies per genotype displayed at the base of each column. Climbing assays: n = 15 for all genotypes 
in (A), n = 20 for all other genotypes. Bars = mean ± SEM. Means were compared by one-way 
parametric ANOVA with Tukey’s post-hoc test. Wing inflation: significance was tested by Chi-
squared test on the raw data. n.s. = not significant, *p < 0.05, ***p < 0.001. 
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8.3 RNA-Seq appendices 
8.3.1 Genes upregulated by TFAM o/e and ATF4 o/e compared to control. 
Cut-offs: FPKM ≥ 1 for at least one condition, fold change ≥1.5, adjusted 
p value < 0.05. Grey shading = gene upregulated in both conditions. Bold outline = gene 
inversely regulated (upregulated by TFAM o/e, downregulated by ATF4 o/e). 
Genes upregulated by TFAM o/e Genes upregulated by ATF4 o/e 
Gene ID Fold change Adj. p value Gene ID Fold change Adj. p value 
CG14850 22.88 0.0119 CG14850 24.54 0.0119 
CG1113 3.59 0.0217 CG1113 4.04 0.0119 
Hsp70Bb 3.59 0.0119 Hsp70Bb 2.39 0.0119 
CG42694 3.54 0.0119 CG42694 3.40 0.0119 
Thor 2.76 0.0119 Thor 3.76 0.0119 
CG17684 1.78 0.0119 CG17684 2.06 0.0119 
ImpE2 1.71 0.0217 ImpE2 1.80 0.0119 
Acf 1.58 0.0453 Acf 1.87 0.0119 
blw 1.56 0.0303 blw 1.59 0.0119 
sfl 1.55 0.0303 sfl 1.74 0.0119 
Hsc70-2 54.84 0.0119 Cpr49Ae 8.17 0.0119 
CG34296 25.12 0.0119 SelG 7.07 0.0119 
Eig71Ee 11.24 0.0119 CG15021 4.86 0.0119 
CG31496 9.33 0.0453 Rgk2 3.26 0.0119 
CG7587 7.66 0.0119 Crg-1 2.61 0.0119 
thw 6.18 0.0119 Cht5 2.25 0.0119 
Sgs7 6.07 0.0119 CG17211 2.20 0.0119 
Sgs5 5.71 0.0119 Blimp-1 2.16 0.0119 
Hsp22 5.67 0.0119 CG34232 2.16 0.0380 
Sgs3 5.50 0.0119 CG5830 2.12 0.0119 
CG15784 5.22 0.0119 spg 2.00 0.0380 
CG33500 4.85 0.0119 CG15864 1.98 0.0119 
ImpL3 3.04 0.0119 Eip93F 1.89 0.0119 
Xrp1 2.68 0.0119 nrm 1.82 0.0303 
CR45315 2.64 0.0119 rdgA 1.81 0.0119 
Arc1 2.59 0.0119 ImpE1 1.78 0.0119 
cv-2 2.43 0.0119 Sec31 1.77 0.0119 
mir-10404-1 2.39 0.0119 CG11700 1.71 0.0119 
NKCC 2.28 0.0303 CR44027 1.66 0.0303 
CG42832 2.26 0.0119 trv 1.61 0.0119 
Gadd45 2.03 0.0119 Indy 1.58 0.0453 
28SrRNA:CR45837 1.95 0.0119 AstC-R2 1.53 0.0119 
CR45481 1.76 0.0217 jeb 1.52 0.0217 
Hex-A 1.75 0.0119 CR46004 1.52 0.0119 
2SrRNA:CR45836 1.72 0.0119 CG43901 1.50 0.0453 




8.3.2 Genes downregulated by TFAM o/e and ATF4 o/e compared to control 
Cut-offs: FPKM ≥ 1 for at least one condition, fold change ≤0.67 (equivalent to ≤ -1.5), 
adjusted p value < 0.05. Grey shading = gene downregulated in both conditions. Bold 
outline = gene inversely regulated (downregulated by ATF4 o/e, upregulated by TFAM 
o/e). 
Genes downregulated by TFAM o/e Genes downregulated by ATF4 o/e 
Gene ID Fold change Adj. p value Gene ID Fold change Adj. p value 
Lcp65Ab1 0.08 0.0119 Lcp65Ab1 0.17 0.0119 
Lcp3 0.09 0.0119 Lcp3 0.32 0.0119 
Jon99Ciii 0.12 0.0217 Jon99Ciii 0.13 0.0119 
CG34166 0.15 0.0119 CG34166 0.33 0.0119 
Obp99b 0.15 0.0119 Obp99b 0.28 0.0119 
Lcp4 0.19 0.0119 Lcp4 0.34 0.0119 
Cyp4d1 0.20 0.0119 Cyp4d1 0.27 0.0217 
CG2233 0.21 0.0119 CG2233 0.40 0.0119 
GstE14 0.21 0.0217 GstE14 0.08 0.0217 
Lcp1 0.21 0.0119 Lcp1 0.37 0.0119 
Lsp2 0.22 0.0119 Lsp2 0.44 0.0380 
CG42500 0.23 0.0119 CG42500 0.41 0.0119 
CG34445 0.23 0.0119 CG34445 0.15 0.0119 
CG32249 0.24 0.0119 CG32249 0.31 0.0119 
CG34446 0.24 0.0119 CG34446 0.25 0.0119 
Lsp1beta 0.26 0.0119 Lsp1beta 0.61 0.0119 
CG43117 0.28 0.0119 CG43117 0.60 0.0119 
CR46006 0.32 0.0119 CR46006 0.38 0.0119 
Cyp28a5 0.36 0.0119 Cyp28a5 0.16 0.0119 
CG18278 0.36 0.0119 CG18278 0.47 0.0119 
CG45087 0.36 0.0119 CG45087 0.32 0.0119 
CG10307 0.42 0.0119 CG10307 0.23 0.0119 
Cyt-c-d 0.42 0.0119 Cyt-c-d 0.51 0.0119 
Akh 0.43 0.0217 Akh 0.27 0.0119 
CG12512 0.43 0.0119 CG12512 0.52 0.0119 
Aldh 0.44 0.0119 Aldh 0.52 0.0119 
CG9657 0.45 0.0119 CG9657 0.46 0.0119 
pyd3 0.48 0.0119 pyd3 0.48 0.0119 
CG14075 0.48 0.0119 CG14075 0.28 0.0119 
Hsp70Aa 0.48 0.0217 Hsp70Aa 0.15 0.0119 
CG30059 0.50 0.0303 CG30059 0.53 0.0453 
CG30197 0.50 0.0119 CG30197 0.59 0.0217 
Syt7 0.51 0.0119 Syt7 0.54 0.0119 
Mlc2 0.51 0.0119 Mlc2 0.54 0.0303 
CG15767 0.53 0.0119 CG15767 0.54 0.0119 
GstD3 0.53 0.0119 GstD3 0.61 0.0119 
ND-B14.5B 0.54 0.0217 ND-B14.5B 0.44 0.0119 
MFS9 0.54 0.0119 MFS9 0.47 0.0119 
Csas 0.57 0.0119 Csas 0.58 0.0119 
CG4686 0.58 0.0303 CG4686 0.50 0.0119 
CG10184 0.58 0.0380 CG10184 0.48 0.0119 
CG44325 0.58 0.0119 CG44325 0.53 0.0119 
Cys 0.60 0.0303 Cys 0.39 0.0119 
Nup44A 0.60 0.0303 Nup44A 0.49 0.0119 
CG5955 0.61 0.0453 CG5955 0.60 0.0453 
CG31549 0.61 0.0217 CG31549 0.60 0.0119 
mRpL36 0.63 0.0380 mRpL36 0.54 0.0119 
CG34305 0.21 0.0453 CG32198 0.01 0.0119 
CG5958 0.23 0.0217 GILT3 0.08 0.0119 
Lcp2 0.24 0.0217 Jon99Fi 0.08 0.0453 
Lsp1gamma 0.24 0.0119 GstE8 0.16 0.0119 
Lsp1alpha 0.24 0.0119 CG8087 0.16 0.0119 
CG33099 0.29 0.0119 CG5867 0.21 0.0119 
CG16743 0.30 0.0119 phm 0.21 0.0380 
CG10226 0.33 0.0119 Ugt86Dd 0.23 0.0217 
CG3987 0.42 0.0119 Cyp6g2 0.24 0.0217 
CG14566 0.43 0.0119 CG11300 0.27 0.0119 
CG43980 0.43 0.0303 Hsp70Bbb 0.28 0.0119 
CG6912 0.46 0.0453 CG14545 0.29 0.0119 
CG13067 0.47 0.0453 CG17105 0.29 0.0453 
CG30379 0.57 0.0380 TotA 0.33 0.0380 
vkg 0.59 0.0217 spok 0.33 0.0119 
Klp68D 0.66 0.0303 Pburs 0.33 0.0119 
   Fit2 0.34 0.0380 
   
ImpL3 0.35 0.0119 
   snRNA:U1:95Ca 0.36 0.0119 
   rtet 0.36 0.0119 
   Ugt86Di 0.38 0.0119 
   CG43085 0.38 0.0119 
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   Sec63 0.39 0.0119 
   Tsp42El 0.41 0.0119 
   snoRNA:Me28S-
C3227a 
0.42 0.0119 
   alpha-Est7 0.43 0.0217 
   Elal 0.44 0.0119 
   Dsk 0.45 0.0119 
   su(r) 0.47 0.0119 
   Ada 0.47 0.0119 
   mt:ND2 0.47 0.0119 
   CG14985 0.47 0.0119 
   Gpa2 0.48 0.0380 
   CG9147 0.48 0.0119 
   NPF 0.49 0.0119 
   CG14572 0.50 0.0217 
   mthl8 0.50 0.0119 
   CR46012 0.51 0.0119 
   Ilp2 0.51 0.0119 
   CG43069 0.52 0.0119 
   Lk 0.52 0.0119 
   CG31437 0.52 0.0119 
   CG4036 0.53 0.0119 
   CG4408 0.53 0.0119 
   CG12926 0.54 0.0119 
   Dhfr 0.54 0.0119 
   Ady43A 0.56 0.0119 
   Tspo 0.56 0.0119 
   Cyp12a4 0.56 0.0217 
   Ssb-c31a 0.57 0.0119 
   CG5567 0.57 0.0119 
   CR44922 0.57 0.0119 
   CG17333 0.58 0.0217 
   mre11 0.59 0.0119 
   CG4789 0.59 0.0303 
   asrij 0.59 0.0119 
   Idgf6 0.59 0.0380 
   Capa 0.59 0.0119 
   CG8369 0.60 0.0217 
   RpS15Ab 0.61 0.0303 
   Tsp42Ej 0.61 0.0119 
   dmGlut 0.62 0.0303 
   Arp10 0.62 0.0119 
   CR45044 0.62 0.0453 
   mRpL46 0.62 0.0217 
   CG8778 0.62 0.0380 
   ND-PDSW 0.63 0.0380 
   Taldo 0.63 0.0119 
   veli 0.63 0.0119 
   ND-B14.7 0.63 0.0303 
   CG6723 0.63 0.0453 
   mus205 0.63 0.0217 
   CG8745 0.63 0.0303 
   DNaseII 0.63 0.0217 
   Dbi 0.64 0.0119 
   Cyp9f2 0.64 0.0217 
   CG7630 0.64 0.0303 
   CG12237 0.64 0.0119 
   CG31220 0.64 0.0303 
   CG5037 0.65 0.0217 
   spab 0.65 0.0380 
   Vha36-1 0.65 0.0217 
   ND-30 0.65 0.0303 
   
Arc1 0.66 0.0119 
   
CR43727 0.66 0.0380 
   eca 0.66 0.0119 










8.3.3 Genes upregulated by TFAM o/e (compared to control) and downregulated 
by ATF4 RNAi (compared to TFAM o/e). 
Cut-offs: FPKM ≥ 1 for at least one condition, fold change ≥ 1.5 for upregulated genes, 
≤ 0.67 (equivalent to ≤ -1.5) for downregulated genes, adjusted p value < 0.05. Grey 
shading = gene significantly regulated in both conditions. Bold outline = gene 
downregulated by both TFAM o/e (vs. control) and ATF4 RNAi (vs. TFAM o/e). 
Genes upregulated by TFAM o/e (compared to 
control) 
Genes downregulated by ATF4 RNAi (compared to 
TFAM o/e) 
Gene ID Fold change Adj. p value Gene ID Fold change Adj. p value 
Hsc70-2 54.83975 0.011923 Hsc70-2 0.023551 0.011923 
CG34296 25.11731 0.011923 CG34296 0.032484 0.011923 
Hsp22 5.665409 0.011923 Hsp22 0.099148 0.011923 
thw 6.176074 0.011923 Thw 0.138438 0.011923 
Thor 2.760883 0.011923 Thor 0.181409 0.011923 
ImpL3 3.040566 0.011923 ImpL3 0.227202 0.011923 
CG7587 7.660826 0.011923 CG7587 0.266966 0.011923 
mir-10404-1 2.393713 0.011923 mir-10404-1 0.366509 0.011923 
CR45315 2.64112 0.011923 CR45315 0.443686 0.030286 
Dgp-1 1.682773 0.038022 Dgp-1 0.451444 0.011923 
2SrRNA:CR45836 1.718037 0.011923 2SrRNA:CR45836 0.460371 0.011923 
28SrRNA:CR45837 1.947199 0.011923 28SrRNA:CR45837 0.461739 0.011923 
ImpE2 1.709605 0.021652 ImpE2 0.560237 0.011923 
CR45481 1.759764 0.021652 CR45481 0.560763 0.011923 
CG17684 1.784646 0.011923 CG17684 0.571801 0.011923 
Hex-A 1.746982 0.011923 Hex-A 0.603018 0.021652 
CG15784 5.217541 0.011923 CG15784 0.625984 0.011923 
CG14850 22.87928 0.011923 CG32198 0.086399 0.011923 
Eig71Ee 11.2393 0.011923 Nvd 0.147745 0.011923 
CG31496 9.333512 0.045272 CG8087 0.262768 0.011923 
Sgs7 6.073213 0.011923 Spok 0.293286 0.011923 
Sgs5 5.707465 0.011923 CG9304 0.42645 0.011923 
Sgs3 5.503807 0.011923 Tret1-1 0.449833 0.011923 
CG33500 4.847531 0.011923 CG7386 0.478006 0.011923 
CG1113 3.5937 0.021652 Cpr49Ac 0.500482 0.011923 
Hsp70Bb 3.592056 0.011923 CG10924 0.506765 0.038022 
CG42694 3.542088 0.011923 CG14566 0.509249 0.030286 
Xrp1 2.68083 0.011923 Nlaz 0.552464 0.030286 
Arc1 2.592457 0.011923 AdamTS-A 0.556644 0.011923 
cv-2 2.427767 0.011923 CG16700 0.55732 0.011923 
NKCC 2.282666 0.030286 ImpE1 0.59857 0.011923 
CG42832 2.262911 0.011923 CG4461 0.598629 0.011923 
Gadd45 2.03214 0.011923 CG42240 0.613788 0.038022 
Acf 1.57506 0.045272 28SrRNA:CR45844 0.626306 0.038022 
blw 1.563285 0.030286 CG9416 0.631623 0.038022 
sfl 1.548391 0.030286 Dtg 0.634611 0.011923 
   Hsp67Bc 0.653536 0.011923 
   CG3036 0.659177 0.011923 
   mthl8 0.661428 0.038022 
   MFS3 0.665052 0.021652 
   CG43083 -∞ 0.011923 
   CR44803 -∞ 0.011923 




8.3.4 Genes downregulated by TFAM o/e (compared to control) and upregulated 
by ATF4 RNAi (compared to TFAM o/e). 
Cut-offs: FPKM ≥ 1 for at least one condition, fold change ≥ 1.5 for upregulated genes, 
≤ 0.67 (equivalent to ≤ -1.5) for downregulated genes, adjusted p value < 0.05. Grey 
shading = gene significantly regulated in both conditions. Bold outline = gene 
upregulated by both TFAM o/e (vs. control) and ATF4 RNAi (vs. TFAM o/e). 
Downregulated by TFAM o/e (compared to 
control) 
Upregulated by ATF4 RNAi (compared to TFAM 
o/e) 
Gene ID Fold change Adj. p_value Gene ID Fold change Adj. p value 
Jon99Ciii 0.117642 0.0001 Jon99Ciii 8.719649 5.00E-05 
Lcp4 0.18671 0.00005 Lcp4 4.298431 5.00E-05 
CG42500 0.226998 0.00005 CG42500 3.761792 5.00E-05 
Lcp65Ab1 0.083695 0.00005 Lcp65Ab1 3.53206 0.00025 
Lcp1 0.214003 0.00005 Lcp1 3.409216 5.00E-05 
Lcp3 0.09438 0.00005 Lcp3 3.360556 5.00E-05 
CG43117 0.27702 0.00005 CG43117 3.217834 5.00E-05 
CG6912 0.458022 0.00025 CG6912 2.517846 5.00E-05 
CG3987 0.422537 0.00005 CG3987 2.259181 5.00E-05 
CG43980 0.43324 0.00015 CG43980 2.128962 0.00025 
Cyp28a5 0.35623 0.00005 Cyp28a5 2.10754 0.00025 
Cyt-c-d 0.418054 0.00005 Cyt-c-d 1.870023 5.00E-05 
CG5955 0.608924 0.00025 CG5955 1.639396 0.00025 
CG34166 0.15204 5.00E-05 CG9377 3.575215 0.0002 
Obp99b 0.152081 5.00E-05 CG9737 3.503799 5.00E-05 
Cyp4d1 0.19976 5.00E-05 Trh 2.150437 5.00E-05 
CG2233 0.20667 5.00E-05 GstT3 2.058338 0.0001 
GstE14 0.209291 0.0001 IntS12 1.817772 5.00E-05 
CG34305 0.213528 0.00025 roq 1.81435 0.00015 
Lsp2 0.21608 5.00E-05 Hsp70Bb 1.556655 5.00E-05 
CG5958 0.226131 0.0001    
CG34445 0.228471 5.00E-05    
CG32249 0.24074 5.00E-05    
Lcp2 0.241096 0.0001    
Lsp1gamma 0.242198 5.00E-05    
CG34446 0.24339 5.00E-05    
Lsp1alpha 0.244707 5.00E-05    
Lsp1beta 0.257381 5.00E-05    
CG33099 0.285126 5.00E-05    
CG16743 0.300197 5.00E-05    
CR46006 0.318369 5.00E-05    
CG10226 0.329315 5.00E-05    
CG18278 0.363715 5.00E-05    
CG45087 0.364874 5.00E-05    
CG10307 0.41605 5.00E-05    
Akh 0.426838 0.0001    
CG12512 0.431039 5.00E-05    
CG14566 0.432505 5.00E-05    
Aldh 0.435203 5.00E-05    
CG9657 0.452475 5.00E-05    
CG13067 0.469511 0.00025    
pyd3 0.477575 5.00E-05    
CG14075 0.481214 5.00E-05    
Hsp70Aa 0.482988 0.0001    
CG30059 0.496178 0.00015    
CG30197 0.50129 5.00E-05    
Syt7 0.508668 5.00E-05    
Mlc2 0.514539 5.00E-05    
CG15767 0.527311 5.00E-05    
GstD3 0.529395 5.00E-05    
ND-B14.5B 0.537751 0.0001    
MFS9 0.538352 5.00E-05    
Csas 0.565448 5.00E-05    
CG30379 0.574726 0.0002    
CG4686 0.575607 0.00015    
CG10184 0.57671 0.0002    
CG44325 0.577882 5.00E-05    
vkg 0.59024 0.0001    
Cys 0.600728 0.00015    
Nup44A 0.604107 0.00015    
CG31549 0.612032 0.0001    
mRpL36 0.631517 0.0002    




8.3.5 Gene ontology terms for genes significantly regulated by TFAM o/e, ATF4 o/e 
(both compared to control) or ‘TFAM o/e, ATF4 RNAi’ (compared to TFAM o/e). 
 
Gene ontological biological process terms for genes significantly regulated in RNA-Seq 
analysis for TFAM o/e, ATF4 o/e (both compared to control) and the compound condition 
TFAM o/e, ATF4 RNAi (compared to TFAM o/e). Terms are those found by functional 
annotation software DAVID under the category ‘GOTERM_BP_DIRECT’. Where no 
gene ontological terms were found, FlyBase.org was searched for functional notes, and 
where found these are added in the ‘Biological process gene ontology terms’ column, and 
the gene highlighted by a bold outline.  
Grey shading = genes consistently regulated in all three conditions (i.e. upregulated by 
TFAM o/e, upregulated by ATF4 o/e and downregulated by ATF4 RNAi or the reverse). 
Orange shading = genes consistently regulated by TFAM o/e and ATF4 o/e (i.e. up- or 
downregulated by both conditions), but not significantly regulated by ATF4 RNAi. 
Blue shading = genes consistently regulated by TFAM o/e and ATF4 RNAi (i.e. 
upregulated by TFAM o/e and downregulated by ATF4 RNAi or vice versa), but not 
significantly regulated by ATF4 o/e. 
Green shading  = gene consistently regulated by ATF4 o/e and ATF4 RNAi (i.e. 
upregulated by ATF4 o/e and downregulated by ATF4 RNAi), but not significantly 
regulated by TFAM o/e. 
U = upregulated, D = downregulated, X = not significantly regulated. 
 


















































CG17684 CG17684 GO:0006508~proteolysis U U D 
ImpE2 
Ecdysone-
inducible gene E2 
GO:0007561~imaginal disc eversion U U D 
Thor Thor 
GO:0001558~regulation of cell growth 
GO:0006641~triglyceride metabolic process 
GO:0006955~immune response 
GO:0006979~response to oxidative stress 




GO:0007525~somatic muscle development 
GO:0008340~determination of adult 
lifespan 
GO:0009617~response to bacterium 
GO:0019731~antibacterial humoral 
response 
GO:0042594~response to starvation 
GO:0045792~negative regulation of cell 
size 
GO:0045947~negative regulation of 
translational initiation 
GO:0070129~regulation of mitochondrial 
translation 





GO:0001666~response to hypoxia 
GO:0006986~response to unfolded protein 
GO:0009408~response to heat 
GO:0031427~response to methotrexate 
GO:0035080~heat shock-mediated polytene 
chromosome puffing 






GO:0006333~chromatin assembly or 
disassembly 
GO:0006334~nucleosome assembly 
GO:0006355~regulation of transcription, 
DNA-templated 
GO:0007399~nervous system development 
GO:0007517~muscle organ development 
GO:0008544~epidermis development 
GO:0016584~nucleosome positioning 
GO:0019233~sensory perception of pain 




GO:0043462~regulation of ATPase activity 








GO:0015986~ATP synthesis coupled proton 
transport 
GO:0015991~ATP hydrolysis coupled 
proton transport 
GO:0015992~proton transport 
GO:0019233~sensory perception of pain 
GO:0019915~lipid storage 
GO:0022900~electron transport chain 
GO:0040007~growth 
GO:1902769~regulation of choline O-
acetyltransferase activity 
U U X 
CG1113 CG1113  U U X 
CG14850 CG14850  U U X 




GO:0006790~sulfur compound metabolic 
process 
U U X 
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GO:0007427~epithelial cell migration, open 
tracheal system 
GO:0007428~primary branching, open 
tracheal system 
GO:0007474~imaginal disc-derived wing 
vein specification 
GO:0007507~heart development 
GO:0007509~mesoderm migration involved 
in gastrulation 
GO:0008543~fibroblast growth factor 
receptor signaling pathway 
GO:0008587~imaginal disc-derived wing 
margin morphogenesis 
GO:0015012~heparan sulfate proteoglycan 
biosynthetic process 
GO:0015014~heparan sulfate proteoglycan 
biosynthetic process, polysaccharide chain 
biosynthetic process 
GO:0016055~Wnt signaling pathway 
GO:0030210~heparin biosynthetic process 
GO:0045570~regulation of imaginal disc 
growth 
GO:0048312~intracellular distribution of 
mitochondria 
GO:0048488~synaptic vesicle endocytosis 
GO:0060828~regulation of canonical Wnt 
signaling pathway 







GO:0003012~muscle system process 
GO:0042595~behavioral response to 
starvation 
U D X 
ImpL3 
Ecdysone-




GO:0007525~somatic muscle development 
GO:0019752~carboxylic acid metabolic 
process 
GO:0055114~oxidation-reduction process 
U D D 
CG15784 CG15784  U X D 
CG34296 CG34296  U X D 
CG7587 CG7587  U X D 
Dgp-1 Dgp-1 GO:0006414~translational elongation, U X D 
Hex-A Hexokinase A 




U X D 
Hsc70-2 
Heat shock protein 
cognate 2 
GO:0006457~protein folding U X D 
Hsp22 
Heat shock protein 
22 
GO:0006979~response to oxidative stress 
GO:0008340~determination of adult 
lifespan 
GO:0009408~response to heat 
GO:0061077~chaperone-mediated protein 
folding 







 U X D 
CR45315 CR45315  U X D 
CR45481 CR45481  U X D 
mir-10404-1 mir-10404-1  U X D 









U X X 
CG33500 CG33500  U X X 
CG42832 CG42832  U X X 
cv-2 crossveinless 2 
GO:0007474~imaginal disc-derived wing 
vein specification 
GO:0007476~imaginal disc-derived wing 
morphogenesis 
GO:0030510~regulation of BMP signaling 
pathway 






U X X 
Gadd45 Gadd45 
GO:0007254~JNK cascade 
GO:0046662~regulation of oviposition 
GO:0051726~regulation of cell cycle 












Salivary glue protein U X X 
Xrp1 Xrp1 
GO:0007476~imaginal disc-derived wing 
morphogenesis 










Cation-coupled chloride transporter U X X 
CG42500 CG42500  D D U 
CG43117 CG43117  D D U 
CG5955 CG5955 NAD-dependent epimerase/dehydratase  D D U 
Cyp28a5 Cyp28a5 
GO:0046680~response to DDT 
GO:0046701~insecticide catabolic process 
GO:0055114~oxidation-reduction process 






transport, ubiquinol to cytochrome c 
GO:0006123~mitochondrial electron 
transport, cytochrome c to oxygen 
GO:0006919~activation of cysteine-type 
endopeptidase activity involved in apoptotic 
process 
GO:0007291~sperm individualization 
GO:0046669~regulation of compound eye 
retinal cell programmed cell death 
GO:0055114~oxidation-reduction process 
D D U 
























D D U 
Lcp65Ab1 Lcp65Ab1 










GO:0010906~regulation of glucose 
metabolic process 
GO:0033500~carbohydrate homeostasis 
GO:0042594~response to starvation 
GO:0055088~lipid homeostasis 




GO:0006090~pyruvate metabolic process 
GO:0006117~acetaldehyde metabolic 
process 
GO:0045471~response to ethanol 
GO:0055114~oxidation-reduction process 
GO:1901215~negative regulation of neuron 
death 
D D X 
CG10184 CG10184 
GO:0006520~cellular amino acid metabolic 
process 
GO:0006545~glycine biosynthetic process 
GO:0006567~threonine catabolic process 
D D X 
CG10307 CG10307 Leucine-rich repeat D D X 
CG12512 CG12512 GO:0008152~metabolic process D D X 









D D X 




D D X 
CG30197 CG30197 Peptidase inhibitor activity D D X 
CG31549 CG31549 Oxidoreductase activity D D X 
CG32249 CG32249  D D X 
CG34166 CG34166  D D X 
CG34445 CG34445 
LPS-induced tumour necrosis factor alpha 
factor  
D D X 
CG34446 CG34446 
LPS-induced tumour necrosis factor alpha 
factor  
D D X 
CG44325 CG44325  D D X 
CG45087 CG45087  D D X 
CG4686 CG4686  D D X 






D D X 
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GO:0006749~glutathione metabolic process 








GO:0001666~response to hypoxia 
GO:0006986~response to unfolded protein 
GO:0009408~response to heat 
GO:0035080~heat shock-mediated polytene 
chromosome puffing 
D D X 
Lsp1beta 
Larval serum 
protein 1 beta 




GO:0008045~motor neuron axon guidance 
GO:0016201~synaptic target inhibition 







D D X 
Mlc2 
Myosin light chain 
2 
GO:0003012~muscle system process 
GO:0030239~myofibril assembly 
GO:0060361~flight 












B14.5 B subunit 
GO:0006120~mitochondrial electron 
transport, NADH to ubiquinone 








GO:0007346~regulation of mitotic cell 
cycle 
GO:0010507~negative regulation of 
autophagy 
GO:0032008~positive regulation of TOR 
signaling 
GO:0034198~cellular response to amino 
acid starvation 
GO:0045793~positive regulation of cell size 
GO:0048477~oogenesis 
GO:0051445~regulation of meiotic cell 
cycle 
GO:1903432~regulation of TORC1 
signaling 





GO:0007606~sensory perception of 
chemical stimulus 
GO:0007608~sensory perception of smell 
GO:0019236~response to pheromone 
GO:0035071~salivary gland cell autophagic 
cell death 
GO:0042048~olfactory behavior 
GO:0048102~autophagic cell death 




GO:0006207~'de novo' pyrimidine 
nucleobase biosynthetic process 
GO:0006208~pyrimidine nucleobase 
catabolic process 
GO:0006807~nitrogen compound metabolic 
process 
D D X 




GO:0016079~synaptic vesicle exocytosis 
GO:0016192~vesicle-mediated transport 
GO:0017158~regulation of calcium ion-
dependent exocytosis 
GO:0048791~calcium ion-regulated 
exocytosis of neurotransmitter 
D D X 
CR46006 CR46006  D D X 
CG3987 CG3987 GO:0007498~mesoderm development D X U 
CG43980 CG43980 
GO:0030162~regulation of proteolysis 
GO:0042787~protein ubiquitination 
involved in ubiquitin-dependent protein 
catabolic process 
GO:0043161~proteasome-mediated 
ubiquitin-dependent protein catabolic 
process 
D X U 
CG6912 CG6912  D X U 
CG14566 CG14566  D X D 
CG10226 CG10226 
GO:0031427~response to methotrexate 
GO:0055085~transmembrane transport 
D X X 
CG13067 CG13067  D X X 
CG16743 CG16743  D X X 
CG30379 CG30379 Bax inhibitor 1-related D X X 
CG33099 CG33099 GO:0055114~oxidation-reduction process D X X 
CG34305 CG34305  D X X 
CG5958 CG5958 GO:0006810~transport D X X 
Klp68D 
Kinesin-like 
protein at 68D 
GO:0007018~microtubule-based movement 
GO:0007608~sensory perception of smell 
GO:0008089~anterograde axonal transport 
GO:0030951~establishment or maintenance 
of microtubule cytoskeleton polarity 








D X X 
Lsp1alpha 
Larval serum 
protein 1 alpha 
Hemocyanin domains D X X 
Lsp1gamma 
Larval serum 
protein 1 gamma 




GO:0007519~skeletal muscle tissue 
development 
GO:0061327~anterior Malpighian tubule 
development 
D X X 
ImpE1 
Ecdysone-
inducible gene E1 




GO:0007186~G-protein coupled receptor 
signaling pathway 
X U X 
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GO:0007187~G-protein coupled receptor 
signaling pathway, coupled to cyclic 




GO:0000122~negative regulation of 
transcription from RNA polymerase II 
promoter 
GO:0035074~pupation 
GO:0035152~regulation of tube 
architecture, open tracheal system 
GO:0071390~cellular response to ecdysone 
X U X 
CG11700 CG11700 
GO:0008340~determination of adult 
lifespan 
GO:0016567~protein ubiquitination 
GO:2000242~negative regulation of 
reproductive process 
X U X 
CG15021 CG15021  X U X 
CG15864 CG15864 GO:0055114~oxidation-reduction process X U X 
CG17211 CG17211 GO:0060562~epithelial tube morphogenesis X U X 
CG34232 CG34232  X U X 
CG43901 CG43901  X U X 




GO:0006032~chitin catabolic process 














GO:0006355~regulation of transcription, 
DNA-templated 






GO:0006919~activation of cysteine-type 




GO:0035071~salivary gland cell autophagic 
cell death 
GO:0035072~ecdysone-mediated induction 
of salivary gland cell autophagic cell death 
GO:0035096~larval midgut cell 
programmed cell death 
GO:0045893~positive regulation of 
transcription, DNA-templated 
GO:0045944~positive regulation of 
transcription from RNA polymerase II 
promoter 
GO:0048102~autophagic cell death 
GO:0071390~cellular response to ecdysone 
GO:0071456~cellular response to hypoxia 
X U X 
Indy I'm not dead yet 
GO:0006814~sodium ion transport 
GO:0006848~pyruvate transport 
GO:0008340~determination of adult 
lifespan 
X U X 
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jeb jelly belly 
GO:0007411~Axon guidance 
GO:0007435~salivary gland morphogenesis 
GO:0007509~mesoderm migration involved 
in gastrulation 
GO:0007522~visceral muscle development 
GO:0042051~compound eye photoreceptor 
development 
GO:0042694~muscle cell fate specification 
GO:0043410~positive regulation of MAPK 
cascade 
GO:0051124~synaptic growth at 
neuromuscular junction 
GO:1900074~negative regulation of 
neuromuscular synaptic transmission 
X U X 








GO:0007015~actin filament organization 
GO:0007205~protein kinase C-activating G-
protein coupled receptor signaling pathway 
GO:0007601~visual perception 
GO:0007602~phototransduction 
GO:0007605~sensory perception of sound 
GO:0007608~sensory perception of smell 
GO:0016056~rhodopsin mediated signaling 
pathway 








GO:0046154~rhodopsin metabolic process 
GO:0046834~lipid phosphorylation 
X U X 
Rgk2 
Rad, Gem/Kir 
family member 2 
GO:0007264~small GTPase mediated signal 
transduction 
GO:1901386~negative regulation of 
voltage-gated calcium channel activity 
X U X 
Sec31 Sec31 ortholog  
GO:0045089~positive regulation of innate 
immune response 
GO:0050829~defense response to Gram-
negative bacterium 
GO:0090114~COPII-coated vesicle budding 
X U X 
SelG Selenoprotein G 
GO:0001700~embryonic development via 
the syncytial blastoderm 
GO:0002376~immune system process 
GO:0006816~calcium ion transport 
GO:0007350~blastoderm segmentation 
GO:0008340~determination of adult 
lifespan 
GO:0009790~embryo development 
GO:0010470~regulation of gastrulation 




calcium ion homeostasis 
GO:0045454~cell redox homeostasis 
spg sponge 
GO:0007264~small GTPase mediated signal 
transduction 
GO:0007417~central nervous system 
development 
GO:0045466~R7 cell differentiation 
GO:0090630~activation of GTPase activity 
X U X 
CR44027 CR44027  X U X 
CR46004 CR46004  X U X 
trv trivet RNA-binding domain superfamily X U X 
CG32198 CG32198  X D D 
CG8087 CG8087  X D D 
mthl8 methuselah-like 8 
GO:0006950~response to stress 
GO:0007186~G-protein coupled receptor 
signaling pathway 
GO:0008340~determination of adult 
lifespan 
GO:0042594~response to starvation 
X D D 
spok spookier 
GO:0006697~ecdysone biosynthetic process 
GO:0007591~molting cycle, chitin-based 
cuticle 
GO:0055114~oxidation-reduction process 




GO:0006154~adenosine catabolic process 
GO:0009117~nucleotide metabolic process 
GO:0046103~inosine biosynthetic process 
X D X 
Ady43A Ady43A Carbohydrate/purine kinase X D X 
alpha-Est7 alpha-Esterase-7 
GO:0007158~neuron cell-cell adhesion 
GO:0007416~synapse assembly 
GO:0008340~determination of adult 
lifespan 
GO:0019915~lipid storage 
GO:0046683~response to organophosphorus 
GO:0050804~modulation of synaptic 
transmission 






GO:0019233~sensory perception of pain 
X D X 
asrij asrij 
GO:0035162~embryonic hemopoiesis 
GO:0035167~larval lymph gland 
hemopoiesis 
GO:0046425~regulation of JAK-STAT 
cascade 
GO:0048542~lymph gland development 
X D X 
Capa Capability 
GO:0006812~cation transport 
GO:0007204~positive regulation of 





GO:0042045~epithelial fluid transport 
X D X 




X D X 
CG12926 CG12926 GO:0006810~transport X D X 
CG14545 CG14545  X D X 
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CG14572 CG14572  X D X 
CG14985 CG14985  X D X 
CG15083 CG15083  X D X 





X D X 
CG31220 CG31220 GO:0006508~proteolysis X D X 
CG31437 CG31437 Collagen triple helix repeat X D X 
CG4036 CG4036 




X D X 
CG43069 CG43069 Ubiquitin domain X D X 
CG43085 CG43085  X D X 
CG4408 CG4408 GO:0006508~proteolysis X D X 
CG4789 CG4789 
GO:0007264~small GTPase mediated signal 
transduction 
X D X 
CG5037 CG5037 
GO:0006783~heme biosynthetic process 
GO:0008535~respiratory chain complex IV 
assembly 
GO:0048034~heme O biosynthetic process 
GO:1902600~hydrogen ion transmembrane 
transport 









X D X 
CG6723 CG6723 GO:0055085~transmembrane transport X D X 
CG7630 CG7630 Deltamethrin resistance X D X 
CG8369 CG8369 
GO:0048190~wing disc dorsal/ventral 
pattern formation 
X D X 
CG8745 CG8745 
GO:0019544~arginine catabolic process to 
glutamate 
GO:0035094~response to nicotine 
X D X 
CG8778 CG8778 
GO:0006635~fatty acid beta-oxidation 
GO:0008152~metabolic process 
GO:0009631~cold acclimation 
X D X 
CG9147 CG9147 
GO:0006635~fatty acid beta-oxidation 
GO:0008152~metabolic process 
X D X 
Cyp12a4 Cyp12a4 
GO:0017085~response to insecticide 
GO:0055114~oxidation-reduction process 
X D X 
Cyp6g2 Cyp6g2 
GO:0017085~response to insecticide 
GO:0046680~response to DDT 
GO:0046701~insecticide catabolic process 
GO:0055114~oxidation-reduction process 
X D X 
Cyp9f2 Cyp9f2 
GO:0035220~wing disc development 
GO:0055114~oxidation-reduction process 












GO:0006545~glycine biosynthetic process 
GO:0006730~one-carbon metabolic process 
GO:0009165~nucleotide biosynthetic 
process 





















GO:0006259~DNA metabolic process 
GO:0006308~DNA catabolic process 
GO:0006309~apoptotic DNA fragmentation 
GO:0030431~sleep 
GO:0045476~nurse cell apoptotic process 
X D X 
Dsk Drosulfakinin 
GO:0006939~smooth muscle contraction 
GO:0006940~regulation of smooth muscle 
contraction 
GO:0007204~positive regulation of 





GO:0008343~adult feeding behavior 
GO:0008344~adult locomotory behavior 
GO:0008345~larval locomotory behavior 
GO:0033555~multicellular organismal 
response to stress 










GO:0034389~lipid particle organization 
GO:0035220~wing disc development 
GO:0048042~regulation of post-mating 
oviposition 
GO:0048193~Golgi vesicle transport 
GO:0061357~positive regulation of Wnt 
protein secretion 
GO:0070863~positive regulation of protein 
exit from endoplasmic reticulum 
GO:0090263~positive regulation of 
canonical Wnt signaling pathway 
X D X 
Elal Elastin-like GO:0035094~response to nicotine X D X 
Fit2 Fermitin 2 
GO:0048738~cardiac muscle tissue 
development 







GO:0055114~oxidation-reduction process X D X 
Gpa2 
Glycoprotein 








GO:0006749~glutathione metabolic process X D X 
Hsp70Bbb Hsp70Bbb 
GO:0001666~response to hypoxia 
GO:0009408~response to heat 
X D X 
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GO:0008284~positive regulation of cell 
proliferation 
GO:0008286~insulin receptor signaling 
pathway 
GO:0008340~determination of adult 
lifespan 
GO:0008361~regulation of cell size 
GO:0009758~carbohydrate utilization 
GO:0010906~regulation of glucose 
metabolic process 





GO:0040009~regulation of growth rate 
GO:0040014~regulation of multicellular 
organism growth 
GO:0040018~positive regulation of 
multicellular organism growth 
GO:0045475~locomotor rhythm 
GO:0046620~regulation of organ growth 
GO:0046626~regulation of insulin receptor 
signaling pathway 
GO:0060180~female mating behavior 
GO:0060250~germ-line stem-cell niche 
homeostasis 
GO:0070328~triglyceride homeostasis 
GO:0071333~cellular response to glucose 
stimulus 
GO:2000252~negative regulation of feeding 
behavior 
X D X 
Jon99Fi Jonah 99Fi GO:0006508~proteolysis X D X 
Lk Leucokinin 
GO:0007204~positive regulation of 
cytosolic calcium ion concentration 
GO:0007218~neuropeptide signaling 
pathway 
GO:0007589~body fluid secretion 
GO:2000252~negative regulation of feeding 
behavior 





GO:0006302~double-strand break repair 
GO:0006974~cellular response to DNA 
damage stimulus 
GO:0007095~mitotic G2 DNA damage 
checkpoint 
GO:0016233~telomere capping 
GO:0031573~intra-S DNA damage 
checkpoint 
GO:0051276~chromosome organization 
GO:0051321~meiotic cell cycle 





GO:0019233~sensory perception of pain 
GO:0032543~mitochondrial translation 

















kDa subunit  
GO:0055114~oxidation-reduction process 
GO:0072593~reactive oxygen species 
metabolic process 













transport, NADH to ubiquinone 
GO:0022008~neurogenesis 
X D X 
NPF neuropeptide F 






GO:0008049~male courtship behavior 
GO:0008345~larval locomotory behavior 
GO:0030536~larval feeding behavior 
GO:0032095~regulation of response to food 
GO:0035176~social behavior 
GO:0035177~larval foraging behavior 
GO:0045475~locomotor rhythm 
GO:0048512~circadian behavior 








GO:0018990~ecdysis, chitin-based cuticle 
GO:0090175~regulation of establishment of 
planar polarity 






GO:0006518~peptide metabolic process 
GO:0007613~memory 
GO:0009620~response to fungus 
GO:0032504~multicellular organism 
reproduction 
GO:0044719~regulation of imaginal disc-
derived wing size 













X D X 




RNA U1 at 95Ca 
GO:0000398~mRNA splicing, via 
spliceosome 






GO:0045892~negative regulation of 
transcription, DNA-templated 




GO:0006207~'de novo' pyrimidine 
nucleobase biosynthetic process 
GO:0006212~uracil catabolic process 
GO:0055114~oxidation-reduction process 





X D X 
TotA Turandot A GO:0006979~response to oxidative stress X D X 
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GO:0009408~response to heat 
GO:0009409~response to cold 
GO:0009411~response to UV 
GO:0009414~response to water deprivation 
GO:0009612~response to mechanical 
stimulus 
GO:0009617~response to bacterium 
GO:0034599~cellular response to oxidative 
stress 
GO:0034605~cellular response to heat 
GO:0034644~cellular response to UV 
GO:0042742~defense response to bacterium 
GO:0045087~innate immune response 
GO:0046689~response to mercury ion 
GO:0051597~response to methylmercury 
GO:0071260~cellular response to 
mechanical stimulus 
Tsp42Ej Tetraspanin 42Ej 
GO:0006897~endocytosis 
GO:0071486~cellular response to high light 
intensity 
X D X 
Tsp42El Tetraspanin 42El 
GO:0007166~cell surface receptor signaling 
pathway 
GO:0030431~sleep 




GO:0002082~regulation of oxidative 
phosphorylation 
GO:0008340~determination of adult 
lifespan 
GO:0043065~positive regulation of 
apoptotic process 












X D X 
veli veli 
GO:0006887~exocytosis 
GO:0007163~establishment or maintenance 
of cell polarity 
GO:0007269~neurotransmitter secretion 
GO:0007298~border follicle cell migration 
GO:0008582~regulation of synaptic growth 
at neuromuscular junction 
GO:0045199~maintenance of epithelial cell 
apical/basal polarity 
GO:1903361~protein localization to 
basolateral plasma membrane 





GO:0015991~ATP hydrolysis coupled 
proton transport 
GO:0015992~proton transport 
X D X 
CR43727 CR43727  X D X 
CR44922 CR44922  X D X 
CR45044 CR45044  X D X 
CR46012 CR46012  X D X 
Idgf6 
Imaginal disc 
growth factor 6 














 X D X 
spab Space blanket  X D X 








GO:0006749~glutathione metabolic process X X U 
IntS12 Integrator 12 
GO:0016180~snRNA processing 
GO:0022008~neurogenesis 
GO:0034472~snRNA 3'-end processing 
X X U 
roq roquin GO:0000209~protein polyubiquitination X X U 
Trh trachealess 
GO:0006351~transcription, DNA-templated 
GO:0006355~regulation of transcription, 
DNA-templated 
GO:0006366~transcription from RNA 
polymerase II promoter 
GO:0007424~open tracheal system 
development 
GO:0007425~epithelial cell fate 
determination, open tracheal system 
GO:0007431~salivary gland development 
GO:0007435~salivary gland morphogenesis 
GO:0007443~Malpighian tubule 
morphogenesis 
GO:0035277~spiracle morphogenesis, open 
tracheal system 
GO:0045944~positive regulation of 





GO:0072175~epithelial tube formation 






type 1 motif A 
GO:0006508~proteolysis 
GO:0007280~pole cell migration 
GO:0007427~epithelial cell migration, open 
tracheal system 
GO:0007436~larval salivary gland 
morphogenesis 
GO:0008078~mesodermal cell migration 
GO:0030198~extracellular matrix 
organization 
X X D 
CG10924 CG10924 GO:0006094~gluconeogenesis X X D 
CG16700 CG16700 
GO:0003333~amino acid transmembrane 
transport 
GO:0022008~neurogenesis 




X X D 
CG42240 CG42240  X X D 
CG43083 CG43083  X X D 
CG4461 CG4461 GO:0009408~response to heat X X D 
CG7386 CG7386 
GO:0006355~regulation of transcription, 
DNA-templated 
GO:0022008~neurogenesis 
X X D 
CG9304 CG9304 
GO:0007186~G-protein coupled receptor 
signaling pathway 
X X D 
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GO:0019236~response to pheromone 







X X D 
Dtg Dpp target gene GO:0007369~gastrulation X X D 
Hsp67Bc 
Heat shock gene 
67Bc 
GO:0006497~protein lipidation 
GO:0009408~response to heat 
GO:0010506~regulation of autophagy 
GO:0010998~regulation of translational 
initiation by eIF2 alpha phosphorylation 
GO:0031427~response to methotrexate 







X X D 
NLaz Neural Lazarillo 
GO:0006979~response to oxidative stress 






X X D 
nvd neverland 
GO:0002168~instar larval development 
GO:0007552~metamorphosis 


















 X X D 
CR44522 CR44522  X X D 













8.3.6 Genes significantly regulated in RNA-Seq analysis that were excluded from 
DAVID functional annotation clustering analysis. 
The following genes with ontological and functional terms relating solely to non-CNS 
structural components of the larvae were excluded from functional annotation cluster 
analysis to permit identification of CNS-related clusters. Ontological and functional 
terms were searched in DAVID, Panther (PantherDB.org) and FlyBase (FlyBase.org). 
Gene symbol Gene name  
Sgs3 Salivary glue protein Sgs-3 
Sgs5 Salivary glue protein Sgs-5 
Sgs7 Salivary glue protein Sgs-7 
Lcp1 Larval cuticle protein 1 
Lcp2 Larval cuticle protein 2 
Lcp3 Larval cuticle protein 3 
Lcp4 Larval cuticle protein 4 
Lcp65Ab1 Larval cuticle protein 5 
Lsp1alpha Larval serum protein 1 alpha chain 
Lsp1gamma Larval serum protein 1 gamma chain 
thw thawb (Chitin binding) 
CG33500 Assigned as Sgs8 by DAVID & Panther 
CG42832 Assigned as Mucin68Ca by DAVID & Panther 
Eig71Ee Ecdysone-induced gene 71Ee (salivary glue/hemolymph clot) 
Mlc2 Myosin light chain 2 
Cht5 Chitinase 5 
Cpr49Ae Cuticular protein 49Ae 
Idgf6 Imaginal disc growth factor 6 
Cpr49Ac Cuticular protein 49Ac 
 
 
 
 
 
 
 
 
 
